Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,42222,-0.225485851620023,0.00529619782677868,-0.23586639936051,-0.215105303879537,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,41771,-0.608702919227851,0.0125614954734794,-0.633323450355871,-0.584082388099831,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,39895,-0.379730804101372,0.00877081644518323,-0.396921604333931,-0.362540003868813,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42097,-0.223915413080902,0.0052234706880411,-0.234153415629463,-0.213677410532342,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,42063,-0.259998983133458,0.00444142552459183,-0.268704177161658,-0.251293789105258,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,42187,-0.299277837389493,0.00645490973319819,-0.311929460466562,-0.286626214312425,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39904,-0.167685935827881,0.00399408211160463,-0.175514336766626,-0.159857534889136,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,39927,0.230059939772386,0.00596396394056382,0.218370570448881,0.241749309095891,5.64377337530828e-306
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,42091,-0.333503210924894,0.00886018134036579,-0.350869166352011,-0.316137255497777,6.24083201352634e-295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,42007,-0.161218215617656,0.00436269487870055,-0.169769097579909,-0.152667333655403,9.35303271099852e-285
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42213,0.47150592443393,0.013310686121678,0.445416979635441,0.497594869232419,5.39112422203071e-263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,41995,-0.325271246452065,0.00921975018741703,-0.343341956819403,-0.307200536084728,8.45438347981348e-261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,39512,-0.35442129668571,0.0104853265861907,-0.374972536794644,-0.333870056576776,2.75606976601387e-238
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,41972,-0.252537735365197,0.00752364944421801,-0.267284088275865,-0.23779138245453,3.18185067485481e-237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,42072,0.169405919005917,0.00506666223839474,0.159475261018664,0.179336576993171,1.53953556250252e-235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,42072,-0.219008679500388,0.00663677347080252,-0.232016755503161,-0.206000603497615,1.01883621234296e-229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41828,-0.28160524394498,0.00861249939845309,-0.298485742765948,-0.264724745124012,1.42601456425013e-225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42111,0.0990340172032568,0.00310657814148752,0.0929451240459413,0.105122910360572,4.37879359373715e-215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39858,-0.187020930805999,0.00597744216129799,-0.198736717442143,-0.175305144169855,3.90918675803188e-206
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FURIN,Furin,42108,-0.108551948855129,0.0035064375296715,-0.115424566413285,-0.101679331296972,2.31544372004286e-203
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,39895,-0.290583331864575,0.00959051689872478,-0.309380744986075,-0.271785918743074,5.97744717119365e-194
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42108,0.106371331926732,0.00352528343191238,0.0994617764001842,0.113280887453281,1.28752477065035e-193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,42172,-0.37751959013271,0.0127526208122881,-0.402514726924794,-0.352524453340625,1.08933061582491e-186
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,42063,-0.123997721009666,0.00421436082380698,-0.132257868224327,-0.115737573795004,1.81974717602992e-184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42048,-0.164833978663639,0.0056409996828978,-0.175890338042118,-0.153777619285159,4.85624544857505e-182
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,41842,-0.255625708132843,0.00878780809371786,-0.27284981199653,-0.238401604269156,2.20536751302779e-180
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,39917,0.212038705823267,0.00727184908107046,0.197785881624369,0.226291530022165,2.70430931576745e-180
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,42121,-0.105017044060352,0.00361791441463924,-0.112108156313045,-0.0979259318076594,9.23814887425021e-180
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,39927,0.0793667195312749,0.00274835550531586,0.0739799427408558,0.084753496321694,5.32160260579164e-177
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41943,-0.0919732065243719,0.00322336237200763,-0.0982909967735069,-0.085655416275237,7.11673684828836e-174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,42017,-0.30923538367119,0.0109782021306236,-0.330752659847212,-0.287718107495168,1.18092086323846e-169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42174,-0.434130782913188,0.0154488628822271,-0.464410554162353,-0.403851011664023,6.19093796816647e-169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,42072,-0.186455893567283,0.00666693114053479,-0.199523078602731,-0.173388708531835,2.33822493930716e-167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39675,0.0912243996298741,0.00326798602176728,0.0848191470272102,0.0976296522325379,8.94398377819399e-166
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39849,-0.2562939649164,0.00921066191547292,-0.274346862270727,-0.238241067562073,7.47363954487729e-165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41828,-0.191791973688279,0.00694746886199255,-0.205409012657785,-0.178174934718774,3.78210003221237e-163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,39590,-0.245287845383142,0.0088653109981663,-0.262663854939548,-0.227911835826736,5.95225459041302e-163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,41154,-0.121549051628927,0.00441445132900337,-0.130201376233774,-0.112896727024081,4.22275409028453e-162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,39927,0.136978812977484,0.0049910921679412,0.127196272328319,0.146761353626649,1.34257643815308e-160
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41828,-0.159229785265098,0.00581627410221841,-0.170629682505446,-0.14782988802475,1.48693601907028e-160
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42046,-0.247177718857438,0.0090582316946215,-0.264931852978896,-0.22942358473598,1.27162197140021e-159
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42155,-0.138948188330058,0.00516697078592977,-0.149075451070481,-0.128820925589636,3.13757124336482e-155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,41995,-0.220502425754199,0.00832253272158822,-0.236814589888512,-0.204190261619886,8.30167055290403e-151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39575,-0.142062840692556,0.00540767754605212,-0.152661888682818,-0.131463792702294,1.43080162309265e-147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41847,-0.407409333542264,0.015624036533934,-0.438032445148774,-0.376786221935753,3.24785071124407e-146
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,39675,-0.0776162921790891,0.00301384034816133,-0.0835234192614853,-0.0717091650966929,4.28224452222093e-142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,42063,0.0732753029328675,0.00289025801587765,0.0676103972217473,0.0789402086439877,1.46325168255887e-138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,42222,-0.0787477231721872,0.00312541237077202,-0.0848735314189003,-0.072621914925474,5.9261638998151e-137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41864,0.144993072620262,0.0057918832016483,0.133640981545032,0.156345163695493,3.50830881213655e-135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42187,-0.0864472372119993,0.00346462107187235,-0.0932378945128692,-0.0796565799111295,2.13565068166997e-134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41771,-0.206199759278089,0.00828880537425123,-0.222445817811622,-0.189953700744557,1.56042177641036e-133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42029,-0.0769412335801804,0.00311431811379698,-0.0830452970832225,-0.0708371700771384,7.97953046160981e-132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41771,-0.172596050398383,0.00700884711302735,-0.186333390739916,-0.158858710056849,6.02750901868286e-131
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,41995,-0.148129550056665,0.00603900607196688,-0.15996600195772,-0.13629309815561,5.26066119353564e-130
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42213,0.158882692342456,0.00648024548975067,0.146181411182544,0.171583973502367,6.12083495977516e-130
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,42056,0.466999213772128,0.0190789222629933,0.429604526136661,0.504393901407595,1.7163522622095e-129
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,42149,-0.127613425283182,0.00522165815224448,-0.137847875261581,-0.117378975304783,4.00669577503215e-129
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42165,-0.0826656188989049,0.00341077688890083,-0.0893507416011506,-0.0759804961966593,4.5235565184255e-127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,42236,-0.132465355235191,0.00551203480594825,-0.143268943454849,-0.121661767015532,5.03163824653095e-125
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39422,-0.083096609211728,0.0034630543085329,-0.0898841956564525,-0.0763090227670035,5.22657308006004e-124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41771,-0.215592832034456,0.00903952479313443,-0.233310300628999,-0.197875363439912,4.04835017719955e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41771,-0.153414879888479,0.00645131227413151,-0.166059451945777,-0.140770307831181,1.98916143282555e-122
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41995,-0.203956863048709,0.00859567076791781,-0.220804377753828,-0.187109348343591,5.99798596816045e-122
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39868,-0.19625401118503,0.00826326641588582,-0.212450013360166,-0.180058009009894,1.03964024036316e-121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFM,Afamin,39917,-0.0513824474248263,0.00216786293386739,-0.0556314587752063,-0.0471334360744462,3.01431607760266e-121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41995,-0.214296578401249,0.00916889409431487,-0.232267610826106,-0.196325545976391,1.89625418162003e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,39575,-0.158034341634355,0.006767326452805,-0.171298301481853,-0.144770381786858,9.37614030931093e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,42063,-0.0707598348577571,0.00304262144335793,-0.0767233728867386,-0.0647962968287756,2.49186778837778e-117
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41995,-0.171258676743786,0.00738616922604722,-0.185735568426838,-0.156781785060733,1.21879168773797e-116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,39869,-0.189807483071393,0.00817644338526451,-0.205833312106512,-0.173781654036275,1.73569295426246e-116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,42119,-0.077355886035009,0.00334336731482447,-0.083908885972065,-0.070802886097953,3.49261884038577e-116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,42187,-0.0838643016271348,0.003627212026348,-0.0909736371987769,-0.0767549660554928,4.89198329806662e-116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39895,-0.0699231629122055,0.00302586346524776,-0.0758538553040912,-0.0639924705203199,1.76937123511059e-115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,41766,-0.129754789527933,0.00567985380325905,-0.140887302982321,-0.118622276073546,2.59338255585616e-113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42039,-0.125647990266131,0.00557065029150751,-0.136566464837486,-0.114729515694776,1.3281207327575e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39667,-0.117842851083749,0.00521682380586716,-0.128067825743249,-0.107617876424249,1.71088711343143e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41995,-0.205850334103925,0.00914685496233937,-0.22377816983011,-0.18792249837774,4.02780463190835e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42198,-0.123548600192702,0.00551017204365113,-0.134348537398258,-0.112748662987146,2.28500699728597e-109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,42118,-0.0788303322642141,0.00355970796922909,-0.0858073598839031,-0.0718533046445251,9.09549598182986e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,42236,-0.120299632855598,0.00544272235062438,-0.130967368662822,-0.109631897048374,2.16874984119741e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELN,Elastin,39895,-0.0827732883819226,0.00374247921296218,-0.0901085476393285,-0.0754380291245167,3.7932806348701e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,39904,0.136375467466086,0.0061739227875275,0.124274578802532,0.14847635612964,6.88764907191687e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,42124,-0.0434165421195407,0.00197922266449345,-0.0472958185419478,-0.0395372656971335,7.82097353288586e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42187,-0.0785493064809376,0.00360928964624791,-0.0856235141875835,-0.0714750987742917,2.9840778444382e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,42222,-0.106530526064997,0.00489846818067731,-0.116131523699125,-0.0969295284308699,4.08353440478915e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42187,-0.0662844883052749,0.00304784980929865,-0.0722582739315002,-0.0603107026790495,4.10536593725193e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,39800,-0.0579119105770461,0.00266435500007289,-0.0631340463771889,-0.0526897747769032,1.2228611751449e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42063,0.0868703414763314,0.00400699776731057,0.0790166258524027,0.0947240571002602,1.78929981914244e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,42129,-0.159221598180339,0.00742081081421726,-0.173766387376205,-0.144676808984473,1.87572608709568e-100
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42072,-0.0716172888107094,0.00334691877855368,-0.0781772496166746,-0.0650573280047441,6.37079818079302e-100
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,42194,0.0869436770766926,0.00406971481038827,0.0789670360483315,0.0949203181050536,1.25689285990471e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42088,-0.0742059160342073,0.00347550333051427,-0.0810179025620153,-0.0673939295063993,1.67426520614675e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39895,-0.152083607706738,0.00713099634484477,-0.166060360542634,-0.138106854870842,5.60955693265669e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41834,-0.191585452600116,0.00900495716628444,-0.209235168646034,-0.173935736554199,8.5597291855066e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41710,-0.125815883175604,0.00591347475933596,-0.137406293703902,-0.114225472647305,8.76055165193533e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42187,-0.28327405658289,0.0133418996372325,-0.309424179871865,-0.257123933293914,1.91078881846358e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,42138,-0.13932893795582,0.00657926669730352,-0.152224300682535,-0.126433575229105,5.9930741283148e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,42187,0.0838487852398084,0.00396202644847896,0.0760832134007896,0.0916143570788272,7.86559967208094e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41766,-0.11547201981601,0.00546128124011021,-0.126176131046626,-0.104767908585394,1.31000051556534e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39675,-0.113870062159582,0.00538542296330705,-0.124425491167664,-0.1033146331515,2.58080632407423e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39675,-0.173185801216331,0.00822623689456985,-0.189309225529688,-0.157062376902974,1.65013612507654e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,39652,-0.089051694853986,0.00423030912649892,-0.0973431007419239,-0.0807602889660482,1.73317856403812e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41995,-0.238892051084976,0.0115283156640236,-0.261487549786463,-0.21629655238349,6.45140866418229e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41893,-0.109766452541235,0.00529777386784417,-0.12015008932221,-0.0993828157602607,7.00740729867018e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41828,-0.204147805435604,0.00988514472800522,-0.223522689102494,-0.184772921768713,2.75644148461189e-93
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,39575,-0.118846360286673,0.00576233616543629,-0.130140539170928,-0.107552181402417,9.33974075473085e-93
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42142,0.0858241415125563,0.00417131244809255,0.0776483691142949,0.0939999139108177,1.19676850795141e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41842,-0.121152454270724,0.0058956829187679,-0.132707992791509,-0.109596915749939,2.14090832862953e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39904,-0.0765737085037635,0.00374369516094045,-0.0839113510192068,-0.0692360659883202,2.46242497574843e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39575,-0.126861944002281,0.00620802491198362,-0.139029672829768,-0.114694215174793,3.99515109791265e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,42050,-0.124163700920778,0.0061015147047189,-0.136122669742027,-0.112204732099529,1.07884857986683e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,39740,-0.0512545156068707,0.00252682051542334,-0.0562070838171004,-0.0463019473966409,7.36389640423619e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39858,-0.116814940914156,0.0057606798221675,-0.128105873365605,-0.105524008462708,8.00727608592046e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42019,-0.114362827796056,0.0056960227835002,-0.125527032451716,-0.103198623140395,2.28472264735088e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41995,-0.0802214345858604,0.00399704702593569,-0.0880556467566944,-0.0723872224150265,2.65851814029765e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,41995,-0.142842307631764,0.00711852509822484,-0.156794616824284,-0.128889998439243,2.86874540422361e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41943,-0.0787055896220949,0.00392468666016827,-0.0863979754760247,-0.0710132037681651,3.68893403977157e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,39675,-0.0596931839159026,0.0029802148928372,-0.0655344051058635,-0.0538519627259417,1.07050648748573e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,39675,-0.13916511555375,0.00694910775995337,-0.152785366763258,-0.125544864344241,1.14555051141829e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39754,-0.0565510827120899,0.00283268046818759,-0.0621031364297376,-0.0509990289944422,3.74764122071711e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42142,-0.0917079178033577,0.00463650634219109,-0.100795470234052,-0.0826203653726632,7.25034626814961e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,39575,-0.134522575018278,0.00680258004489932,-0.147855631906281,-0.121189518130276,1.48820104947405e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEP,Leptin,42072,-0.148251519838326,0.00752406848334707,-0.162998694065686,-0.133504345610965,3.16610553270694e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42236,0.071115650841162,0.00361869000700214,0.0640230184274378,0.0782082832548862,8.20237398085632e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,39872,-0.0894401470605397,0.00456348682825817,-0.0983845812439257,-0.0804957128771537,3.92770816515607e-84
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42108,-0.0474472921632058,0.00243304639325573,-0.052216063093987,-0.0426785212324246,1.50510633952255e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,42222,-0.0725182988634485,0.00373200270914362,-0.07983302417337,-0.065203573553527,5.5346257088888e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,39869,-0.234619353676471,0.0120752213353977,-0.25828678749385,-0.210951919859091,9.67696945371901e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41924,-0.150989459434173,0.00779986643058359,-0.166277197638117,-0.135701721230229,2.3524839314557e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42063,0.0671836080166332,0.00347282373971724,0.0603768734867874,0.073990342546479,2.89708187899627e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,42048,-0.10995866859355,0.00569553871539574,-0.121121924475726,-0.0987954127113742,6.10909421517708e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42222,-0.0689185023276904,0.0035740085836423,-0.0759235591516293,-0.0619134455037515,9.09915187899645e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39895,-0.119689137999798,0.00621192601096615,-0.131864512981292,-0.107513763018305,2.01972394249969e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,42051,0.0927278444597909,0.004831518275319,0.0832580686401657,0.102197620279416,5.17938907821672e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42048,-0.0574075456000045,0.00300761271672605,-0.0633024665247875,-0.0515126246752214,3.67605075989852e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42187,-0.0760046585831929,0.00398385529145349,-0.0838130149544418,-0.0681963022119441,4.26154355939974e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39927,-0.0447209796264395,0.00234444201690099,-0.0493160859795654,-0.0401258732733135,7.19138288104868e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,39744,-0.0548780473471102,0.00290747598631194,-0.0605767002802816,-0.0491793944139388,3.03370978470886e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41943,-0.11712156139628,0.00624628190782804,-0.129364273935623,-0.104878848856937,1.88846347613241e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42222,-0.152982153287137,0.00816820905746766,-0.168991843039773,-0.1369724635345,2.6804841372782e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,42063,-0.112749240232841,0.00603629051738499,-0.124580369646915,-0.100918110818766,6.91336021904646e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,39897,-0.0589601256919751,0.00315444622767259,-0.0651428402982134,-0.0527774110857368,8.37433095848958e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,42222,-0.0617368865532766,0.00331053723871349,-0.0682255395411551,-0.0552482335653982,1.16423442401934e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,39410,0.0851697344154572,0.00456042000559876,0.0762313112044837,0.0941081576264308,1.24240275725609e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,42155,0.0550203322427967,0.00295345545369948,0.0492315595535457,0.0608091049320477,1.67769522420316e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,42072,-0.127260525856815,0.00683929657359209,-0.140665547141056,-0.113855504572575,2.53226134057924e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42027,-0.0402317527666885,0.0021694731061125,-0.044483920054669,-0.035979585478708,7.97631576043686e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41771,-0.165485606450427,0.00892887515362859,-0.182986201751539,-0.147985011149315,1.00985707991491e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42063,-0.106689943392672,0.00575857252365086,-0.117976745539028,-0.0954031412463168,1.08578263901095e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42172,-0.0844640444802351,0.00456897175950578,-0.0934192291288665,-0.0755088598316038,2.23030874405339e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,41755,-0.118642218260084,0.00642471469098024,-0.131234659054405,-0.106049777465762,3.41462616823544e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41995,-0.0825300282107915,0.00447196534328245,-0.0912950802836251,-0.0737649761379579,4.04791350313832e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39773,-0.0598907778932935,0.00325939822529242,-0.0662791984148666,-0.0535023573717203,2.586587504312e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,42108,-0.107771092077615,0.00588012958376612,-0.119296146061797,-0.0962460380934337,3.90690961451329e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41995,-0.0649500616292704,0.00354713738290395,-0.0719024508997622,-0.0579976723587787,5.43459661953835e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,42130,-0.130881685714128,0.00720469862632928,-0.145002895021734,-0.116760476406523,7.01414579058855e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41662,-0.040528209346214,0.00223913181144293,-0.0449169076966422,-0.0361395109957859,2.4347893415129e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39512,-0.134526758878644,0.00743207388035304,-0.149093623684136,-0.119959894073152,3.55098054595109e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42108,-0.0477732767240435,0.00264723602254262,-0.052961859328227,-0.0425846941198599,5.87446326229322e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,42048,-0.0770544266773952,0.00428480828954382,-0.0854526509249011,-0.0686562024298893,1.81041385730274e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41943,-0.0657319260231381,0.00366203311936051,-0.0729095109370847,-0.0585543411091915,3.31887552282823e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,42085,0.0373697160244487,0.00208240153501308,0.033288209015823,0.0414512230330743,3.49532852782237e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39858,-0.109604362383796,0.00610922196970083,-0.12157843744441,-0.0976302873231829,5.49100153235472e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39675,-0.0724598669825733,0.00406134162977382,-0.08042009657693,-0.0644996373882166,3.22809433976455e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,42222,-0.0504587568294189,0.00283620118283063,-0.0560177111477669,-0.0448998025110708,5.13577761918302e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,42111,-0.0812434015980168,0.00458243441469138,-0.0902249730508119,-0.0722618301452217,1.52467112372043e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42121,-0.045372322480298,0.00256103409341914,-0.0503919493033995,-0.0403526956571965,1.90533219814396e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41943,-0.139627182092366,0.00791978220484758,-0.155149955213867,-0.124104408970864,8.68999840209305e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42174,-0.109439328690945,0.00623071704678007,-0.121651534102634,-0.0972271232792557,2.62065491027231e-68
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,42072,-0.0667655575484728,0.00383008209930148,-0.0742725184631037,-0.0592585966338419,2.58521325012125e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42174,-0.0985202458710122,0.00565279747680384,-0.109599728925548,-0.0874407628164767,2.70133861139455e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39675,-0.0416924569154227,0.0023941667772436,-0.0463850237988201,-0.0369998900320252,5.01404086300741e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42108,-0.0702450324215121,0.00404194927261192,-0.0781672529958314,-0.0623228118471927,6.35118065035488e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41771,-0.210320293576816,0.0121317883820771,-0.234098598805687,-0.186541988347945,1.3706296846377e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,42141,-0.113085734647089,0.00652757736719687,-0.125879786286794,-0.100291683007383,1.60560904894523e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42108,-0.0654471840359607,0.00380850384500587,-0.0729118515721722,-0.0579825164997492,1.72151011713155e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41972,-0.0484479585367957,0.00282146880333334,-0.0539780373913291,-0.0429178796822623,2.18933253139234e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39858,-0.132593499092225,0.00773300027435287,-0.147750179629956,-0.117436818554493,4.46489723097367e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,42063,-0.04315556317309,0.00252458286952938,-0.0481037455973676,-0.0382073807488124,7.91756443671065e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,39904,-0.210965681427701,0.0123375528018045,-0.235147284919238,-0.186784077936165,9.73087154065076e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41771,-0.126401460984303,0.00742002532088594,-0.140944710613239,-0.111858211355366,2.20021585869133e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39575,0.104365734689067,0.00613439383956755,0.0923423227635145,0.116389146614619,4.33234211193397e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41828,-0.102648697216439,0.00604082089410928,-0.114488706168893,-0.0908086882639846,4.45804333276351e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39512,-0.112148404246266,0.00660068931327689,-0.125085755300289,-0.0992110531922432,6.39683388691351e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41995,-0.232065273269057,0.0137012077725261,-0.258919640503208,-0.205210906034906,1.09235857673927e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,42187,-0.0863493463580901,0.00512151032785035,-0.0963875066006768,-0.0763111861155034,3.87028591254045e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,42174,-0.0684637465173405,0.00406131489939173,-0.0764239237201483,-0.0605035693145327,4.04638833378298e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,42174,-0.0444492765406235,0.00263889714068143,-0.0496215149363591,-0.0392770381448879,5.07276600525885e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42124,0.0531099557604,0.00316307578412236,0.0469103272235201,0.0593095842972798,1.23047528930712e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41995,-0.145922441190805,0.00873926545595508,-0.163051401484477,-0.128793480897133,5.79140034023199e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,39895,-0.121493791308985,0.00731018819403106,-0.135821760169285,-0.107165822448684,2.67178286043955e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,42174,-0.0824960381528233,0.00497470191238688,-0.0922464539011016,-0.072745622404545,3.68553510676559e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42142,0.0574859649745534,0.00347507281355181,0.0506748222599919,0.064297107689115,7.18014314597248e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,42164,-0.0362180718798819,0.00218962606712231,-0.0405097389714416,-0.0319264047883222,7.35581169459464e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41995,-0.204606090601856,0.0123970725766919,-0.228904352852172,-0.18030782835154,1.35124412634982e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41929,-0.0648447707671137,0.00393782502196191,-0.072562907810159,-0.0571266337240683,2.48806794996324e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,39597,-0.150156548739543,0.0091135267906086,-0.168019061249136,-0.13229403622995,2.86083087508661e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39597,-0.082572176447207,0.00501725719256602,-0.0924060005446364,-0.0727383523497776,3.86147659271065e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41766,-0.0940880335017081,0.00574225606004974,-0.105342855379406,-0.0828332116240107,9.50865030063658e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42072,-0.0602076998497356,0.00368758031467617,-0.0674353572665009,-0.0529800424329703,2.3478908911625e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,39904,0.0671497176379367,0.0041108547374098,0.0590924423526135,0.0752069929232599,2.66393404439346e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,42077,-0.0580532785066002,0.00356364087221945,-0.0650380146161503,-0.05106854239705,4.23097981606373e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39852,-0.19495815567867,0.0119737652797675,-0.218426735627014,-0.171489575730326,6.22418258955822e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,39917,-0.034350409335542,0.00211029732915476,-0.0384865921006853,-0.0302142265703987,6.63886322901517e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42048,-0.0860960841315586,0.00530071103704414,-0.0964854777641651,-0.0757066904989521,9.16135840805751e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,41766,-0.118020201452286,0.00726835895452646,-0.132266185003157,-0.103774217901414,1.01701313247351e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39883,0.0873592571232955,0.00538208532116885,0.0768103698938046,0.0979081443527865,1.38927337218082e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,41766,-0.0903417071578678,0.00558180436108979,-0.101282043705604,-0.0794013706101318,2.3498808792275e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,42056,-0.06675635420503,0.00415155900995704,-0.0748934098645458,-0.0586192985455142,1.21606930600115e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39895,-0.0521230516476712,0.00323924851537376,-0.0584719787378038,-0.0457741245575386,1.28493117654927e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,41995,-0.123890632173952,0.0077145013313057,-0.139011054783311,-0.108770209564593,1.68829601403095e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42048,-0.102629952176855,0.00639396851612765,-0.115162130468465,-0.0900977738852448,1.91862364947653e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39872,-0.101653135909329,0.00635187482958522,-0.114102810575316,-0.0892034612433418,5.10880160042109e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,42010,-0.0542251576205084,0.00340001828399725,-0.060889193457143,-0.0475611217838738,9.69481186106786e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,39895,-0.158429382896684,0.00993456061436227,-0.177901121700834,-0.138957644092533,1.23265942810914e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41995,0.0338077191015593,0.00212520964530665,0.0296423081967582,0.0379731300063603,1.83420271437109e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39868,-0.0836170218038212,0.00525246194339329,-0.0939118472128721,-0.0733221963947704,1.90790269024341e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42048,-0.0699258822786952,0.00440292687936812,-0.0785556189622567,-0.0612961455951336,2.75481590962965e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,41757,-0.0849413499147993,0.00534842800235762,-0.0954242687994202,-0.0744584310301784,2.83219867259075e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42048,0.0616044325779168,0.00387952041372994,0.0540005725670061,0.0692082925888275,2.85522613221503e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42048,-0.113668750145228,0.00715987420135435,-0.127702103579882,-0.0996353967105733,3.02025392946492e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42210,-0.0670339309435417,0.00422488433724396,-0.0753147042445399,-0.0587531576425435,3.44793825493577e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42108,-0.157859350487872,0.00995786227311714,-0.177376760543181,-0.138341940432562,4.30966203374896e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39872,-0.109211184367431,0.00691312335924092,-0.122760906151543,-0.0956614625833191,1.27346701298581e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,39575,-0.101981123098221,0.00647245005920514,-0.114667125214263,-0.0892951209821792,2.51113210632033e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42010,-0.0331039387671184,0.00210663140900922,-0.0372329363287765,-0.0289749412054603,3.75299721738189e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,42041,-0.157523749173665,0.0100502871469294,-0.177222311981646,-0.137825186365683,7.01614579942777e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39895,-0.14277931778038,0.00910766595377394,-0.160630343049777,-0.124928292510983,8.22535878575463e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,42142,-0.0971039604713763,0.00621298609614118,-0.109281413219813,-0.0849265077229396,1.38011696692827e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39895,-0.12936887029858,0.00827738838531342,-0.145592551533794,-0.113145189063366,1.71164678197269e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42072,-0.130277332617689,0.0083438692055373,-0.146631316260542,-0.113923348974835,1.76642758811639e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41667,-0.170368954907753,0.0109179670073866,-0.191768170242231,-0.148969739573275,2.10081642828139e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,42048,-0.15108059775752,0.00970482243769537,-0.170102049735403,-0.132059145779637,3.58797127287333e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39597,-0.146643194104545,0.00944323074932606,-0.165151926373224,-0.128134461835866,8.22430189284503e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,42072,-0.0450162045945127,0.00290179388934117,-0.0507037206176214,-0.039328688571404,8.23816443465082e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39895,-0.122839619404399,0.00791236693972463,-0.138347858606259,-0.107331380202539,8.43633356283102e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,39895,-0.0465827059756097,0.00301116247297125,-0.0524845844226334,-0.0406808275285861,1.95061985708794e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39869,-0.182970332613555,0.0118501666112982,-0.206196659171699,-0.15974400605541,3.07167359300124e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,41995,-0.0588312867202299,0.00382271439262822,-0.0663238069297812,-0.0513387665106786,5.4302904474714e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,42187,-0.0436691214805424,0.00284814441948399,-0.049251484542731,-0.0380867584183538,1.27865486174827e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41995,-0.162956774495973,0.0106276972889271,-0.183787061182271,-0.142126487809676,1.28282369197554e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,42236,-0.103172660412935,0.00674714486967343,-0.116397064357495,-0.0899482564683752,2.3741439367022e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41771,-0.121962113017648,0.00797697959209895,-0.137596993018162,-0.106327233017134,2.53551171727571e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,39675,-0.0770334855771978,0.00503963697595752,-0.0869111740500745,-0.0671557971043211,3.25290092730114e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,39858,-0.167231579590362,0.0109628213681612,-0.188718709471958,-0.145744449708766,5.08878595211727e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,42187,-0.105953695391386,0.00695799543189355,-0.119591366437897,-0.0923160243448746,6.21987327651586e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39848,-0.130138249882072,0.00854196248871863,-0.146880496359961,-0.113396003404184,6.80033718950156e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,41943,-0.144667662952641,0.0095625046760879,-0.163410172117774,-0.125925153787509,2.79044318952365e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41995,-0.111031931537758,0.00734261783741969,-0.1254234624991,-0.0966404005764151,3.08931490063905e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41981,-0.17307673247801,0.0114836429291034,-0.195584672619053,-0.150568792336968,6.51529020539339e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39858,-0.130800580047648,0.00867756727096996,-0.147808611898749,-0.113792548196547,7.58350710435353e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39597,-0.113284771159985,0.00752252544274065,-0.128028921027756,-0.0985406212922128,9.58685857675865e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39869,-0.0462946169197991,0.00307481520293489,-0.0523212547175515,-0.0402679791220467,9.79845427609776e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41995,-0.0600794730163795,0.00400172026648552,-0.0679228447386911,-0.0522361012940679,1.54484247078184e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,42222,-0.0688457064734049,0.004603789459652,-0.0778691338143228,-0.059822279132487,3.6579887156049e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42048,-0.173197119596274,0.0115825733413705,-0.19589896334536,-0.150495275847188,3.75001897968443e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42236,-0.108006651225104,0.00722442995410841,-0.122166533935157,-0.0938467685150516,3.87376602523922e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42236,0.0408060993650876,0.00273096537290315,0.0354534072341974,0.0461587914959777,4.37200205926915e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41771,-0.105903260468101,0.00709419608944168,-0.119807884803406,-0.0919986361327949,5.53658500124339e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,42236,-0.0706650618723058,0.00473692681419983,-0.0799494384281375,-0.0613806853164741,6.23830586591253e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42048,-0.162416100975764,0.010891098519694,-0.183762654074365,-0.141069547877164,6.81759254102299e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,39675,-0.0622598462839935,0.00417282575545119,-0.0704385847646779,-0.0540811078033092,7.40639357298562e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39675,-0.06648759530434,0.0044633404970928,-0.0752357426786419,-0.0577394479300381,1.05242571170072e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41842,-0.114701299902804,0.00771048132686216,-0.129813843303454,-0.0995887565021539,1.1868189284953e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41919,-0.144809974437596,0.00977247173787022,-0.163964019043822,-0.12565592983137,2.75943928197689e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42174,0.0342231522200584,0.00231018839589324,0.0296951829641076,0.0387511214760091,2.88324837296239e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,41995,-0.062854245037517,0.00426066650480967,-0.071205151386944,-0.0545033386880901,7.19672194368158e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42198,-0.0313999153623998,0.00213532199058311,-0.0355851464639427,-0.0272146842608569,1.41270269258019e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41771,-0.0780514302678769,0.00531779055856578,-0.0884742997626659,-0.067628560773088,2.16755052038145e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41995,-0.0707134833695159,0.00482460556623809,-0.0801697102793425,-0.0612572564596892,2.87892230414345e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39575,-0.135580620331822,0.00924406627349123,-0.153698990227865,-0.117462250435779,3.00774072035997e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39872,-0.159768885889689,0.0108973409763662,-0.181127674203367,-0.138410097576011,3.16887239212223e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,42111,0.0653708053660755,0.00446669318693225,0.0566160867196883,0.0741255240124627,3.91193864856433e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39512,-0.107869242224623,0.00737201084560181,-0.122318383482003,-0.0934201009672435,4.97878162186627e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42156,-0.0483760451659291,0.0033165594182089,-0.0548765016256186,-0.0418755887062397,7.91437179088689e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41771,-0.100772530127309,0.00694158992251153,-0.114378046375432,-0.0871670138791865,2.18813545438537e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,42181,-0.0384290819454547,0.00266194276522069,-0.0436464897652873,-0.0332116741256222,6.78227829442831e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41995,-0.0938309873190641,0.00650839338011033,-0.10658743834408,-0.0810745362940478,9.06550845223267e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,39675,-0.185028121745868,0.0128442585972818,-0.21020286859654,-0.159853374895195,1.25954057938113e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41696,-0.131346558647388,0.00914621934920763,-0.149273148571835,-0.113419968722941,2.05353469802298e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42142,-0.0669024688044713,0.00466144175749938,-0.0760388946491701,-0.0577660429597725,2.2546261427438e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,42108,-0.0874817921151563,0.00610008122878742,-0.0994379513235797,-0.075525632906733,2.64941382867637e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39869,-0.0470112773600753,0.00327635028578735,-0.0534329239202185,-0.0405896307999321,2.77478243595778e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42048,-0.11716072887229,0.00817277757680095,-0.13317937292282,-0.10114208482176,2.87854194404134e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,42048,-0.0873847796109178,0.00609571093797881,-0.0993323730493563,-0.0754371861724794,2.87982855711635e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,39868,-0.0604277039166608,0.00421473678716848,-0.068688588019511,-0.0521668198138106,3.26228865821082e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,42111,-0.0556791213233089,0.00389592226076953,-0.0633151289544172,-0.0480431136922006,5.33794145774197e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,41943,-0.0823774759359262,0.00576723458209006,-0.0936812557168228,-0.0710736961550297,6.02959196022979e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42050,-0.0424620971632816,0.00298078282677443,-0.0483044315037595,-0.0366197628228037,1.03093860226065e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39869,-0.217884454954068,0.0153023103904962,-0.24787698331944,-0.187891926588695,1.3098314177386e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41943,-0.0816236954494155,0.00574179488735996,-0.0928776134286411,-0.07036977747019,1.57321117620896e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39512,-0.0863571429443391,0.00609996115713126,-0.0983130668123164,-0.0744012190763619,4.23479801103871e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,39927,-0.0447677105398132,0.00316725516388716,-0.050975530661032,-0.0385598904185943,5.60545744479229e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42063,-0.0368857991228077,0.00261288629427856,-0.0420070562595937,-0.0317645419860218,6.25069416746367e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42236,-0.0611155673769076,0.00433116389155119,-0.0696046486043479,-0.0526264861494672,6.75582670562155e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42048,-0.065834982982646,0.00466767293432639,-0.0749836219339257,-0.0566863440313663,7.4418253531504e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42048,-0.140154183961345,0.00995786557603301,-0.15967160049037,-0.12063676743232,1.12685426254193e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,39904,-0.0431251085314276,0.00306245623283003,-0.0491275227477744,-0.0371226943150807,1.16982737644232e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39597,-0.0792169474135503,0.00562596689006605,-0.0902438425180798,-0.0681900523090209,1.21964327764936e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42108,-0.127432012591073,0.00906108512554793,-0.145191739437147,-0.109672285744999,1.31045801306875e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41995,-0.0431174400616978,0.003065968375329,-0.0491267380773426,-0.037108142046053,1.32618466442093e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,42222,-0.0571728782405835,0.00406598175935385,-0.0651422024889171,-0.04920355399225,1.34664735482826e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42174,-0.053090237838425,0.00377606954656448,-0.0604913341496914,-0.0456891415271587,1.38078600785276e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39868,-0.107011483878314,0.00762049249079627,-0.121947649160275,-0.0920753185963537,2.02402062586078e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,42108,-0.061454756145625,0.00439148789271721,-0.0700620724153507,-0.0528474398758993,3.44718246597674e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,42236,-0.0983488854460057,0.00704321594347592,-0.112153588695218,-0.0845441821967929,5.21966184195847e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41842,-0.130036609999222,0.00931874476437166,-0.148301349737391,-0.111771870261054,6.06151411538212e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42092,-0.128793095483045,0.00923708154724369,-0.146897775315643,-0.110688415650448,6.9891531260393e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39696,-0.173450217511422,0.0124645672770478,-0.197880769374436,-0.149019665648408,1.18645204677473e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,39868,-0.198349551433387,0.0142694716982394,-0.226317715961936,-0.170381386904838,1.44337450665318e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41771,-0.100416152230222,0.00723539476832919,-0.114597525976147,-0.0862347784842966,1.73097129452513e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,42048,-0.145857574965149,0.0105198219472044,-0.16647642598167,-0.125238723948629,2.05246720042022e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,39895,-0.0458569893451432,0.00331691675106724,-0.052358146177235,-0.0393558325130514,4.03014304599309e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,42175,-0.0761374363347115,0.00551370518540894,-0.086944298498113,-0.0653305741713099,4.41190267501546e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,39872,-0.0667019504781832,0.00482905677099354,-0.0761669017493306,-0.0572369992070359,4.79223462142731e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42072,-0.04180093236625,0.00303170784640196,-0.0477430797451978,-0.0358587849873021,5.8971977994928e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39512,-0.112649088598576,0.00816522121533057,-0.128652922180623,-0.0966452550165277,6.15461920482522e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39590,-0.185569909758092,0.0134647539129776,-0.211960827427529,-0.159178992088656,7.43584610563513e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39895,-0.0940490696193281,0.00683824575585633,-0.107452031300806,-0.0806461079378497,1.07238442838582e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,42200,0.0805219520065549,0.00586145893587209,0.0690334924922456,0.0920104115208642,1.16551284382266e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41915,-0.0553459961093864,0.00403515827626335,-0.0632549063308626,-0.0474370858879103,1.58527891627352e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42066,-0.0590120266021848,0.00430424474395113,-0.067448346300329,-0.0505757069040406,1.70152382748266e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42141,-0.0861651839079853,0.00628606448910899,-0.0984858703066389,-0.0738444975093317,1.76259055565908e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,39675,0.0355564763656096,0.0025932235863112,0.0304737581364397,0.0406391945947796,1.92841222456798e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41771,-0.0737589671271498,0.0053856658344351,-0.0843148721626426,-0.063203062091657,2.11004235921113e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,42110,-0.0425932422709256,0.00311983758442422,-0.048708123936397,-0.0364783606054541,3.71927858246478e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,42098,0.0579044067403897,0.00424374354231092,0.0495866693974603,0.0662221440833191,4.13227350073334e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39597,-0.119787511069135,0.0087806380726412,-0.136997561691512,-0.102577460446759,4.93358777247956e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42142,0.063623596796554,0.0046806646992159,0.0544494939860908,0.0727976996070172,8.30085085460218e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39597,-0.0660683725510384,0.00486442889440551,-0.0756026531840732,-0.0565340919180036,1.11063335364111e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,42124,-0.0379194511325445,0.0027947584107485,-0.0433971776176116,-0.0324417246474775,1.16018453770251e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,39904,-0.111320723308507,0.00820319027443141,-0.127398976246392,-0.0952424703706213,1.26980755141705e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,41624,-0.0594649325746851,0.00439263278036523,-0.0680744928242009,-0.0508553723251692,1.79335411388561e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,42048,-0.117955224095703,0.00877551912621834,-0.135155241583091,-0.100755206608315,6.35304422522376e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39868,-0.0605516482498122,0.00450837974945185,-0.0693880725587378,-0.0517152239408866,8.20505684561504e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42050,0.0507248066458814,0.00377940206175757,0.0433171786048366,0.0581324346869262,8.29392775720643e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39845,-0.16122952139732,0.0120304636008641,-0.184809230055013,-0.137649812739626,1.20989557516903e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42164,-0.0943891668753031,0.00705593154242127,-0.108218792698449,-0.0805595410521574,1.48344956472707e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41943,-0.0765161631226322,0.00571991779509117,-0.0877272020010109,-0.0653051242442535,1.50062342151607e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41766,-0.0428797232101569,0.00320829635951948,-0.0491679840748151,-0.0365914623454987,1.77091785220593e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42048,-0.126547328026045,0.00947028698859433,-0.14510909052369,-0.1079855655284,1.81239199457326e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,41950,-0.105188481682022,0.00788874721573177,-0.120650426224856,-0.0897265371391879,2.65769089991494e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42222,-0.110080488866066,0.00825878472594848,-0.126267706928925,-0.0938932708032072,2.80981561450977e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41995,-0.121581526077203,0.00912635679383454,-0.139469185393118,-0.103693866761287,3.10740690154014e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,41771,-0.109259956037309,0.0082055768535,-0.125342886670169,-0.0931770254044494,3.42865697385247e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42072,-0.125881067869983,0.00947511432111836,-0.144452291939375,-0.107309843800591,5.02031584423058e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,39584,-0.0403589123409061,0.00303608493589974,-0.0463096388152696,-0.0344081858665426,5.17041004089619e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,42048,-0.133771358118991,0.0100714882021187,-0.153511474995144,-0.114031241242839,5.24595992269206e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42174,0.0672749747191411,0.00507491404689403,0.0573281431872288,0.0772218062510533,7.33068959702362e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41856,-0.0657410095595072,0.00496382076396284,-0.0754700982568744,-0.0560119208621401,8.74040248894038e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42174,-0.0983721586078831,0.00742861804931678,-0.112932249984544,-0.0838120672312222,8.81926149418691e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41766,-0.0886597844502055,0.00669840821945461,-0.101788664560337,-0.0755309043400745,9.75850250874952e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39538,-0.0736896966481799,0.00559147942089617,-0.0846489963131364,-0.0627303969832234,2.31359306817695e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42222,-0.0555504668266878,0.00422742142765317,-0.063836212824888,-0.0472647208284876,3.34022866422333e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,42155,-0.0991843133002862,0.00754795534727155,-0.113978305780938,-0.0843903208196339,3.34724422951079e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39675,-0.119097165364079,0.00906092408402157,-0.136856576568761,-0.101337754159397,3.61465487043093e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,39904,0.0580459649841038,0.00441875492758895,0.0493852053260294,0.0667067246421781,3.94563380877971e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42185,-0.116564297162236,0.00888330249843531,-0.133975570059169,-0.0991530242653025,4.27339436118921e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42174,-0.136616875472777,0.0104168932502116,-0.157033986243192,-0.116199764702362,4.67103372394978e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41842,-0.088154194410687,0.00672295078000652,-0.1013311779395,-0.0749772108818742,4.89214999090919e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,42063,0.0401766872745367,0.00306545795213577,0.0341683896883506,0.0461849848607228,5.25300164160701e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,39892,0.0508043710524231,0.00387713637764439,0.04320518375224,0.0584035583526061,6.03868750669794e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,42048,0.0483843744091606,0.0036950381404687,0.0411420996538419,0.0556266491644792,6.13162944728041e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41842,-0.0626227729163984,0.00478770385990468,-0.0720066724818116,-0.0532388733509852,7.46588038121452e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42111,-0.0424049162554191,0.00324540009830666,-0.0487659004481002,-0.0360439320627381,8.82897838807099e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,39675,-0.0754640956718267,0.00578986221239458,-0.0868122256081201,-0.0641159657355333,1.50855575623941e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41995,-0.0864482692133442,0.00665098899764971,-0.0994842076487376,-0.0734123307779508,2.14865892420011e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42048,-0.147456676074993,0.0113520590993392,-0.169706711909698,-0.125206640240289,2.38928126605219e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39869,-0.0878437754941024,0.00676035565537944,-0.101094072578646,-0.0745934784095587,2.49493093193021e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42048,-0.0537528791227822,0.00414713241628386,-0.0618812586586986,-0.0456244995868659,3.42620879294109e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,39840,-0.103489125506081,0.00798388570665777,-0.119137541491131,-0.0878407095210322,3.75723888181328e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39597,-0.0458505142444429,0.00353912301565937,-0.0527871953551353,-0.0389138331337506,4.16313892845854e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42179,-0.0798539143085711,0.00618086698946384,-0.0919684136079202,-0.067739415009222,5.84443922792165e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39850,-0.0814075283673993,0.00629964241248734,-0.0937548274958745,-0.0690602292389241,6.2477788940947e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,39895,-0.0655508978341831,0.00507280988214967,-0.0754936052031964,-0.0556081904651697,6.27686116592096e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42025,0.0908941319461023,0.00705382138065192,0.0770686420400246,0.10471962185218,9.05948629245853e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,39868,-0.054379784271789,0.0042199512661842,-0.06265088875351,-0.046108679790068,9.91886497197145e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39575,-0.09653386975559,0.00749762944822917,-0.111229223474119,-0.0818385160370609,1.16156158072326e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,41995,-0.143532493278012,0.0111707488272096,-0.165427160979343,-0.121637825576681,1.45270462121434e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39895,-0.108344171240908,0.00843417564775604,-0.12487515551051,-0.0918131869713061,1.66036907909996e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,42048,-0.101968268136266,0.00796056540564719,-0.117570976331335,-0.0863655599411977,2.40774221271498e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,42093,-0.0451003241686929,0.00352179314132177,-0.0520030387256835,-0.0381976096117022,2.50067685908361e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,42048,-0.118879495230426,0.00929431847630996,-0.137096359443993,-0.100662631016858,3.05126963846679e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,39869,-0.146666540726095,0.0114616577385756,-0.169131389893703,-0.124201691558486,3.12257445032869e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,39872,-0.149284106707705,0.0116777181894453,-0.172172434359018,-0.126395779056392,3.66334957630805e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41766,-0.110153638499943,0.00863844917326508,-0.127084998879542,-0.093222278120343,5.05897276740979e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,41771,-0.0895621798906629,0.00702881735424728,-0.103338661904988,-0.0757856978763383,5.6985008919373e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,39512,-0.107568570483826,0.00843811041136895,-0.124107266890109,-0.0910298740775431,5.87000668215878e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,42072,0.0530115386290083,0.00416289273610031,0.0448522688662517,0.0611708083917649,6.22338987625839e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,41919,-0.0699009141157033,0.00549412834590684,-0.0806694056736807,-0.0591324225577259,7.23506937517795e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,41725,-0.0975381131211826,0.00767767314291329,-0.112586352481293,-0.0824898737610726,9.23187210995383e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39798,-0.0382785783309,0.00301345492333323,-0.0441849499806331,-0.0323722066811669,1.02507525330056e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39869,-0.119737903327226,0.00942650105669831,-0.138213845398354,-0.101261961256097,1.0251131912646e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41766,-0.0920442801982407,0.00725229517269757,-0.106258778736728,-0.0778297816597535,1.07764594419998e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,39895,-0.104032703768158,0.00819922646542,-0.120103187640381,-0.0879622198959345,1.22348142544791e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42172,-0.0394786493545897,0.00311375230068136,-0.0455816038639252,-0.0333756948452543,1.25025597713617e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39575,-0.101055112943819,0.00796799657403509,-0.116672386228928,-0.08543783965871,1.33286728711783e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39869,-0.0712917650694293,0.00562583278078762,-0.0823183973197731,-0.0602651328190856,1.49626444230982e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42063,-0.0638739202254753,0.00504818938131393,-0.0737683714128506,-0.0539794690381,1.74051378704564e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42222,-0.0587273286192527,0.00464213368966239,-0.0678259106509909,-0.0496287465875144,1.77285162234139e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39868,-0.0885066450853976,0.00700099306460634,-0.102228591492026,-0.0747846986787692,2.18641538123669e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,41995,-0.0741063033519221,0.005869390382181,-0.0856103085009968,-0.0626022982028473,2.44782397724761e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42111,-0.0907584886843909,0.00719178699991313,-0.104854391204221,-0.0766625861645611,2.63368958435153e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,39575,-0.0711093387579566,0.00563476435378121,-0.0821534768913678,-0.0600652006245454,2.93331691602642e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42048,-0.0823336342548478,0.0065295085748173,-0.0951314710614897,-0.0695357974482059,3.00247309774725e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,42222,-0.130021513707911,0.01033786835646,-0.150283735686572,-0.109759291729249,4.47074794350646e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,39696,-0.177383987476594,0.0141025671607153,-0.205025019111596,-0.149742955841592,4.9040152684581e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42072,-0.0592854713731202,0.0047260955587501,-0.0685486186682704,-0.05002232407797,6.78017558126518e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,42174,-0.0783514686550017,0.00625003538412826,-0.0906015380078931,-0.0661013993021103,7.4768863320443e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,39917,-0.0280525227837566,0.00223653184560759,-0.0324361252011474,-0.0236689203663657,7.52871156527641e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,42222,-0.0649954600895927,0.00518892256359621,-0.0751657483142413,-0.0548251718649441,8.49338173672324e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,39356,-0.0320247854958421,0.00256229917146214,-0.0370468918719078,-0.0270026791197763,1.34446384475775e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41924,-0.0312943186799832,0.00251000060711463,-0.0362139198699278,-0.0263747174900385,1.76331766937921e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,41943,-0.0583099282753428,0.00469481769570597,-0.0675117709589265,-0.049108085591759,3.1841477377641e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41771,-0.0826704404098802,0.00665777706927716,-0.0957196834656634,-0.0696211973540969,3.32109949692714e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,42048,-0.109426400530401,0.00881470722548453,-0.126703226692351,-0.0921495743684517,3.41690476836922e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,42048,-0.117229278124488,0.00945783443533788,-0.13576663361775,-0.0986919226312255,4.32702966944071e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39869,-0.138928062949516,0.0112047826336824,-0.160889436911533,-0.116966688987498,4.4793071762637e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41995,-0.18516427107479,0.0149534175663538,-0.214472969504843,-0.155855572644737,5.03795030534976e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,42056,-0.0409159163522331,0.00331662849459093,-0.0474165082016313,-0.0344153245028349,8.86874461155116e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39512,-0.0484413843113884,0.00393280980266547,-0.0561496915246127,-0.0407330770981641,1.24200790105856e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39868,-0.119003537959758,0.0096635351119287,-0.137944066779138,-0.100063009140378,1.26021960691469e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,42187,-0.073308872500332,0.00595764399905149,-0.0849858547384729,-0.0616318902621911,1.30109484933949e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42108,-0.0368102113576235,0.00299237973580709,-0.0426752756398054,-0.0309451470754416,1.36465650740947e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39858,-0.153642225494083,0.0124927894048045,-0.1781280927275,-0.129156358260666,1.53737992910665e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39679,-0.0616819599002644,0.00501779422145559,-0.0715168365743173,-0.0518470832262114,1.66429875487057e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39675,-0.0309802060018002,0.00252319833676865,-0.0359256747418668,-0.0260347372617337,1.98659253178062e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,42174,-0.0788931497597941,0.00643346455785919,-0.0915027402931981,-0.0662835592263901,2.17742074938472e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,42142,-0.0746899475734836,0.0060936060418636,-0.0866334154155362,-0.0627464797314309,2.34036576734341e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,42187,-0.0523143999098335,0.00427509132315531,-0.0606935789032179,-0.0439352209164491,2.98536220500614e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39597,-0.167244334088155,0.0136918927522984,-0.19408044388266,-0.14040822429365,4.30558284004383e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39575,-0.0990997568077777,0.0081162566407372,-0.115007619823623,-0.0831918937919328,4.56893007174823e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,42174,-0.030274708856133,0.00248259342837585,-0.0351405919757497,-0.0254088257365164,4.99183799820521e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,42063,-0.0512880753385316,0.00420659041814551,-0.0595329925580968,-0.0430431581189664,5.16147539884674e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,39868,-0.0875565637944591,0.00719034354678955,-0.101649637146167,-0.0734634904427516,6.73128796804627e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42072,-0.0833599888919309,0.00685672101758689,-0.0967991620864012,-0.0699208156974606,7.87780826200421e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,41759,-0.0527159789969126,0.00433928871701106,-0.0612209848822543,-0.0442109731115709,8.85648260375395e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39868,-0.144732677375594,0.0119150617428131,-0.168086198391507,-0.12137915635968,9.6644450850601e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39800,-0.0387393574815222,0.00319020577264136,-0.0449921607958992,-0.0324865541671451,1.01499318980124e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,42010,-0.0558925130176476,0.00460616548088056,-0.0649205973601735,-0.0468644286751217,1.04401920518018e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41943,-0.0567352375967304,0.00468386142671873,-0.0659156059930991,-0.0475548692003617,1.35390892365965e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42236,-0.0664336115540923,0.00548549536634579,-0.07718518247213,-0.0556820406360545,1.37738247198773e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42056,-0.163699436238935,0.0135259921438729,-0.190210380840926,-0.137188491636944,1.52845426670276e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39868,-0.0821761609617114,0.00678958612263145,-0.095483749762069,-0.0688685721613537,1.63766388265081e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,42187,0.0611826198615281,0.00505873375566779,0.0512675017004192,0.0710977380226369,1.67929578177347e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39868,-0.118510592118711,0.00981672624703722,-0.137751375562904,-0.0992698086745184,2.37528572437983e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,39927,0.0651085679342059,0.00539428052532863,0.0545357781045617,0.07568135776385,2.43832086440579e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,42156,-0.0493158083903482,0.00409257574251088,-0.0573372568456695,-0.0412943599350269,2.86628959748199e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,42236,-0.0601029489161892,0.00498902144144299,-0.0698814309414174,-0.0503244668909609,2.96548509909704e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,39868,-0.0802698124161841,0.00667465092509203,-0.0933521282293645,-0.0671874966030037,4.13286585335343e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,39858,-0.110437717088627,0.00919299382422593,-0.12845598498411,-0.0924194491931443,4.81901188579299e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41943,-0.0732228285680395,0.00611384532019963,-0.0852059653956308,-0.0612396917404483,6.95046927784055e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,41771,-0.128860210174441,0.0107624029237598,-0.14995451990501,-0.107765900443872,7.27262262885757e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42138,-0.0432056122834427,0.00361255145023624,-0.0502862131259057,-0.0361250114409797,8.43487370607945e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39895,-0.0950423565231818,0.00796763633943029,-0.110658923748465,-0.0794257892978984,1.31859188275178e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42055,-0.0657835519012412,0.00552343830958889,-0.0766094909880354,-0.0549576128144469,1.53163138507792e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39872,-0.095290528735034,0.00799998745897352,-0.110970504154622,-0.0796105533154459,1.61857332574581e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42210,-0.0676276190438625,0.00568177787873637,-0.0787639036861858,-0.0564913344015392,1.66403034377049e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42222,-0.126836082278815,0.0106691582591834,-0.147747632466815,-0.105924532090816,1.97407535368344e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,39895,-0.0596172461737845,0.00502177737437073,-0.0694599298275511,-0.0497745625200179,2.58280654754109e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42063,-0.0341599894827648,0.00288264818038043,-0.0398099799163105,-0.0285099990492192,3.1039220917684e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41995,-0.100338584691093,0.00846819143215717,-0.116936239898121,-0.0837409294840653,3.1589640048127e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39904,-0.0509954601399871,0.00430473492945447,-0.0594327406017178,-0.0425581796782563,3.48290051670049e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,39675,-0.0902800246921842,0.00762368214533527,-0.105222441697041,-0.0753376076873271,3.69754992398362e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42063,0.0347848613626624,0.00294104692085719,0.0290204093977823,0.0405493133275425,4.06384377226606e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42164,-0.0458727755265574,0.00387945836261608,-0.0534765139172849,-0.0382690371358299,4.19097471948698e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42108,-0.0323676820267219,0.0027376808593027,-0.0377335365109552,-0.0270018275424886,4.27216569497135e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNST,Consortin,42072,-0.14071929130761,0.0119049417223008,-0.16405297708332,-0.117385605531901,4.41909586761133e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,42111,-0.0612398997804628,0.00518527296196477,-0.0714030347859137,-0.0510767647750119,4.95977953589694e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42046,-0.0790857665650238,0.00670443426059895,-0.0922264577157977,-0.0659450754142498,5.87964913991612e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41828,-0.122322257819309,0.010379128768324,-0.142665350205224,-0.101979165433393,6.70171664652915e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42172,-0.0716195795629354,0.00608849988614368,-0.083553039339777,-0.0596861197860938,8.6284329975333e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41842,-0.0897191691383639,0.00762999206219807,-0.104673953580272,-0.0747643846964557,9.1590902089228e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,41766,-0.0435012891610485,0.00370745664830041,-0.0507679041917173,-0.0362346741303797,1.23409910054418e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41766,-0.109104589878351,0.00930156866517225,-0.127335664462088,-0.0908735152946133,1.28958107523543e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42063,-0.0638249514431874,0.00544879376552189,-0.0745045872236103,-0.0531453156627645,1.54433495830423e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39927,0.0347335594631503,0.0029670801366741,0.0289180823952691,0.0405490365310316,1.79564645438081e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",39917,-0.0212823915571938,0.0018181228150162,-0.0248459122746256,-0.0177188708397621,1.80921084604357e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,39904,-0.0519516335784375,0.00444245060684833,-0.0606588367678602,-0.0432444303890148,2.06535458536668e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41771,-0.0356950412678759,0.00305382740281391,-0.0416805429773911,-0.0297095395583606,2.08253266540287e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39858,-0.0924336464970024,0.00790823205866561,-0.107933781331987,-0.0769335116620178,2.22053308751144e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,42074,-0.0592337944257585,0.00508465411439904,-0.0691997164899806,-0.0492678723615364,3.25630303693391e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,41766,-0.0802834148852258,0.00691597673210777,-0.093838729280157,-0.0667281004902945,5.28786957509864e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42128,0.0405866098384977,0.00350022486540582,0.0337261691023023,0.0474470505746932,6.08760267958364e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42048,-0.0878240387425282,0.00757756036199275,-0.102676057052034,-0.0729720204330224,6.49378009743173e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39917,0.0336305991454804,0.00290382294018459,0.0279391061827186,0.0393220921082422,7.63195235896256e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,41943,-0.0843055141872755,0.00728327557243171,-0.0985807343092417,-0.0700302940653094,7.72451428277991e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42048,-0.0624254268267296,0.00539539167658633,-0.0730003945128388,-0.0518504591406204,8.16963137797588e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42111,-0.158448265371933,0.0136970898432384,-0.18529456146468,-0.131601969279186,8.35836916490035e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,39752,-0.139392965922287,0.0120576731103986,-0.163026005218668,-0.115759926625905,9.77437467915916e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,41771,-0.049545726440292,0.00429272350521648,-0.0579594645105163,-0.0411319883700677,1.14055467532879e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39696,-0.0682652621014432,0.00591358809087432,-0.0798558947595569,-0.0566746294433295,1.18707209844876e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,42080,0.0638687758769886,0.00553697108535344,0.0530163125496959,0.0747212392042813,1.22428350055329e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,39915,-0.0703751513609645,0.0060994147945681,-0.082330004358318,-0.0584202983636111,1.25881958009104e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39917,-0.0320139618808736,0.00277506267632107,-0.0374530847264629,-0.0265748390352844,1.28377200238114e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42108,-0.119515179663156,0.0103715993794405,-0.139843514446859,-0.0991868448794526,1.39893693958523e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REN,Renin,42072,-0.10212066567915,0.00886581235137963,-0.119497657887854,-0.0847436734704461,1.48015580807714e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42048,-0.0741053975254655,0.00643597318323591,-0.0867199049646079,-0.0614908900863231,1.55475620922864e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39858,-0.0617225543074093,0.00535827303873877,-0.0722247694633373,-0.0512203391514813,1.56696632266731e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39872,-0.101987110552857,0.00888479715799246,-0.119401312982522,-0.0845729081231915,2.48399802744417e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39869,-0.135973293581792,0.0118484090819252,-0.159196175382365,-0.112750411781218,2.56368258137849e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42236,-0.050502354267666,0.00440923793430246,-0.0591444606188988,-0.0418602479164332,3.09547978198479e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42111,-0.0488117459294252,0.00426661353911133,-0.0571743084660834,-0.040449183392767,3.61657383170039e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39674,-0.0828030570503263,0.00723636985871919,-0.0969863419734159,-0.0686197721272367,3.78088091971309e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39858,-0.0556632669496614,0.00487933771327716,-0.0652267688676847,-0.0460997650316382,5.5741724013412e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,41919,-0.06446971582947,0.00565966869728856,-0.0755626664761556,-0.0533767651827845,6.37181118301765e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,41771,-0.0595870774733351,0.00523319404173659,-0.0698441377951388,-0.0493300171515314,6.74587560900943e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39675,-0.0958737577027068,0.0084275267801934,-0.112391710191886,-0.0793558052135278,8.03600089070826e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42174,-0.07793826185768,0.00686120976223268,-0.0913862329916561,-0.064490290723704,9.08987665660263e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,42222,-0.0420212141894,0.0037057937099348,-0.0492845698608722,-0.0347578585179278,1.13801275247374e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,42072,-0.0699763815453087,0.00617096971184755,-0.0820714821805299,-0.0578812809100875,1.13826662164742e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42092,0.0550628960172134,0.00486595149799558,0.0455256310811421,0.0646001609532847,1.4865953614533e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39872,-0.0689998665317898,0.00609789402604664,-0.0809517388228412,-0.0570479942407384,1.58907528278998e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41752,-0.0728561924765422,0.00645923927737916,-0.0855163014602054,-0.0601960834928791,2.26328817680652e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41771,-0.0697554014887235,0.00618925730707768,-0.0818863458105957,-0.0576244571668512,2.50277562812174e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42149,-0.089804487243123,0.00796921182566042,-0.105424142421417,-0.0741848320648286,2.52279490105078e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41766,-0.0657410806617377,0.00583363052019589,-0.0771749964813216,-0.0543071648421538,2.53348888785628e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39868,-0.106932190667123,0.0095090468131223,-0.125569922420843,-0.0882944589134038,3.49271347102937e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42070,-0.0625629475130845,0.00557007200465584,-0.0734802886422099,-0.051645606383959,3.82719265997639e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,41842,-0.0578701419739378,0.00515400257291201,-0.0679719870168453,-0.0477682969310302,4.01363131956937e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41958,-0.0352952372727128,0.00314517862295363,-0.0414597873737019,-0.0291306871717237,4.29026890636496e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39869,-0.0947586902771733,0.00844249091727919,-0.111305972475041,-0.0782114080793061,4.43283037212437e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,39895,-0.0398996416015447,0.00355596983658055,-0.0468693424812425,-0.0329299407218468,4.60883289109326e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42048,0.048340764040485,0.00431392001892795,0.0398854808033862,0.0567960472775838,5.13622065850716e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41943,-0.0496629030056216,0.00443589544875107,-0.0583572580851737,-0.0409685479260695,5.76207764067902e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39590,-0.0858949349801834,0.00767994694693776,-0.100947630996181,-0.0708422389641854,6.96773501268063e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,42174,-0.0742748135150449,0.00665221543372646,-0.0873131557651488,-0.061236471264941,8.03802621846294e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39575,-0.118228756127561,0.0105965766503811,-0.138998046362308,-0.0974594658928135,9.42109696778547e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41943,-0.115300696421253,0.0103459008064749,-0.135578662001944,-0.0950227308405619,1.01897598936199e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41972,-0.0920733808431483,0.00826544917263729,-0.108273661221517,-0.0758731004647792,1.07693455385127e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,42048,0.053820399244529,0.00484137455819223,0.0443313051104722,0.0633094933785858,1.38510306220341e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41995,-0.0651063472677239,0.0058581003065075,-0.0765882238684786,-0.0536244706669692,1.43138295943639e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41995,-0.102977484065337,0.00926773615753322,-0.121142246934103,-0.0848127211965724,1.47174310677033e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39869,-0.0580163852739725,0.00523335673686134,-0.0682737644782207,-0.0477590060697242,2.05975359192029e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,39575,-0.0538417127808881,0.00486038242915607,-0.063368062342034,-0.0443153632197422,2.27576012712801e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42011,-0.0242019455058363,0.00218954767637811,-0.0284934589515374,-0.0199104320601352,2.79578651672044e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,42059,0.0472390077115981,0.00427496597701378,0.0388600743966511,0.0556179410265452,2.8950853904728e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41757,-0.0470915228016711,0.0042624359788319,-0.0554458973201816,-0.0387371482831606,2.98251771058107e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,39869,-0.0820778477905604,0.00744009904831223,-0.0966604419252523,-0.0674952536558684,3.73889632078133e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42063,0.0477655572191889,0.0043327017748668,0.03927346174045,0.0562576526979278,3.84411875627343e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42111,-0.128693524807138,0.0116775020450491,-0.151581428815434,-0.105805620798842,4.00401757148513e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,39597,-0.114874276178274,0.0104310658519751,-0.135319165248145,-0.0944293871084027,4.65063182257761e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,41888,-0.0573557548662419,0.00522164472326965,-0.0675901785238504,-0.0471213312086334,6.00186401651974e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,42072,-0.147518278060698,0.0134353341287721,-0.173851532953091,-0.121185023168305,6.27220832380564e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,42124,-0.0384859452615647,0.0035116152110804,-0.0453687110752822,-0.0316031794478471,7.82389613965683e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41771,-0.0678309632674315,0.00619419295858265,-0.0799715814662535,-0.0556903450686095,8.68453534624102e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,42185,-0.0319955857957855,0.00292644258017243,-0.0377314132529235,-0.0262597583386475,1.04246799733771e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42111,-0.0470855297766819,0.00430765479076382,-0.055528533166579,-0.0386425263867848,1.07411697856473e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39895,-0.0987422435115797,0.00904243857747999,-0.11646542312344,-0.0810190638997189,1.27276132635769e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39872,-0.0756845222828203,0.00693193993381375,-0.0892711245530953,-0.0620979200125454,1.29650759239335e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41766,-0.0457030669042286,0.0041897702552294,-0.0539150166044783,-0.037491117203979,1.38126339439831e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39564,-0.0944366744529437,0.00865650115818551,-0.111403416722987,-0.0774699321829001,1.44106884757926e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39872,-0.0717084494055994,0.00657622346171351,-0.0845978473905579,-0.058819051420641,1.51048843201155e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39872,-0.100841680208552,0.00925066331197493,-0.118972980300023,-0.082710380117081,1.56361089305297e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42222,-0.047221577050398,0.00433582773056116,-0.0557197994022979,-0.0387233546984981,1.6515459531131e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42070,-0.0374595006012128,0.00344572914863628,-0.0442131297325399,-0.0307058714698857,2.05291954755493e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42070,0.039094638589525,0.00359656894262796,0.0320453634619742,0.0461439137170758,2.08217881868905e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,42236,-0.0685497576884217,0.00631570628535397,-0.0809285420077155,-0.0561709733691279,2.47282351684997e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,42124,0.033518597667664,0.00309181227746283,0.0274586456038369,0.0395785497314912,2.84612085615574e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,42010,-0.0386685879809523,0.00357022017621619,-0.045666219526336,-0.0316709564355685,3.18606865024608e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,39869,-0.0846662788708886,0.00782185268059696,-0.0999971101248586,-0.0693354476169185,3.59105346494886e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41924,-0.13174075836348,0.0121854625424985,-0.155624264946777,-0.107857251780183,3.94351184861961e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42048,-0.133593640353569,0.0123597517465027,-0.157818753776714,-0.109368526930423,4.04370427405681e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,41828,-0.0631513945499837,0.00584762324887077,-0.0746127361177704,-0.051690052982197,4.48831603321627e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39453,-0.0628234984967742,0.00581990315126927,-0.0742305086732619,-0.0514164883202864,5.00668169593106e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42072,-0.0436483824749763,0.00404628507986604,-0.0515791012315137,-0.0357176637184388,5.09731977529505e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39868,-0.098443476320056,0.00912990239072808,-0.116338085005883,-0.080548867634229,5.63562332927166e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42137,-0.120666389422501,0.0112026939857745,-0.142623669634619,-0.0987091092103827,6.05450620449357e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42056,-0.0897928704014553,0.00834142928440111,-0.106142071798881,-0.0734436690040291,6.50369737576877e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,39880,0.022317657423755,0.00207293999339528,0.0182546950367003,0.0263806198108098,6.71673498523797e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,39526,-0.0478886204940696,0.00445090539263646,-0.056612395063637,-0.0391648459245021,7.30275740829549e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,42056,-0.0363236464106489,0.00337855996306667,-0.0429456239382596,-0.0297016688830382,7.51732928191066e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41771,-0.0743624478042587,0.00691699518887329,-0.0879197583744503,-0.060805137234067,7.60161530356139e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39512,-0.0737885774395268,0.00687375861164986,-0.0872611443183605,-0.0603160105606931,9.49871064907506e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),39713,0.21401012920017,0.0199425392405775,0.174922752288638,0.253097506111702,9.80570999400437e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,39886,-0.0518552904038626,0.00483728458016,-0.0613363681809762,-0.042374212626749,1.10305679234459e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39603,-0.0319543705449796,0.00298190912487602,-0.0377989124297366,-0.0261098286602226,1.15801705718391e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,39917,-0.0815096233383613,0.00761895375871904,-0.0964427727054506,-0.0665764739712719,1.38922560850754e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42111,-0.12146608929259,0.0113648801109476,-0.143741254310047,-0.0991909242751325,1.48141648650466e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39872,-0.0908621684498153,0.00850555285181633,-0.107533052039375,-0.0741912848602553,1.64251541712093e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,42056,-0.0451749380062559,0.00423267889725771,-0.053470988644881,-0.0368788873676308,1.73967005417208e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,42063,-0.0523398210849226,0.00491960281695357,-0.0619822426061516,-0.0426973995636936,2.49546037513276e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39597,-0.105788291479971,0.00993903135307739,-0.125268792932002,-0.0863077900279391,2.50498016017631e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41771,-0.0676076354029967,0.00636592574197621,-0.08008484985727,-0.0551304209487233,3.06367805470177e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,39868,-0.0630779512827147,0.00593950462656597,-0.074719380350784,-0.0514365222146454,3.19753469893162e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42072,0.0928482648392268,0.00875184871820522,0.0756946413515446,0.110001888326909,3.43362766564075e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39575,-0.0719558189214117,0.00678320422779678,-0.0852508992078933,-0.05866073863493,3.66378914456189e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,41888,-0.0466824360266995,0.00440471772860268,-0.0553156827747607,-0.0380491892786382,3.8592260134883e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,39868,-0.125739796485335,0.0118815099558801,-0.14902755599886,-0.10245203697181,4.74395841726257e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39575,-0.119079046928156,0.0112637834686371,-0.141156062526685,-0.0970020313296275,5.36616236112772e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42236,0.0369496255587522,0.00349823007922291,0.0300930946034752,0.0438061565140291,5.60947697168697e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,41924,-0.0725152837972078,0.0068705905988485,-0.0859816413709509,-0.0590489262234647,6.13251664178178e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,41943,-0.069799431057168,0.00662287689919769,-0.0827802697795955,-0.0568185923347405,7.20505815450418e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39858,-0.0429260574267189,0.00407151413769577,-0.0509062251366026,-0.0349458897168352,7.22092691588847e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,42074,-0.0716499271132301,0.00680542261088713,-0.0849885554305689,-0.0583112987958913,8.05400618550699e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,42063,-0.0670385332429915,0.006374318881246,-0.0795321982502336,-0.0545448682357493,9.08157549016627e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39869,-0.0468697785315159,0.00445553735245714,-0.0556026317423319,-0.0381369253206999,9.25123066780691e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39889,0.0170672907153573,0.00162291478024747,0.0138863777460722,0.0202482036846423,9.5430751415536e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42092,-0.0599355757589868,0.00570625312094899,-0.0711198318760468,-0.0487513196419268,1.04598960512453e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,42142,-0.115550714305677,0.0110311835341909,-0.137171834032691,-0.093929594578663,1.41071221822019e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,39575,-0.0447188247912392,0.00428221734362239,-0.0531119707847391,-0.0363256787977393,2.07668617448089e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39675,-0.0330432232002455,0.00316512195867294,-0.0392468622392444,-0.0268395841612465,2.14009913155337e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,41828,-0.0614138858295914,0.0058859766698472,-0.072950400102492,-0.0498773715566909,2.17747255936082e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,39869,-0.108747964463364,0.010435611169486,-0.129201762355556,-0.088294166571171,2.59519644444711e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,42072,-0.0775241721487883,0.00745115645780906,-0.0921284388060941,-0.0629199054914826,2.95347792431861e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39675,-0.0455351053145718,0.00437698584042023,-0.0541139975617954,-0.0369562130673481,3.12950524786781e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,42072,0.0578212974965007,0.00556258370230644,0.0469186334399801,0.0687239615530214,3.2649374676895e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39575,-0.0603133368388188,0.00580520276441974,-0.0716915342570815,-0.0489351394205562,3.61955982266477e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42032,-0.0724353933987632,0.00697757986716308,-0.0861114499384029,-0.0587593368591236,3.76027128320687e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,42048,-0.0373143660469126,0.00360063110683784,-0.0443716030163148,-0.0302571290775105,4.52616140054224e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39426,-0.0347847755226538,0.00336173112200726,-0.0413737685217881,-0.0281957825235196,5.6279916847572e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39872,-0.0545483128593487,0.00528074573102627,-0.0648985744921601,-0.0441980512265372,6.68140159940843e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,39872,-0.07518757657063,0.0072789072544183,-0.0894542347892899,-0.0609209183519702,6.69152648158179e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42145,-0.0749910855260287,0.00727223545184409,-0.0892446670116431,-0.0607375040404142,7.68651963233246e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41842,-0.0669546495705403,0.00649488321506377,-0.0796846206720653,-0.0542246784690153,7.978162284243e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,42072,0.0353569638948732,0.00343005193460147,0.0286340621030543,0.0420798656866921,8.01764430915959e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39590,-0.0550320829374477,0.00533863646336721,-0.0654958104056474,-0.0445683554692479,8.38563146753592e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39575,-0.0426143162742993,0.00413723134273518,-0.0507232897060602,-0.0345053428425383,9.11510691218798e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39597,-0.109294307531667,0.0106168498308253,-0.130103333200085,-0.0884852818632498,9.66906479383868e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,42201,-0.0764997872193629,0.00744071280484447,-0.0910835843168581,-0.0619159901218678,1.05428449773304e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39675,-0.0763349019748642,0.00742462321279375,-0.0908871634719399,-0.0617826404777885,1.10440035844157e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39895,-0.121337022653092,0.011805342155094,-0.144475493277076,-0.0981985520291073,1.13536805018629e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,41943,0.038707496156604,0.00376742199042292,0.0313233490553751,0.0460916432578329,1.13733294939552e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,42002,-0.0432299850701744,0.00421897012442002,-0.0514991665140376,-0.0349608036263111,1.51031388851095e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,39858,-0.0411134657241457,0.00401678126544663,-0.0489863570044211,-0.0332405744438703,1.76109463169824e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41882,-0.0393821709575992,0.00384914815297173,-0.0469265013374238,-0.0318378405777746,1.76788196939844e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42048,-0.0813998004358611,0.00795817288825417,-0.0969978192968393,-0.065801781574883,1.81738142239998e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,39858,-0.0248848020837975,0.00243436837590721,-0.0296561641005756,-0.0201134400670194,2.01452291246847e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39872,-0.074234436586069,0.00726397684628544,-0.0884718312047885,-0.0599970419673495,2.07136769265969e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41766,-0.0653690874731552,0.00643036373756281,-0.0779726003987783,-0.0527655745475321,3.46519401977706e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,42063,-0.0275547241607756,0.00271489351616637,-0.0328759154524617,-0.0222335328690895,4.06877301015094e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,42111,-0.0861214211138405,0.00848980950240904,-0.102761447738562,-0.0694813944891188,4.29422060118053e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39904,-0.0261647467612075,0.00257869841055664,-0.0312189956458986,-0.0211104978765165,4.35565839445307e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41943,-0.0805931898530834,0.00794910043749437,-0.0961734267105724,-0.0650129529955945,4.54946432892848e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42092,0.0870261364398734,0.00859674646039683,0.0701765133774956,0.103875759502251,5.31329345612056e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,41918,-0.0573352900003586,0.00566409896973272,-0.0684369239810347,-0.0462336560196824,5.35776327325813e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42051,-0.0848717633628653,0.00839110523280971,-0.101318329619172,-0.0684251971065583,5.80415513484957e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39597,-0.0612663108800274,0.00606915088420986,-0.0731618466130787,-0.0493707751469761,7.40603895580162e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41828,-0.104839359529549,0.0103938452679316,-0.125211296254695,-0.0844674228044029,7.71648139846889e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,42048,-0.0651045079096738,0.00645624471309076,-0.0777587475473317,-0.052450268272016,7.90578557201485e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,39512,-0.0434661808597939,0.00431073516532511,-0.0519152217838311,-0.0350171399357567,8.33016526636134e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39872,-0.0865398872151343,0.00858357536470128,-0.103363694929949,-0.0697160795003197,8.36832283479637e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41828,-0.0803022877666504,0.00797065746849529,-0.0959247764049011,-0.0646797991283996,8.70540840300128e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,39858,-0.0688858490112265,0.00683767590209148,-0.0822876937793258,-0.0554840042431272,9.03559572241735e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42236,0.0311651491745866,0.00310102487798541,0.0250871404137352,0.037243157935438,1.11121417776814e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,39917,0.0300707255400479,0.00299307933367442,0.024204290046046,0.0359371610340497,1.19278161170623e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41766,-0.0606644429331215,0.00604372837557942,-0.0725101505492572,-0.0488187353169858,1.26698934456844e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42111,-0.094006813898911,0.00936854255768272,-0.112369157311969,-0.0756444704858529,1.30300826852566e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39759,-0.0363054114187259,0.00361701758731501,-0.0433947658898633,-0.0292160569475884,1.31467544368162e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39869,-0.112935847250327,0.0112534756577351,-0.134992659539488,-0.0908790349611665,1.33496165583066e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39872,-0.0539191565417356,0.00537300888936576,-0.0644502539648925,-0.0433880591185787,1.34096928717837e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,41995,-0.0975626475032802,0.00972917429528393,-0.116631829122037,-0.0784934658845237,1.39272948211993e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42088,-0.0770255180562796,0.00769051657570968,-0.0920989305446706,-0.0619521055678887,1.57215817814284e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39868,-0.0456408868342751,0.00455541487262013,-0.0545694999846106,-0.0367122736839397,1.57699662374771e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39675,-0.06320173945838,0.0063087713231482,-0.0755669312517505,-0.0508365476650096,1.59861469004041e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,39675,-0.0375804214739778,0.00375252323515692,-0.0449353670148854,-0.0302254759330703,1.6534878877642e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42048,-0.111406314939291,0.0111319247885279,-0.133224887524806,-0.0895877423537765,1.70159050070298e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41766,-0.0544476230326351,0.00544277095919623,-0.0651154541126597,-0.0437797919526105,1.78129053403292e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42072,0.0295639418373302,0.00295624609923549,0.0237696994828287,0.0353581841918318,1.8305845600994e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39895,-0.0279035111263783,0.00279181526211013,-0.0333754690401141,-0.0224315532126424,2.01018290689407e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42063,-0.0330298876675514,0.00330592932714357,-0.0395095091487528,-0.02655026618635,2.01154228328664e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,39675,-0.0641022996852974,0.00642052673637573,-0.0766865320885939,-0.051518067282001,2.24914248442891e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,39858,-0.0362391398724479,0.00363125312736839,-0.0433563960020899,-0.0291218837428058,2.33632008105993e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,42108,-0.0585601997805379,0.00587652904804859,-0.0700781967147132,-0.0470422028463627,2.60752124137746e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41771,-0.0843528349660915,0.00846887579737964,-0.100951831528956,-0.0677538384032274,2.7475392774057e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39883,0.0795597184302236,0.00799697703915816,0.0638856434334736,0.0952337934269736,3.18341175007806e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,39858,-0.0441839787907064,0.00444236871836502,-0.0528910214787019,-0.035476936102711,3.27122706927526e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39869,-0.0909190655108201,0.00915569133510869,-0.108864220527633,-0.0729739104940071,3.82375374653941e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39575,-0.0842344380896918,0.00848257218510341,-0.100860279572495,-0.0676085966068891,3.84758717168044e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42187,0.0365219323879778,0.00368071568626531,0.0293077296428978,0.0437361351330578,3.98270206863455e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,42187,-0.120289650863153,0.0121246300950078,-0.144053925849369,-0.0965253758769381,4.03895499176232e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42108,-0.0658663059518547,0.00664884769433518,-0.0788980474327516,-0.0528345644709577,4.67817332687455e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,41828,-0.0610787114477481,0.00616720767022012,-0.0731664384813795,-0.0489909844141167,4.82064839897207e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,41766,-0.0771185276025706,0.00780565107415694,-0.0924176037079182,-0.061819451497223,6.11859734125836e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39675,-0.0728106236666867,0.0073670924582437,-0.0872501248848443,-0.058371122448529,6.12431465736316e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42222,-0.0596509068551414,0.00604126423324439,-0.0714917847523004,-0.0478100289579824,6.44862283936429e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42041,-0.086778280566862,0.00879564201403658,-0.104017738914374,-0.0695388222193503,6.98668995402508e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,39675,-0.0718185092687762,0.00727919112847929,-0.0860857238805957,-0.0575512946569568,7.2415028293529e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39675,-0.0565158270938302,0.00573918012412559,-0.0677646201371164,-0.0452670340505441,8.72708220614208e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,39575,-0.0747547390464961,0.0075971714340392,-0.0896451950572129,-0.0598642830357792,9.42031942756758e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39868,-0.0364643289389225,0.00370731018831702,-0.0437306569080238,-0.0291980009698211,9.74626017566214e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41706,-0.0352507442589549,0.00359489411413877,-0.0422967367226669,-0.0282047517952429,1.27180189179555e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39872,-0.0711014151774345,0.00724930881972788,-0.0853100604641012,-0.0568927698907679,1.28063572240944e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,39597,-0.0499912233287772,0.00509708358163957,-0.0599815071487908,-0.0400009395087637,1.29003951825965e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,39675,-0.0583812253823734,0.00595303684625661,-0.0700491776010363,-0.0467132731637104,1.29883488385375e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42072,-0.078812319032529,0.00804698891799766,-0.0945844173118044,-0.0630402207532536,1.42085932090317e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41984,-0.050521921366583,0.00516840193091189,-0.0606519891511703,-0.0403918535819957,1.71172547343447e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39858,-0.0664983908872242,0.00680268375008152,-0.079831651037384,-0.0531651307370644,1.76550744637641e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,42187,0.0177743441082971,0.00182026465979777,0.0142066253750935,0.0213420628415008,1.89146344072117e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,41771,-0.102522365797737,0.0105226934593629,-0.123146844978088,-0.0818978866173854,2.35196208774384e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,39575,-0.0335333732772978,0.0034406156228514,-0.0402769798980865,-0.0267897666565091,2.3563385304476e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,41924,-0.0736311834383445,0.00756144184894055,-0.0884516094622679,-0.058810757414421,2.47109825420937e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42049,-0.0471938599026659,0.00485325930782962,-0.056706248146012,-0.0376814716593199,2.81638980697069e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39895,-0.0634549385650601,0.006526432184035,-0.0762467456457687,-0.0506631314843515,2.94793348915989e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,39895,-0.0575395315758758,0.00593217999636618,-0.0691666043687535,-0.0459124587829981,3.69460229601329e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42057,-0.0601689388732759,0.00620889369797921,-0.0723383705213151,-0.0479995072252366,3.89850990020293e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39575,-0.033316468187024,0.0034442646240153,-0.040067226850094,-0.026565709523954,4.80719107476156e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39868,-0.0327415331043413,0.00338597947413444,-0.0393780528736448,-0.0261050133350378,4.93704346898696e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,41668,-0.0880768458562124,0.00911139881996392,-0.105935187543342,-0.0702185041690831,4.95082988836933e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42111,-0.115307095389648,0.0119555710568921,-0.138740014661156,-0.0918741761181392,6.09527673343383e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39512,-0.0452300473673606,0.00469050340980294,-0.0544234340505743,-0.0360366606841468,6.44194540602466e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41771,-0.0601560399806259,0.00625372741993931,-0.072413345723707,-0.0478987342375449,7.82429895115406e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39895,-0.0965034552628563,0.0100295383108395,-0.116161350352102,-0.076845560173611,7.83458232214926e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,39869,-0.0735237513156249,0.00764955423900859,-0.0885168776240818,-0.0585306250071681,8.66589084049686e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42026,-0.0874272901090733,0.00909974857457485,-0.10526279731524,-0.0695917829029066,8.72109084138029e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,41919,-0.0338359882569574,0.003523668975339,-0.0407423794486218,-0.0269295970652929,9.17879415312128e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42046,-0.103100304216821,0.0107471584403096,-0.124164734759828,-0.0820358736738143,1.00166860799897e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39575,-0.0513721862605848,0.00535532641803798,-0.0618686260399392,-0.0408757464812304,1.04358762972924e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,39872,-0.0579538367752818,0.00605382805755129,-0.0698193397680823,-0.0460883337824813,1.25381100740795e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,42011,-0.087396429144782,0.00913922782586976,-0.105309315683487,-0.0694835426060772,1.34332176232617e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41771,-0.0373451650157056,0.00390614434702046,-0.0450012079358657,-0.0296891220955455,1.37540528096345e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39601,-0.0412259108052781,0.00431237926978805,-0.0496781741740627,-0.0327736474364936,1.42947472423325e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41995,-0.0473955370772722,0.00496031513136931,-0.0571177547347561,-0.0376733194197884,1.44849334815595e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39895,-0.104335693928389,0.0109186223149367,-0.125736193665665,-0.0829351941911134,1.47995690831784e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41828,-0.0392199485308834,0.00411039229653808,-0.047276317432098,-0.0311635796296688,1.6485303923404e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41995,0.0445778140996794,0.00467528161166315,0.0354142621408196,0.0537413660585391,1.75712932104527e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,42069,-0.109818036264109,0.0115330212789016,-0.132422757970756,-0.0872133145574616,1.9830729226006e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,39429,-0.073568350289759,0.00772481327270714,-0.088708984304265,-0.058427716275253,2.02814691382674e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39526,-0.0877433121608719,0.00922271947976506,-0.105819842341211,-0.0696667819805324,2.22357701780715e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,41809,-0.0538627746861534,0.00566924229673587,-0.0649744895877557,-0.0427510597845511,2.43487210771644e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,39675,-0.0322653877652812,0.00339724079824775,-0.0389239797298468,-0.0256067958007156,2.59054885238065e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,41943,-0.0999304465253909,0.01054624877545,-0.120601094125273,-0.0792597989255088,3.09744334089575e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39872,-0.0982258641134256,0.0103642267908801,-0.118539748623551,-0.0779119796033006,3.12734205959552e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39868,-0.0866442310486061,0.0091487706169137,-0.104575821457757,-0.0687126406394553,3.33650916731094e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39597,-0.0815904559280249,0.00861494475404877,-0.0984757476459605,-0.0647051642100893,3.34448540024039e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39869,-0.151547880917953,0.0160159702589042,-0.182939182625405,-0.120156579210501,3.60965452729363e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42222,-0.0690574211698264,0.00730676207325485,-0.0833786748334059,-0.0547361675062469,3.88933464773157e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,41997,-0.0457532552054605,0.00484126561120397,-0.0552421358034203,-0.0362643746075008,3.91704204393501e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,41995,-0.0573486087583532,0.00607440788062398,-0.0692544482043762,-0.0454427693123302,4.2930561980547e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,42041,-0.0418878610004311,0.00443683800041233,-0.0505840634812392,-0.0331916585196229,4.29467549748349e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,41766,-0.0531054645838521,0.00563877629160827,-0.0641574661154043,-0.0420534630522999,5.35745988015146e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,41901,0.0282460362360095,0.00299956377539399,0.0223668912362372,0.0341251812357817,5.40984428504187e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39872,-0.0688603764229927,0.00731102919278064,-0.0831899936408428,-0.0545307592051427,5.45440211372828e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,39868,-0.0743679116525001,0.00790510911379687,-0.089861925515542,-0.0588738977894583,6.05880781516107e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39512,-0.0685917409844007,0.00729758107108478,-0.0828949998837269,-0.0542884820850745,6.59182475500249e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39353,-0.0509133153981566,0.00542091069646504,-0.0615383003632281,-0.0402883304330851,7.07482831469623e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,41995,-0.0789398896958447,0.0084146549104246,-0.0954326133202769,-0.0624471660714125,7.55407668532763e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,41995,-0.0329262818451711,0.00350996059830877,-0.0398058046178563,-0.0260467590724859,7.58451403720502e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,39675,-0.0523390201081723,0.0055785238607408,-0.0632729268752243,-0.0414051133411203,7.71671265171544e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39872,-0.0787050048530769,0.0083916080147358,-0.0951525565619591,-0.0622574531441948,7.92966570575236e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,39868,-0.0780910777946153,0.00833136153272082,-0.0944205463987481,-0.0617616091904825,8.38007808413581e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,39297,-0.0249292785633982,0.00265942357634958,-0.0301417487730434,-0.019716808353753,8.3951042118449e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,39869,-0.0609704255347686,0.00650899108516081,-0.0737280480616838,-0.0482128030078534,8.86945526650686e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,39675,-0.0553738988507486,0.00591309922648203,-0.0669635733346534,-0.0437842243668438,9.10722467970034e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42050,-0.0972419271301198,0.0103966423518305,-0.117619346139708,-0.076864508120532,9.82860091084628e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39869,-0.0777502460216021,0.00831446849456983,-0.094046604270959,-0.0614538877722452,1.0298703483896e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39575,-0.0625823179385719,0.00669242776528281,-0.0756994763585262,-0.0494651595186176,1.03447779255843e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42149,-0.0599265606454977,0.00641220227696167,-0.0724944771083426,-0.0473586441826528,1.05347499408129e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,41620,-0.0919922005756221,0.00986429705175949,-0.111326222797071,-0.0726581783541735,1.27739017666745e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,42072,-0.0557583946500251,0.00598674476298576,-0.0674924143854772,-0.044024374914573,1.42402248748086e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39575,-0.0771247637173042,0.00829907509969624,-0.0933909509127089,-0.0608585765218996,1.78019389767249e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39917,-0.0317274623628435,0.00341961975389895,-0.0384299170804855,-0.0250250076452016,2.0387414474745e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39872,-0.12083538776372,0.0130312443710765,-0.146376626731029,-0.0952941487964096,2.14375180169357e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39858,-0.0876449505298556,0.00945831635781401,-0.106183250591171,-0.0691066504685402,2.27364449416697e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39590,-0.0741301278636506,0.00800386100344787,-0.0898176954304084,-0.0584425602968928,2.38364853208043e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,39575,-0.0752097817587629,0.00812494562122323,-0.0911346751763604,-0.0592848883411654,2.5009669445576e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41828,-0.0578419624943283,0.00626049758884918,-0.0701125377684727,-0.0455713872201839,2.85771318058393e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39579,-0.0861668915939946,0.00932553091758293,-0.104444932192457,-0.067888850995532,2.92171115929806e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,39868,-0.0942261291661182,0.0102147821853163,-0.114247102249338,-0.0742051560828982,3.35556543882925e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42048,-0.10513656699521,0.0114069433429552,-0.127494175947402,-0.0827789580430179,3.50645853051791e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,39804,-0.0962121731354559,0.0104676591364343,-0.116728785042867,-0.0756955612280446,4.56150104155878e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42048,-0.0962772016947979,0.0104857797735915,-0.116829330051037,-0.0757250733385585,4.85550973013331e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39675,-0.0725790565909334,0.00791155334058997,-0.0880857011384897,-0.057072412043377,5.37355430204837e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39872,-0.0771143224128923,0.0084070700387064,-0.0935921796887569,-0.0606364651370278,5.42040621736247e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,41995,0.0781695500121643,0.00852493379212241,0.0614606797796043,0.0948784202447242,5.4353469908936e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,39512,-0.0664294393592611,0.00724696205837992,-0.0806334849936857,-0.0522253937248365,5.76014789255049e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,41766,-0.0682039449152632,0.00745860916165387,-0.0828228188721048,-0.0535850709584216,6.87007024759501e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,39927,-0.0733203388248942,0.00802136789341157,-0.0890422198959808,-0.0575984577538075,7.26441244791385e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42222,-0.0547501397580587,0.0059922404474045,-0.0664949310349715,-0.0430053484811459,7.32621692091186e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42063,-0.0421392303774403,0.00461218475426665,-0.0511791124958029,-0.0330993482590776,7.36032638173825e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39868,-0.0682503338864905,0.00747684238497863,-0.0829049449610487,-0.0535957228119324,8.14611071814277e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41765,-0.0792234550488635,0.00868248540908747,-0.096241126450675,-0.0622057836470521,8.24095469816716e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42048,-0.0726233235198269,0.00796534850442436,-0.0882354065884987,-0.0570112404511552,8.77125667751072e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39597,-0.048903584575839,0.00536368729978426,-0.0594164116834161,-0.0383907574682618,9.01956649460208e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,39597,-0.0425561864085625,0.00466754712288718,-0.0517045787694214,-0.0334077940477036,9.02520508696238e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,39597,-0.045262048698658,0.0049650114469931,-0.0549934711347645,-0.0355306262625516,9.12994196717647e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39868,-0.044325696039866,0.00486737326491664,-0.0538657476391026,-0.0347856444406294,9.92157239184353e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42174,-0.0685083612319781,0.00753300561582055,-0.0832730522389864,-0.0537436702249698,1.08126071273546e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42108,-0.0551173439217729,0.00606157804299283,-0.0669980368860388,-0.0432366509575069,1.09710597372693e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,42050,0.0572052730638792,0.00629766667817236,0.0448618463746613,0.069548699753097,1.19550363741917e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41995,0.0403562091191342,0.00444943271775996,0.0316353209923247,0.0490770972459437,1.35422742621879e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39590,-0.0790462485185972,0.0087185791808404,-0.0961346637130444,-0.06195783332415,1.43856746131494e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,39917,-0.0270200729572917,0.00298191358697795,-0.0328646235877685,-0.0211755223268149,1.50009410053903e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39872,-0.0402939257382106,0.00445442198571,-0.0490245928302022,-0.031563258646219,1.72815453676342e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39868,-0.063139691688082,0.0069818366458377,-0.0768240915139239,-0.0494552918622401,1.76642085645897e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,41922,0.0270555396661806,0.00299639408975705,0.0211826072502568,0.0329284720821044,1.96103153738973e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,42172,-0.0508900980745301,0.00563866273408014,-0.0619418770333272,-0.039838319115733,2.03176751357077e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41995,-0.0196603520651374,0.00217920671427091,-0.0239315972251084,-0.0153891069051664,2.09915199688177e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41842,-0.0540457603413545,0.00599432539171058,-0.0657946381091072,-0.0422968825736017,2.21253989969692e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,39839,-0.0448886068928009,0.00498118372227896,-0.0546517269884677,-0.0351254867971342,2.3576155148335e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,41919,-0.045325353243985,0.00503326968735315,-0.0551905618311972,-0.0354601446567728,2.44278015067568e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39696,-0.0563408776590272,0.00625510606930078,-0.0686008855548567,-0.0440808697631977,2.45928978935949e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39872,-0.105137141368787,0.0116943570520825,-0.128058081190869,-0.0822162015467055,2.85513861545247e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,39590,-0.129878016502457,0.0144540424630549,-0.158207939730045,-0.10154809327487,2.99376103880265e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39652,-0.0848495141898718,0.00944365830634256,-0.103359084470303,-0.0663399439094404,3.01210559212099e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,41924,-0.0787109188256773,0.00876437187612375,-0.0958890877028799,-0.0615327499484748,3.0451221537542e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,42213,0.0431139458181183,0.00480322718839091,0.0336996205288721,0.0525282711073645,3.17014018182555e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,39895,-0.0639037692364572,0.00711880866836716,-0.0778566342264568,-0.0499509042464576,3.2290730440599e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,39590,-0.080968876823032,0.00902242944624663,-0.0986528385376754,-0.0632849151083886,3.31830311797381e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,39590,-0.0490197954954109,0.00547141645516305,-0.0597437717475305,-0.0382958192432913,3.79591932452396e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,39845,-0.0320104619803214,0.00357340724522573,-0.0390143401809638,-0.025006583779679,3.82715753477151e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,39808,-0.0318450519868617,0.00355561477342199,-0.0388140569427688,-0.0248760470309546,3.8878530894637e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,42111,-0.0907456968759989,0.0101421117933494,-0.110624235990964,-0.0708671577610341,4.10730472648704e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39927,-0.0469050354943805,0.00524811166660816,-0.0571913343609325,-0.0366187366278285,4.59544662360923e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42063,-0.0377326312041857,0.00422447692914267,-0.0460126059853053,-0.029452656423066,4.72429830132526e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,42077,-0.0395183353463912,0.00442855823212489,-0.048198309481356,-0.0308383612114265,5.0932656968549e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42174,-0.0452419441532388,0.00507145470667888,-0.0551819953783294,-0.0353018929281482,5.21009142996148e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41943,-0.0781877300617062,0.0087831656414835,-0.0954027347190139,-0.0609727254043985,6.18518296162721e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42174,-0.0630018398364338,0.00708582900215042,-0.0768900646806486,-0.049113614992219,6.79653642145932e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,41747,-0.0462760900039795,0.00521433251612884,-0.0564961817355921,-0.036055998272367,7.90373938754084e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,42026,-0.0467150659293152,0.00526676406642147,-0.0570379234995013,-0.0363922083591291,8.24417945887753e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39564,-0.0552596358435434,0.0062382444008353,-0.0674865948691806,-0.0430326768179062,9.38406730690861e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39858,-0.0343817873693748,0.00388616362112466,-0.0419986680667791,-0.0267649066719704,1.03083168353848e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,39872,-0.0502620114582526,0.00568444851702405,-0.0614035305516197,-0.0391204923648855,1.0795355367058e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42236,-0.0345836853798704,0.00391537386856137,-0.0422578181622507,-0.0269095525974901,1.14423126389514e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39895,-0.046906314143311,0.00531348199892103,-0.0573207388611962,-0.0364918894254258,1.22465239788737e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42174,-0.0294594625624454,0.00333856538766458,-0.036003050722268,-0.0229158744026228,1.23800562492398e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41828,0.0212282784976013,0.00241600698439925,0.0164929048081788,0.0259636521870238,1.73092148222854e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42174,-0.0598554091663968,0.00681504335962872,-0.0732128941512691,-0.0464979241815245,1.78293457431359e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,39868,-0.0451418145153176,0.00513966689671525,-0.0552155616328795,-0.0350680673977558,1.82106742836452e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41771,-0.0430490186401248,0.00490329693342495,-0.0526594806296377,-0.0334385566506119,1.8408440041003e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42023,-0.0651345229339686,0.00742086779007846,-0.0796794238025224,-0.0505896220654149,1.8761904620743e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42048,0.0503718038638733,0.00574869100556306,0.0391043694929697,0.0616392382347769,2.13962668606601e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39597,-0.0560866859165178,0.00639922320677525,-0.0686291634017973,-0.0435442084312384,2.14944301253344e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,42092,-0.083609236980607,0.00954980448945031,-0.10232685377993,-0.0648916201812844,2.27978726971998e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39904,-0.0529381463295397,0.00604936751938914,-0.0647949066675424,-0.0410813859915369,2.41378604133627e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39696,-0.0478376090498758,0.00547014112348322,-0.0585590856519029,-0.0371161324478487,2.5464047089308e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41771,-0.0867638524430267,0.00993297814099391,-0.106232489599375,-0.0672952152866787,2.72963160188064e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39858,-0.0277384523479928,0.00317480279279033,-0.0339610658218618,-0.0215158388741237,2.73057642357711e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,39858,-0.0386212480640543,0.00442278912858897,-0.0472899147560887,-0.0299525813720199,2.84656705658064e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42114,0.0286093414446781,0.00328262519662361,0.0221753960592958,0.0350432868300604,3.23183116259199e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39597,-0.0330849121740247,0.00379944797198642,-0.0405318301991181,-0.0256379941489313,3.54023726787605e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42048,-0.0628418514400433,0.00722524552653825,-0.0770033326720582,-0.0486803702080283,3.78133064948603e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41828,-0.073101422629955,0.00840893808503529,-0.0895829412766241,-0.0566199039832858,3.93140140676242e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39869,-0.0471352633587814,0.00542335033004774,-0.057765030005675,-0.0365054967118879,4.08254412357001e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,39868,-0.0599329303549489,0.00689720003106856,-0.0734514424158433,-0.0464144182940545,4.14418766016991e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,42055,-0.0298067267950404,0.00343606542738963,-0.036541415032724,-0.0230720385573567,4.61873346307559e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,42009,-0.0831887749286242,0.00960079983277759,-0.102006342600868,-0.0643712072563801,5.03735810601526e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42198,-0.0314883037087094,0.0036375692958975,-0.0386179395286685,-0.0243586678887503,5.41055899292582e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39927,-0.0629846311526828,0.0072754404245524,-0.0772444943848055,-0.0487247679205601,5.49012150324004e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42063,0.0493017906116216,0.00569797186274473,0.038133765760642,0.0604698154626013,5.60349559948711e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42039,-0.0253691735635422,0.00294024480731632,-0.0311320533858822,-0.0196062937412022,6.92258802661682e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39597,-0.0524676847280555,0.00607914745736438,-0.0643828137444896,-0.0405525557116213,6.93302790069149e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,42222,-0.0462508661856887,0.00537651692061218,-0.0567888393500885,-0.0357128930212888,8.65327551971471e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41771,-0.0426466098620317,0.00496160755726754,-0.0523713606742761,-0.0329218590497873,9.23168099334855e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,39917,-0.0388168756654975,0.00451658759578307,-0.0476693873532323,-0.0299643639777627,9.47662698328683e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,42142,0.0453502827514448,0.00528444353489564,0.0349927734230494,0.0557077920798403,1.03436140130884e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42092,-0.0715052738109143,0.00833372460548633,-0.0878393740376676,-0.0551711735841611,1.04931792013471e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42072,-0.0756072551451226,0.00882772370193313,-0.0929095936009116,-0.0583049166893337,1.19963340958939e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,39852,-0.0914717954977241,0.010679571241401,-0.11240375513087,-0.0705398358645781,1.22008534379854e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,42063,-0.025319722594233,0.00295784176869823,-0.0311170924608815,-0.0195223527275845,1.24774713165017e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42236,-0.0672434917450365,0.00786260299846854,-0.0826541936220348,-0.0518327898680381,1.33379320442769e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42108,-0.0665496437935932,0.00778393877881978,-0.08180616380008,-0.0512931237871065,1.36659376242535e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,39575,-0.0821742080902713,0.00961790165733955,-0.101025295338657,-0.0633231208418858,1.46942345970633e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39575,-0.0855863739905932,0.0100192205172846,-0.105224046204471,-0.0659487017767154,1.49058030951557e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,41842,-0.0507138279061196,0.00594834129449973,-0.0623725768433391,-0.0390550789689002,1.6820319175081e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,42174,0.0349776771163039,0.00410329626428234,0.0269352164383105,0.0430201377942973,1.69847471077108e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,39868,-0.0209509425122058,0.00246249199781312,-0.0257774268279195,-0.0161244581964921,1.99267340468125e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,42003,-0.0214751748969716,0.00252757556788884,-0.0264292230100337,-0.0165211267839094,2.16112262900205e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,42048,-0.0615579513922439,0.00725276289311328,-0.075773366662746,-0.0473425361217419,2.33016016757402e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42142,-0.0298464753397368,0.00352046142690968,-0.0367465797364797,-0.0229463709429938,2.52600657893807e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,39868,-0.127655787734553,0.0150578194523823,-0.157169113861223,-0.098142461607884,2.58254032052021e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39597,-0.0470701750012581,0.00555466147742634,-0.0579573114970137,-0.0361830385055025,2.6733557314627e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39917,-0.0153230638807445,0.00181151971187522,-0.0188736425160199,-0.0117724852454691,3.03606775042699e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42023,-0.0628602472047517,0.00743603555601829,-0.0774348768945476,-0.0482856175149559,3.11722494210489e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39887,-0.0363849217322451,0.00430627230513444,-0.0448252154503086,-0.0279446280141816,3.28991844297088e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39872,-0.0726737397624721,0.00860131735359496,-0.0895323217755182,-0.0558151577494259,3.29446636923539e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39869,-0.0594660867828231,0.00704832681033701,-0.0732808073310836,-0.0456513662345625,3.65576452893415e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42032,-0.0316627689708218,0.00375655439483513,-0.0390256155846987,-0.024299922356945,3.84920454281178e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39597,-0.0411460183533477,0.00488359793525738,-0.0507178703064522,-0.0315741664002433,4.04424391633444e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,42007,-0.0959728879363254,0.0113980501274895,-0.118313066186205,-0.0736327096864461,4.14022390023463e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,42029,-0.0609444170484154,0.00724906438244086,-0.0751525832379995,-0.0467362508588313,4.61850641565254e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39675,-0.039465759984888,0.00469528283438899,-0.0486685143402904,-0.0302630056294855,4.78518950271408e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,39904,0.0471397758796808,0.00561658079031251,0.0361312775306683,0.0581482742286934,5.30401980333396e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42063,-0.0510560068593388,0.00610266232594421,-0.0630172250181895,-0.0390947887004882,6.53288933729918e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,39590,-0.0397149483002974,0.00474814556560034,-0.0490213136088741,-0.0304085829917207,6.77726366437726e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41943,-0.0721760557400362,0.00863322909476059,-0.0890971847657669,-0.0552549267143054,6.87337766256445e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39872,-0.0492231513779899,0.00588918776443737,-0.0607659593962871,-0.0376803433596926,7.11343198186009e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39872,-0.0572910868968779,0.00685506227939007,-0.0707270089644824,-0.0438551648292733,7.15779322826871e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42111,0.0186033056600754,0.00222707209540321,0.0142382443530851,0.0229683669670657,7.28298676032482e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42048,-0.0769961866482294,0.00921873845615382,-0.0950649140222909,-0.058927459274168,7.3550758581834e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,41580,0.02872535655707,0.00344318225652393,0.0219767193342831,0.0354739937798569,7.99154478078928e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,42070,-0.0270431186064949,0.00324234358245194,-0.0333981120281007,-0.0206881251848891,8.10370096380668e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42174,-0.0464568963073351,0.00557177926450186,-0.0573775836657588,-0.0355362089489115,8.28517564459973e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39858,-0.076740031222244,0.00921318464686739,-0.0947978731301041,-0.0586821893143839,9.06782917836437e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,41986,-0.0506890575534305,0.00608857307115174,-0.0626226607728879,-0.0387554543339731,9.22368690524153e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41995,-0.106399173144375,0.0127804984143072,-0.131448950036417,-0.081349396252333,9.2353504390476e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39512,-0.0613659371130584,0.00738117171812894,-0.0758330336805911,-0.0468988405455256,1.03641924767253e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41771,-0.0552483018495478,0.00664804257581357,-0.0682784652981424,-0.0422181384009532,1.0460272514338e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39858,-0.0476094517387353,0.0057277114966598,-0.0588357662721885,-0.0363831372052821,1.04788716484286e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39675,-0.0627740239473452,0.00755308215469797,-0.0775780649705532,-0.0479699829241371,1.05927662902688e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41771,-0.0890523337982569,0.010718279755146,-0.110060162118343,-0.0680445054781706,1.06377916511538e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,42108,-0.063464242107751,0.00765485038465142,-0.0784677488616678,-0.0484607353538342,1.23121926330266e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39904,0.0299534477987515,0.00361339938462774,0.0228711850048812,0.0370357105926219,1.26520520237027e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39917,-0.0298409958752338,0.00360358190824655,-0.0369040164153971,-0.0227779753350706,1.3595056821644e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,41671,0.0831100512824036,0.0100417358472698,0.0634282490217547,0.102791853543052,1.39119933894274e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41995,-0.0815730834731511,0.00986253207659056,-0.100903646343269,-0.0622425206030336,1.45278830253225e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42222,0.0230624885888079,0.00278981242958161,0.0175944562268279,0.0285305209507878,1.50396927393382e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41943,-0.0505408265370381,0.00611530426645451,-0.0625268228992889,-0.0385548301747873,1.53251209777455e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42072,-0.116660584534689,0.0141453848414593,-0.144385538823949,-0.088935630245429,1.76995859850334e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,39868,-0.0621676137426906,0.00755343871055495,-0.0769723536153783,-0.0473628738700029,2.07165178489826e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,39512,-0.044118327345249,0.00536963030311608,-0.0546428027393565,-0.0335938519511415,2.3365067241509e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41828,-0.0377548997519975,0.00459985612590432,-0.04677061775877,-0.0287391817452251,2.45913655986147e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,39917,-0.0308328581528346,0.00376531702116895,-0.0382128795143257,-0.0234528367913434,2.9250504152051e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42070,-0.0229821523633878,0.00280916748301666,-0.0284881206301005,-0.0174761840966751,3.06253020837685e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42063,-0.0687114496944735,0.00840533169915109,-0.0851858998248096,-0.0522369995641374,3.22830495916946e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39868,0.0330441544555872,0.00404261793042341,0.0251206233119574,0.0409676855992171,3.30368242125758e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,39640,-0.0583441632715225,0.00713763463587325,-0.072333927157834,-0.0443543993852109,3.30486766030631e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42111,-0.114111464990581,0.0139927546476239,-0.141537264099923,-0.0866856658812378,3.79657990228526e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42048,-0.0544794585261756,0.00668162517216683,-0.0675754438636226,-0.0413834731887286,3.84258906253737e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39575,-0.0379452809819968,0.00465357036474996,-0.0470662788969068,-0.0288242830670869,3.90345589621725e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41943,-0.0514352470430799,0.00630969772896193,-0.0638022545918453,-0.0390682394943145,3.90403911758418e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41771,-0.0514355136568878,0.00631408367346747,-0.063811117656884,-0.0390599096568915,4.09330745244462e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39869,-0.0793917873020819,0.00974550049533725,-0.0984929682729429,-0.0602906063312209,4.14084241883387e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,39869,-0.0703187295205305,0.00863477108781415,-0.0872428808526462,-0.0533945781884148,4.23847874976453e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42063,-0.0267992630019568,0.00329739953771264,-0.0332621660958735,-0.02033635990804,4.76669231830051e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,41771,-0.0396200675949254,0.00487561573136715,-0.049176274428405,-0.0300638607614457,4.82375751351229e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,39846,-0.0763292194595379,0.0093916258649454,-0.0947368061548308,-0.0579216327642449,4.846122839825e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41943,-0.0703411047191143,0.00866695017042923,-0.0873283270531556,-0.053353882385073,5.23675972488345e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,39590,-0.0408707113820089,0.00503665693040949,-0.0507425589656115,-0.0309988637984063,5.39072360457874e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39868,-0.0477214450576604,0.00588733530597306,-0.0592606222573676,-0.0361822678579532,5.7821386055113e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,39836,-0.0781528418798479,0.00964917357928483,-0.0970652220952462,-0.0592404616644497,6.09172946659857e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,39789,-0.0876397493552263,0.0108217132184287,-0.108850307263347,-0.0664291914471061,6.14042228263596e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39843,-0.0402277410594055,0.0049752993653859,-0.0499793278155619,-0.0304761543032492,6.82578914271633e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42029,-0.0215965440946298,0.00267413494458872,-0.0268378485860237,-0.0163552396032359,7.25463631031191e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,42029,0.0552757523566918,0.00684474929547048,0.0418600437375697,0.0686914609758139,7.28089861068102e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39575,-0.0467100074835372,0.00578384432407104,-0.0580463423587165,-0.035373672608358,7.39578215468557e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39869,-0.0801170316380945,0.00992489750958086,-0.099569830756873,-0.060664232519316,7.59727173228553e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41995,-0.0768625484703133,0.00952720729175418,-0.0955358747621515,-0.0581892221784751,7.77024738237835e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,41842,-0.0705265733354631,0.00874620015828735,-0.0876691256457064,-0.0533840210252199,8.03562279142405e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39575,-0.041274018607778,0.00511816730450367,-0.0513056265246052,-0.0312424106909508,8.13672788312938e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39597,-0.0778610509755981,0.00965751313839862,-0.0967897767268594,-0.0589323252243368,8.26807710141824e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,39904,-0.0753093010267995,0.00934413741604417,-0.0936238103622461,-0.056994791691353,8.42927529237655e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41771,-0.02792062493137,0.00346644060634269,-0.0347148485198017,-0.0211264013429384,8.6593371237773e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,41943,0.0293899634643535,0.00364992905252877,0.0222361025213971,0.0365438244073099,8.8171833485007e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,42222,-0.0559044380020941,0.00694944562154007,-0.0695253514203127,-0.0422835245838756,9.37555523327088e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39696,-0.0932079429546725,0.0115893422109788,-0.115923053688191,-0.0704928322211539,9.69243663503458e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39872,-0.0580187546449541,0.00722259606951209,-0.0721750429411978,-0.0438624663487104,1.04622087571435e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42048,-0.0543348762321419,0.00677038902586215,-0.0676048387228317,-0.0410649137414521,1.09567838802756e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41771,-0.0381967207671623,0.0047608921666255,-0.0475280694137483,-0.0288653721205763,1.11862812443406e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,39675,-0.09575159431419,0.0119377286728567,-0.119149542512989,-0.0723536461153909,1.15523082475226e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42030,-0.0987153183415374,0.0123275909863649,-0.122877396674813,-0.0745532400082622,1.26466093139718e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,42048,-0.0419191578246255,0.00524059325988832,-0.0521907206140066,-0.0316475950352444,1.35712265404338e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPART,Spartin,39675,-0.0682137830482323,0.00853837063710186,-0.084948989496952,-0.0514785765995127,1.49408995000215e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39868,-0.0414851910300968,0.00519619597915415,-0.051669735149239,-0.0313006469109547,1.55711724710368e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42108,-0.0297844193272571,0.00373155428953593,-0.0370982657347475,-0.0224705729197667,1.5582603176296e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41766,-0.054396521300187,0.00681574311572461,-0.0677553778070073,-0.0410376647933668,1.57100214663127e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39512,-0.0581940546676972,0.00729522178602436,-0.072492689368305,-0.0438954199670895,1.64910765007294e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,42072,-0.0398946906539651,0.00500427679083581,-0.0497030731640033,-0.030086308143927,1.68470677345365e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41995,0.0210686499262412,0.00264669980555761,0.0158811183073483,0.0262561815451341,1.85297890582659e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,41995,-0.0514335499739712,0.0064628556053178,-0.0641007469603941,-0.0387663529875483,1.88326256765466e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41995,-0.0287615398690509,0.00361475728327716,-0.0358464641442741,-0.0216766155938277,1.90813682810993e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,42187,-0.0350323307366513,0.0044048675447077,-0.0436658711242784,-0.0263987903490242,1.96212108731426e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39869,-0.0908239080591206,0.0114223067471033,-0.113211629283443,-0.0684361868347981,2.01928323800414e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39512,-0.0246066809888251,0.00309499130270909,-0.0306728639421349,-0.0185404980355153,2.04105265888825e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39895,-0.0774772829054971,0.00974626897012953,-0.096579970086951,-0.0583745957240432,2.05187564468973e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,39850,-0.0563836839530093,0.00709695514516003,-0.070293716037523,-0.0424736518684957,2.13080588393243e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,41682,-0.0942760272011028,0.0118726607320558,-0.117546442235932,-0.0710056121662735,2.1755740709387e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42222,-0.0305353232330586,0.00385136965911015,-0.0380840077649145,-0.0229866387012027,2.39114557152489e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,39927,-0.0607412690382713,0.00766450262074234,-0.0757636941749263,-0.0457188439016163,2.49481072341493e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39575,-0.0544684590962931,0.00687440731933481,-0.0679422974421893,-0.0409946207503968,2.53506405554397e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42048,-0.0328427622661737,0.00415016178769786,-0.0409770793700615,-0.0247084451622859,2.69501206997584e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41943,-0.0809089559142199,0.0102250781558076,-0.100950109099603,-0.0608678027288369,2.71421746633371e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,39869,-0.0501706846338451,0.00634287261076852,-0.0626027149509514,-0.0377386543167388,2.81934731090278e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41842,-0.0325642953693495,0.00412076379253695,-0.0406409924027219,-0.0244875983359771,2.94894387233031e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39872,-0.0991832833467224,0.0125570920086185,-0.123795183683615,-0.0745713830098302,3.08261659875676e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39872,-0.0412665990432175,0.00522862800067825,-0.0515147099245469,-0.0310184881618881,3.23765032079055e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSG,Basigin,42210,-0.0179831364647393,0.00227923275810446,-0.022450432670624,-0.0135158402588546,3.25158871797539e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41814,-0.0344974254451049,0.00437297565520447,-0.0430684577293057,-0.0259263931609042,3.29055966925531e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,39872,0.0422797918541268,0.00537174731564743,0.0317511671154578,0.0528084165927957,3.84702724059977e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39639,-0.0469989429896362,0.00597396565853005,-0.0587079156803551,-0.0352899702989174,3.96210458396379e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39580,-0.0231402001822666,0.00294258962760584,-0.028907675852374,-0.0173727245121592,4.07265768052866e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39872,-0.0505009535986168,0.00642618670695248,-0.0630962795442437,-0.03790562765299,4.23692931468094e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39895,-0.0295222059576979,0.00375679188119227,-0.0368855180448348,-0.0221588938705611,4.24505704205067e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39590,-0.0376576377378694,0.00479289841008296,-0.047051718621632,-0.0282635568541068,4.30245734767406e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42088,-0.0427332094530514,0.00544108331720692,-0.0533977327547769,-0.0320686861513258,4.33978968014131e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42174,-0.0203608450286853,0.00259367859775338,-0.0254444550802819,-0.0152772349770887,4.46445615926127e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,42236,0.0260099837868025,0.00331816003544561,0.0195063901173291,0.0325135774562759,4.88941029485267e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,42038,-0.0567540233625439,0.00724240635931618,-0.0709491398268036,-0.0425589068982842,4.98566049663085e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41828,-0.0416764601077573,0.00532145190163969,-0.0521065058349711,-0.0312464143805435,5.17516149897828e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39872,0.0383333265246782,0.00489777652761686,0.0287336845305492,0.0479329685188073,5.45699972337377e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42008,-0.0271008147994543,0.00346395162882088,-0.0338901599919432,-0.0203114696069654,5.51302450914669e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39895,-0.0234736854624736,0.00300298708279504,-0.0293595401447519,-0.0175878307801953,5.90009967344143e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41995,-0.0294912805469016,0.0037741421824891,-0.0368885992245802,-0.0220939618692229,5.94982896759706e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,42033,-0.0782659188648304,0.0100171939454396,-0.0978996189978919,-0.0586322187317689,5.99001206449135e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39869,-0.0646941538620716,0.00829287465638764,-0.0809481881885914,-0.0484401195355518,6.67451452001905e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41657,-0.105682939969052,0.0135557421717499,-0.132252194625682,-0.079113685312422,6.86319315834929e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,41980,-0.0589723761441828,0.00756886816231712,-0.0738073577423243,-0.0441373945460412,7.11176601807947e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,42072,-0.0329719245537392,0.0042367084090165,-0.0412758730354116,-0.0246679760720669,7.63050171480723e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42111,-0.0553735852008251,0.00711765193721947,-0.0693241829977753,-0.041422987403875,7.79185534174752e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39811,-0.0534923227853664,0.00688391821604302,-0.0669848024888107,-0.039999843081922,8.49188262625883e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39869,-0.054888474850833,0.00707502672895607,-0.0687555272395869,-0.0410214224620791,9.36764313226469e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42051,-0.0246706959007156,0.00319049765396386,-0.0309240713024847,-0.0184173204989464,1.12878201345968e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,42063,-0.0427914773557362,0.00553958286844754,-0.0536490597778934,-0.031933894933579,1.20043940051001e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,41808,-0.0307246196890234,0.00398245795133246,-0.038530237273635,-0.0229190021044118,1.29647194389666e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39744,-0.0475649747127457,0.0061652938168208,-0.0596489505937144,-0.0354809988317769,1.31344097083755e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,42048,-0.0382186274931675,0.00495607696709936,-0.0479325383486823,-0.0285047166376528,1.33095843545601e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42111,-0.0209813783415304,0.00272320554095013,-0.0263188612017926,-0.0156438954812681,1.4030730476693e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,39597,-0.0485968943028781,0.00631192827134726,-0.0609682737147187,-0.0362255148910374,1.48642992068666e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42072,-0.0296386392744306,0.00385089892276072,-0.0371864011630416,-0.0220908773858196,1.49490426680934e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39597,-0.030736467673382,0.00400163260471314,-0.0385796675786197,-0.0228932677681442,1.71279653361064e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,42011,-0.0654419034492573,0.00852254470291509,-0.0821460910669709,-0.0487377158315438,1.71837733957873e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41771,-0.0326222463390693,0.00425039571870105,-0.0409530219477233,-0.0242914707304152,1.76888791086898e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42111,-0.0231796243905171,0.00302249706588177,-0.0291037186396454,-0.0172555301413888,1.85119408840472e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39895,-0.0753716156221721,0.0098445012764838,-0.0946668381240803,-0.0560763931202638,2.07102137662929e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41766,-0.0539823875599928,0.00706713874806071,-0.0678339795061918,-0.0401307956137938,2.349003432113e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42108,0.0231937742056632,0.00303789971626012,0.0172394907617934,0.0291480576495331,2.41311435875115e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41995,-0.0173208272041127,0.00227009776128588,-0.0217702188162331,-0.0128714355919924,2.50591713716546e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,39917,0.0194407030338123,0.00254856222156154,0.0144455210795516,0.0244358849880729,2.57317542751102e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42072,-0.0560692558581053,0.00736355678949116,-0.070501827165508,-0.0416366845507026,2.82466577954392e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41828,-0.0307412208970215,0.00403870819993882,-0.0386570889689015,-0.0228253528251414,2.88922246843849e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39858,-0.0463736127158907,0.00609336817302838,-0.0583166143350263,-0.034430611096755,2.94816655477602e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,42092,-0.0485303879758471,0.00638613753536931,-0.061047217545171,-0.0360135584065233,3.17250784234389e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39597,-0.0310934009905445,0.00409594203322746,-0.0391214473756703,-0.0230653546054187,3.42424697302929e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,42063,0.0411017119764611,0.00543229279959405,0.0304544180892568,0.0517490058636655,4.09262953820091e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39575,-0.0204960947273311,0.00271270320459294,-0.0258129930083333,-0.015179196446329,4.50111459022852e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_E,,42048,-0.0242489628492222,0.00321247023093405,-0.0305454045018529,-0.0179525211965914,4.69006862039241e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,39874,-0.0267449883227801,0.0035457657026477,-0.0336946890999696,-0.0197952875455907,4.95347877058299e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,39696,-0.0446629169710162,0.00592589597431382,-0.0562776730806713,-0.0330481608613611,5.18731457568077e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41828,-0.0289873984830942,0.00384744935295463,-0.0365283992148853,-0.0214463977513032,5.23264584340721e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,39698,-0.0202330679411704,0.00268568280688667,-0.0254970062426683,-0.0149691296396725,5.31649551698346e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39675,-0.0865959003649448,0.0114970287896491,-0.109130076792657,-0.0640617239372324,5.38474345685713e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,39675,0.0386656749992808,0.00513855161001767,0.0285941138436462,0.0487372361549154,5.69697175815795e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41771,-0.0702029585683954,0.00933933701902662,-0.0885080591256876,-0.0518978580111032,5.9706197884386e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,39575,-0.0974057642502665,0.0129660294647894,-0.122819182001254,-0.0719923464992792,6.25736900049827e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42111,-0.0228826054572032,0.00305284776001705,-0.0288661870668367,-0.0168990238475698,7.01540179442583e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,41995,-0.0245861993491952,0.00328219823072359,-0.0310193078814134,-0.0181530908169769,7.27524310722224e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,39648,-0.0422172515952873,0.00564049428011534,-0.0532726203843134,-0.0311618828062612,7.71796445786467e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39895,-0.0244225018278495,0.00326761101667787,-0.0308270194205382,-0.0180179842351609,8.34682986504422e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39675,-0.0713375768853782,0.0095498042522729,-0.0900551932198331,-0.0526199605509233,8.61920226157752e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42032,-0.0546830794840348,0.00732284684170566,-0.0690358592937778,-0.0403302996742917,8.67920307977409e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,39675,-0.0608118629370482,0.00814193984192536,-0.0767700650272219,-0.0448536608468745,8.69063127945973e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39868,-0.0322400415387576,0.00431700483467628,-0.0407013710147231,-0.0237787120627921,8.73349465256138e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAT,Catalase,39765,-0.0428115065402449,0.00573593709149017,-0.0540539432395657,-0.0315690698409242,9.03586433071724e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42174,-0.0458700908452314,0.00614983813554503,-0.0579237735908997,-0.0338164080995632,9.26458965742945e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39575,-0.0258508802422927,0.00347157499918588,-0.0326551672406971,-0.0190465932438884,1.03081487787617e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,41766,-0.0388299068315318,0.00521875788920463,-0.0490586722943729,-0.0286011413686907,1.06559882741286e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41800,-0.0385716972611562,0.00519101975805272,-0.0487460959869395,-0.0283972985353729,1.14866274653474e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39869,-0.0409200635123911,0.0055076429594801,-0.0517150437129721,-0.0301250833118101,1.16724723505495e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,39868,-0.068875919290353,0.00928492523625196,-0.0870743727534069,-0.0506774658272992,1.27408803907317e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41995,-0.0434751526746517,0.00587001307504081,-0.0549803783017316,-0.0319699270475717,1.37618261566956e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41771,-0.0684273772677512,0.00924258673957905,-0.0865428472773262,-0.0503119072581763,1.40705276248495e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,39895,-0.0435163743640044,0.00587853087733282,-0.0550382948835767,-0.031994453844432,1.43040476572155e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,39869,-0.0839623156709799,0.0113509719419302,-0.106210220677163,-0.0617144106647967,1.49268478298746e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39512,-0.0560711162777299,0.00758309376447969,-0.0709339800561101,-0.0412082524993497,1.52658986445714e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39927,-0.020045801668373,0.00271183609653128,-0.0253610004175743,-0.0147306029191717,1.54864159994976e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,42063,-0.072155323244271,0.00976936303755026,-0.0913032747978695,-0.0530073716906725,1.60352764046437e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,41995,-0.0767277907678436,0.0103962654088801,-0.0971044709692486,-0.0563511105664386,1.67208288691686e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42108,-0.0581372833465714,0.00787799837251012,-0.0735781601566912,-0.0426964065364516,1.67905474025092e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42048,-0.0294433423062303,0.00399003524874691,-0.0372638113937742,-0.0216228732186863,1.68556734968895e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39590,-0.0381243219380932,0.0051653174560349,-0.0482483441519216,-0.0280002997242648,1.68669744611115e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42063,0.0361390497233504,0.00489899554530657,0.0265370184545496,0.0457410809921513,1.71585953343751e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39869,-0.0469804928293161,0.00636912942424536,-0.059463986500837,-0.0344969991577952,1.74199457043612e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42072,-0.0232110514514435,0.00314784076824606,-0.0293808193572058,-0.0170412835456813,1.75715670986931e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39889,-0.0385302423893618,0.00522469291708895,-0.0487706405068562,-0.0282898442718675,1.7632462489504e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41771,-0.0527322928700846,0.00715280036236075,-0.0667517815803117,-0.0387128041598576,1.77771752015711e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39834,-0.036861743583904,0.00499919541337905,-0.0466601665941269,-0.0270633205736811,1.77847594788779e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,41960,-0.0548747176924103,0.00744542019703462,-0.0694677412785981,-0.0402816941062224,1.80292367675738e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42142,-0.0372266283977708,0.00505869582734304,-0.0471416722193632,-0.0273115845761785,1.96051855418243e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39597,0.0262100299291099,0.0035615028237916,0.0192294843944783,0.0331905754637414,1.9812155845132e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42108,-0.0275750672992473,0.00374951370923549,-0.0349241141693488,-0.0202260204291457,2.02972852056944e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41771,-0.0541629346770424,0.00736785326781134,-0.0686039270819526,-0.0397219422721322,2.07943747329672e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39868,-0.0804362657446749,0.0109485497580281,-0.10189542327041,-0.0589771082189398,2.17112501113742e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,41771,-0.031093976411085,0.00423863238292356,-0.0394016958816152,-0.0227862569405549,2.33202872350425e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,39863,-0.0205938056057643,0.00280729745268935,-0.0260961086130354,-0.0150915025984932,2.35521234904644e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,39917,-0.0172267016441873,0.00234838536344916,-0.0218295369565476,-0.0126238663318269,2.35902727347894e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,42236,0.0128124692629981,0.00174794856203101,0.00938649008141735,0.0162384484445789,2.43095408343265e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41842,-0.0744141603536518,0.0101559967143829,-0.0943199139138424,-0.0545084067934613,2.48772274618611e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39696,-0.0536923175271943,0.00733547782016791,-0.0680698540547234,-0.0393147809996652,2.66026920459017e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42072,-0.0265756118829994,0.00364139120443082,-0.0337127386436838,-0.019438485122315,3.07961182905717e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39868,-0.0792778302505123,0.0108699263828944,-0.100582885960985,-0.0579727745400394,3.22695273778934e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,42095,0.0218262865582828,0.00299446656368863,0.0159571320934531,0.0276954410231125,3.29933764592465e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,42236,0.0193291166331586,0.00265497799829432,0.0141253597565017,0.0245328735098154,3.51233436632238e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39858,-0.0572154823469761,0.00786316035764944,-0.072627276647969,-0.0418036880459833,3.65651638670341e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41849,-0.0228315603564765,0.00314567730657293,-0.0289970878773595,-0.0166660328355936,4.14505247438228e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39696,-0.02741305461581,0.00377968808869013,-0.0348212432696426,-0.0200048659619773,4.35665405407211e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39512,-0.0957610139973081,0.0132144602510714,-0.121661356089408,-0.0698606719052081,4.55947687077162e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42048,-0.0295746116280062,0.00408363131638574,-0.0375785290081222,-0.0215706942478901,4.65349430783968e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39675,-0.0344614568268239,0.00476117850227231,-0.0437933666912776,-0.0251295469623701,4.85457861036707e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39575,-0.0720957355574856,0.00996926695421835,-0.0916354987877536,-0.0525559723272176,5.08375317903307e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39590,-0.0532463805887906,0.00736920512077058,-0.067690022625501,-0.0388027385520803,5.32242669405941e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,41879,-0.0554868984914786,0.00768154764061846,-0.0705427318670908,-0.0404310651158665,5.34665366906906e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39500,-0.0397304099674564,0.0055048341106092,-0.0505198848242505,-0.0289409351106624,5.65294297798331e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39512,-0.0519146794265605,0.00721216948252509,-0.0660505316123097,-0.0377788272408113,6.50204387499804e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,41766,0.058864776148235,0.00818558285007599,0.0428210337620861,0.0749085185343839,6.76553663892635e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39597,-0.0713146418130009,0.00992705949517166,-0.0907716784235373,-0.0518576052024644,7.21521514693718e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39827,0.0214943935665879,0.00299309975622478,0.0156279180443873,0.0273608690887885,7.34097152004649e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41943,-0.0784980177430965,0.0109357653717012,-0.0999321178716309,-0.0570639176145622,7.44244637707281e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42072,-0.0647793760446986,0.00904257626187688,-0.0825028255179773,-0.0470559265714199,8.25354448473427e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42020,-0.0701682300768983,0.00980330491471416,-0.089382707709738,-0.0509537524440585,8.63619821158532e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,42016,-0.0518343463461834,0.00724901431852069,-0.0660424144104839,-0.0376262782818828,9.0914276216713e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39597,-0.0694321793830587,0.00971982670789976,-0.0884830397305422,-0.0503813190355751,9.68379910258326e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42236,0.018320893115309,0.00256862256659276,0.0132863928847872,0.0233553933458308,1.03473974113948e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39872,-0.0668079261427818,0.00936885082426111,-0.0851708737583336,-0.04844497852723,1.058516991497e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,42222,-0.0277188156012936,0.00389245629763123,-0.0353480299446508,-0.0200896012579364,1.12385878099333e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39575,-0.0336731343044818,0.00473579120494594,-0.0429552850661758,-0.0243909835427877,1.22946120134527e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,39815,-0.0368209200872168,0.00518444908038055,-0.0469824402847627,-0.026659399889671,1.302324564304e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,39526,-0.0499563186025467,0.00706331573827902,-0.0638004174495736,-0.0361122197555198,1.61302835648024e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42063,0.0219230101367273,0.00310045006580274,0.015846128007754,0.0279998922657007,1.61509778294618e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,41886,-0.0335371289282792,0.00475281106631052,-0.0428526386182478,-0.0242216192383106,1.79507678138598e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,39590,-0.0529682085632173,0.00754078412368717,-0.0677481454456441,-0.0381882716807904,2.27972928981874e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39597,-0.0621606041186261,0.0088575387279079,-0.0795213800253256,-0.0447998282119267,2.38622390922728e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39872,-0.0306514249783773,0.00436796978101843,-0.0392126457491735,-0.0220902042075812,2.3914581819423e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42108,0.0179945810799609,0.00256548977033625,0.0129662211301019,0.02302294102982,2.42460946954726e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39895,-0.0206397066221795,0.00294568009079291,-0.0264132396001336,-0.0148661736442254,2.57758381356308e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42187,-0.0310872727610944,0.00444081731437268,-0.0397912746972649,-0.022383270824924,2.67308281542234e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,39652,-0.0797562144897242,0.0113920105953476,-0.102084555256605,-0.057427873722843,2.68755364646841e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,41995,-0.0238378267104379,0.00340689655487902,-0.0305153439580008,-0.017160309462875,2.7406082557296e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAX,Protein max,41766,-0.0813870816476284,0.0116409719957738,-0.104203386759345,-0.0585707765359118,2.85211622368261e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39675,-0.0637550997470547,0.00912703658944052,-0.0816440914623582,-0.0458661080317513,3.00547075912056e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDK,Midkine,42056,-0.0391405668721074,0.00561211889991744,-0.0501403199159456,-0.0281408138282692,3.21765817713886e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39696,-0.0399543445726906,0.00572858087245617,-0.0511823630827047,-0.0287263260626765,3.24278332740801e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,41828,-0.0643732846541018,0.00924994459673839,-0.082503176063709,-0.0462433932444945,3.58038043744082e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,42187,-0.0284597323534366,0.00409279962711731,-0.0364816196225865,-0.0204378450842867,3.7232343964253e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,41995,-0.0572376941120954,0.00823191937306927,-0.0733722560833112,-0.0411031321408797,3.73798724481757e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42222,-0.0209031203761204,0.0030127754135211,-0.0268081601866218,-0.0149980805656191,4.15179197525187e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39904,-0.0328816383129919,0.00474272105502158,-0.0421773715808342,-0.0235859050451496,4.34229721516617e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39895,-0.0306142708324185,0.00441910890876583,-0.0392757242935996,-0.0219528173712375,4.50984166418206e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39696,-0.0339945396568847,0.00490951091445168,-0.0436171810492099,-0.0243718982645594,4.62601595492292e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39858,-0.0821630308473837,0.0118723453708052,-0.105432827774162,-0.0588932339206054,4.74368614261827e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39872,-0.0364187645668341,0.00526642096012089,-0.046740949648671,-0.0260965794849971,4.92202584376283e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41771,-0.039621235965134,0.00573290054531144,-0.0508577210339444,-0.0283847508963236,5.02679143226415e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41771,-0.0395165694466947,0.00571889247370586,-0.0507255986951582,-0.0283075401982312,5.0755172640228e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42050,-0.0298933124021268,0.00432970721229152,-0.0383795385382182,-0.0214070862660354,5.27396259732837e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41828,-0.0385235651234658,0.00558201369572749,-0.0494643119670917,-0.0275828182798399,5.38482552080776e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39675,-0.0636402828599167,0.00922729296813455,-0.0817257770774604,-0.045554788642373,5.60213827802113e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42187,0.0447798767035722,0.00653182227994861,0.0319775050348729,0.0575822483722715,7.4054327537177e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39536,-0.0313337289315139,0.00457030882053741,-0.0402915342197672,-0.0223759236432606,7.46667869146615e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42072,-0.0495553800119283,0.00722965799049402,-0.0637255096732965,-0.03538525035056,7.46987723379034e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41943,0.0273126285375796,0.00398655170102113,0.0194989872035782,0.035126269871581,7.64495893609243e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,39597,-0.0341365979939373,0.00498202331011767,-0.0439013636817679,-0.0243718323061066,7.67419476401493e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39895,-0.0546720219302611,0.00798426267948282,-0.0703211767820474,-0.0390228670784747,7.90655177312241e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41771,-0.0570790877497785,0.0083455464347266,-0.0734363587618426,-0.0407218167377144,8.29970518112879e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42063,-0.0231186068029047,0.0033893138906749,-0.0297616620286275,-0.0164755515771818,9.42507288995108e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,39764,0.0821718231337502,0.0120838087653305,0.0584875579537024,0.105856088313798,1.09839720335133e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,42063,0.0233971257009759,0.00345300437776288,0.0166292371205606,0.0301650142813911,1.28797549813117e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39575,0.0251212761542051,0.0037092770321334,0.0178510931712237,0.0323914591371866,1.32997354229706e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41828,-0.0359484739199642,0.00531554011307534,-0.0463669325415919,-0.0255300152983365,1.40937598431094e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39869,-0.0652824850979521,0.0096592906614943,-0.0842146947944809,-0.0463502754014232,1.46290029771209e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,39872,-0.0571606886125175,0.00846071644917546,-0.0737436928529014,-0.0405776843721336,1.48830165779987e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39526,-0.0735416816045506,0.0108903916099784,-0.0948868491601083,-0.0521965140489929,1.52278983530438e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41766,-0.0505837517400389,0.00749420265195716,-0.0652723889378749,-0.0358951145422028,1.54337844450602e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41924,-0.0716517723376379,0.0106356242220958,-0.0924975958129456,-0.0508059488623302,1.68377210672408e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39868,-0.0335618599798058,0.00498131979887261,-0.0433252467855961,-0.0237984731740154,1.68937628887589e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39895,-0.0455350081438912,0.00676641720845567,-0.0587971858724643,-0.0322728304153181,1.78412118137607e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,42048,-0.0509826932881233,0.00757772730017812,-0.0658350387964724,-0.0361303477797742,1.79013239442271e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,41766,-0.0267143640217727,0.00397201596438651,-0.0344995153119702,-0.0189292127315751,1.82036576129305e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,42063,-0.0468529567725865,0.0069729348864823,-0.0605199091500918,-0.0331860043950812,1.89995677889656e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39895,-0.072724749464067,0.0108343021048169,-0.0939599815895082,-0.0514895173386258,2.00545578620565e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41771,-0.03823823671196,0.00570038562671912,-0.0494109925403294,-0.0270654808835905,2.05356987103086e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,41759,-0.0798620430455865,0.0119063051956912,-0.103198401229141,-0.0565256848620317,2.06019861927405e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,42048,-0.0502382594939723,0.00749519294829877,-0.0649288376726379,-0.0355476813153067,2.12715093784325e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,41766,-0.0450939004101184,0.00673453029879687,-0.0582935797957603,-0.0318942210244766,2.23008182296201e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39512,-0.0266066733318192,0.00397830841026627,-0.0344041578159411,-0.0188091888476973,2.37406333857013e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,42050,-0.0199789407364237,0.00299450604225037,-0.0258481725792345,-0.014109708893613,2.62456117806243e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39675,-0.087710555419441,0.0131546430533435,-0.113493655803994,-0.0619274550348878,2.72298769163855e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,39869,-0.0268728675252211,0.0040319533373988,-0.0347754960665228,-0.0189702389839194,2.77063980895692e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,41842,-0.0350391035511569,0.00525811839160575,-0.0453450155987042,-0.0247331915036096,2.77374778319561e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41995,-0.0414597239975667,0.00622225384657807,-0.0536553415368597,-0.0292641064582737,2.78523392638681e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,42108,-0.0446720812205717,0.00671993196009602,-0.0578431478623599,-0.0315010145787835,3.09144066981194e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,42236,0.0194217262413079,0.00292248880506898,0.0136936481833727,0.0251498042992431,3.13430793249495e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41842,-0.0478757399717108,0.00721999912335549,-0.0620269382534876,-0.033724541689934,3.46379445495756e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42142,0.0425525394488894,0.00641932758514535,0.0299706573820045,0.0551344215157743,3.5120629623907e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42168,-0.0663884443647523,0.0100220755523047,-0.0860317124472695,-0.0467451762822352,3.62242287466518e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39872,-0.0340958692659014,0.00515320917951569,-0.0441961592577522,-0.0239955792740506,3.84639454652988e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39917,0.0177696581644545,0.00268601998941098,0.0125050589852089,0.0230342573437,3.86714869727128e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42108,-0.019807553637993,0.00299898644548271,-0.0256855670711391,-0.0139295402048469,4.13092022761818e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42048,-0.0563413206106095,0.00855305364508607,-0.0731053057549782,-0.0395773354662408,4.64634305523751e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,41817,-0.0406779162166903,0.00617927215125645,-0.0527892896331529,-0.0285665428002276,4.78579600321242e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFP,Properdin,39917,-0.0170828639134938,0.00259563483730238,-0.0221703081946065,-0.0119954196323812,4.86687825329561e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42056,-0.0342106428517911,0.00519935216562668,-0.0444013730964194,-0.0240199126071628,4.88549630304484e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39696,-0.0532697991478713,0.00809910200138791,-0.0691440390705916,-0.037395559225151,5.00784640136442e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42236,-0.0167600182854245,0.00255535297299176,-0.0217685101124883,-0.0117515264583606,5.62024751004978e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,39858,-0.0346857201900571,0.00528861392525314,-0.0450514034835532,-0.0243200368965609,5.67076606804973e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42222,-0.0339037947447828,0.00517127703185164,-0.044039497727212,-0.0237680917623536,5.71947016499478e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,42095,0.0265743542979563,0.00405700537544817,0.0186226237620779,0.0345260848338347,5.95271680190337e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,42164,-0.0435401871007793,0.00664933554402258,-0.0565728847670635,-0.030507489434495,6.03919451781626e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41995,-0.0416822111281904,0.00636794364179778,-0.054163380666114,-0.0292010415902667,6.14020866538793e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42236,0.0222081053349966,0.00339289918281707,0.0155580229366752,0.0288581877333181,6.14311685910539e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42063,-0.0305356987531597,0.00466742937199423,-0.0396838603222684,-0.021387537184051,6.27723807816475e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,42123,-0.0211708911798105,0.00324185314351229,-0.0275249233410946,-0.0148168590185265,6.78973077225398e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39904,0.01950474215284,0.00298754948562482,0.0136491451610153,0.0253603391446646,6.91958956289738e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,39288,-0.088807858273864,0.0136092005223084,-0.115481891297588,-0.0621338252501396,7.08075128311065e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,42222,-0.0436520457925797,0.00669861037024885,-0.0567813221182675,-0.030522769466892,7.44572474020746e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,42048,-0.0401492646501803,0.00616133186073672,-0.0522254750972243,-0.0280730542031364,7.4615994318447e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41828,-0.036754815748146,0.00565104017953073,-0.0478308545000262,-0.0256787769962658,8.09815596967203e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41828,-0.0366082507543532,0.00563468677986777,-0.047652236842894,-0.0255642646658123,8.490216945398e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42236,-0.0302431854623235,0.0046569983730783,-0.039370902273557,-0.02111546865109,8.64050156404843e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39590,-0.0437191040943957,0.00673441811987657,-0.0569185636093537,-0.0305196445794376,8.84192489898871e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,42222,-0.0415590002360853,0.0064107172408543,-0.0541240060281598,-0.0289939944440109,9.31760748685987e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42048,-0.0291921451909977,0.00451197690148845,-0.038035619917915,-0.0203486704640803,1.01448299170538e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39575,-0.0181380585616112,0.00280704798146457,-0.0236398726052817,-0.0126362445179406,1.07980905091862e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,42114,-0.0255292523651996,0.00395250751012338,-0.0332761670850414,-0.0177823376453578,1.09003645239749e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,39575,-0.0365873865705173,0.0056647620692836,-0.0476903202263132,-0.0254844529147215,1.10022264396741e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41766,-0.051048182917395,0.00790680256588504,-0.0665455159465297,-0.0355508498882603,1.11105566133296e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39575,-0.0557712318826678,0.00865200802579157,-0.0727291676132193,-0.0388132961521164,1.1962355436117e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39858,-0.0410792930938853,0.00637332328530821,-0.0535710067330894,-0.0285875794546812,1.199241909928e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41943,-0.0237932676250101,0.00369240466268106,-0.031030380763865,-0.0165561544861552,1.20488955322028e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41766,-0.0788201700390355,0.0122351579354279,-0.102801079592474,-0.0548392604855969,1.21926386849857e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39872,-0.0420791410271675,0.0065408571374456,-0.0548992210165609,-0.0292590610377741,1.29941353199551e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,39869,-0.0617376998496181,0.00961088336215579,-0.0805750312394435,-0.0429003684597928,1.3833336945462e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39868,0.0500689103969924,0.00779894056038242,0.0347829868986428,0.0653548338953419,1.4178584294362e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39696,-0.0504661932950439,0.007863425665983,-0.0658785076003706,-0.0350538789897172,1.43858713447538e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,39895,0.019644326150387,0.00306109780259832,0.0136445744572943,0.0256440778434797,1.44158980306191e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39575,-0.0403808288123626,0.00629705669661424,-0.0527230599377265,-0.0280385976869987,1.48887666455885e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,42236,-0.0617416656893605,0.00964411447435045,-0.0806441300590873,-0.0428392013196336,1.58371601254891e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,41681,-0.0528917722196855,0.0082615153749356,-0.0690843423545592,-0.0366992020848117,1.58398316992947e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,42149,-0.0487691785118957,0.00761955320308712,-0.0637035027899465,-0.033834854233845,1.59937276807876e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39526,-0.053063420844792,0.00829082196801034,-0.0693134319020923,-0.0368134097874918,1.61466608443891e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42174,-0.054734022839972,0.00855508601130941,-0.0715019914221384,-0.0379660542578056,1.62767324975617e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,42198,-0.0199894824567183,0.00312664895246787,-0.0261177144035554,-0.0138612505098813,1.67688540573912e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,41924,0.0321201707310794,0.00502420318298369,0.0222727324924313,0.0419676089697274,1.67989027665772e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39597,-0.0262370107872893,0.00410884770424629,-0.034290352287612,-0.0181836692869666,1.77737801791481e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39590,-0.0462962320174163,0.00725748501559037,-0.0605209026479734,-0.0320715613868592,1.85289531952064e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,41995,0.0317365470942906,0.00497881501022732,0.021978069674245,0.0414950245143361,1.89803051548459e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41828,-0.0647108072196583,0.0101566968628323,-0.0846179330708095,-0.044803681368507,1.93711590146957e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,39575,-0.0205352205093029,0.00322341405403525,-0.026853112055212,-0.0142173289633938,1.95773378764723e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42048,-0.0240804939146955,0.00378267993913131,-0.0314945465953929,-0.0166664412339982,2.00338404662985e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,42048,-0.0600917653059932,0.00946796959166056,-0.0786489857056479,-0.0415345449063385,2.26823257676241e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39597,-0.0309439804784471,0.00487966378480994,-0.0405081214966745,-0.0213798394602196,2.36593235739262e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39675,-0.0414364570014972,0.00653777148502577,-0.0542504891121477,-0.0286224248908467,2.41798727249567e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,41943,-0.0272098749867429,0.00430138176561691,-0.035640583247352,-0.0187791667261337,2.5989022873423e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39512,-0.0488987123604059,0.00773613722081599,-0.0640615413132053,-0.0337358834076066,2.70338453784577e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,39575,-0.0357217885498615,0.0056526204969335,-0.0468009247238512,-0.0246426523758719,2.72568595260568e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,39898,-0.0258998386030037,0.00410595175142474,-0.0339475040357962,-0.0178521731702113,2.93460803585964e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42043,-0.064133053800971,0.0101882562510814,-0.0841020360530906,-0.0441640715488514,3.1735635187109e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39858,-0.0655612171602861,0.0104200365618782,-0.0859844888215674,-0.0451379454990048,3.25370108509109e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,41943,-0.0225507662560607,0.0035857434095978,-0.0295788233388724,-0.015522709173249,3.29468857476295e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42174,-0.0349415556580835,0.00556676572230767,-0.0458524164738066,-0.0240306948423605,3.56092763108321e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39868,-0.039257265661284,0.00625427436071564,-0.0515156434082867,-0.0269988879142814,3.58151359787461e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,41771,-0.0549289009970218,0.00875619326163345,-0.0720910397898234,-0.0377667622042202,3.64890556041392e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39927,-0.0183940419297563,0.00293287920105646,-0.024142485163827,-0.0126455986956857,3.70216112288918e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,39883,-0.0328572320523387,0.00524074658225028,-0.0431290953535493,-0.0225853687511282,3.75268980730057e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,41766,-0.0497230683109518,0.00793263751471009,-0.0652710378397836,-0.03417509878212,3.76731443928965e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39869,-0.0364498279603227,0.00582100084095267,-0.04785898960859,-0.0250406663120555,3.94458603305089e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,42141,-0.0401982939145187,0.00642165756668265,-0.0527847427452166,-0.0276118450838207,3.97100311171965e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,41748,0.0808492349147921,0.012951748673171,0.055463807515377,0.106234662314207,4.44320980867018e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39512,-0.0300253654904568,0.00481026507191746,-0.039453485031415,-0.0205972459494986,4.48236524924334e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,39927,-0.0149338713408089,0.00239344512518079,-0.0196250237861632,-0.0102427188954545,4.54676710798453e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,42222,-0.0591219253300619,0.00947953327085434,-0.0777018105409364,-0.0405420401191873,4.5982023587676e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,42111,-0.0260985453278079,0.00419425998501457,-0.0343192948984364,-0.0178777957571793,5.03925290943025e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41924,-0.0507303887367325,0.00816182603480166,-0.0667275677649437,-0.0347332097085212,5.26640597673895e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,42187,-0.0166883537631956,0.0026905953158541,-0.0219619205822697,-0.0114147869441216,5.7192929942076e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42012,-0.0433131538921207,0.00698667351044022,-0.0570070339725835,-0.0296192738116579,5.83420378504147e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42128,-0.0772990679258735,0.0124743733732319,-0.101748839737408,-0.0528492961143389,5.93586331217423e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42236,-0.0220422477731844,0.00356361872073291,-0.0290269404658209,-0.0150575550805479,6.3733158574512e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42221,-0.0189178974878189,0.00305982055399673,-0.0249151457736525,-0.0129206492019853,6.48211544638742e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42108,-0.0466019843078919,0.0075413345980304,-0.0613830001200314,-0.0318209684957523,6.61359209610039e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42174,-0.0191215480407414,0.00309632745968221,-0.0251903498617185,-0.0130527462197642,6.78110747731036e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41990,-0.0307618331110129,0.00498208406075454,-0.0405267178700918,-0.020996948351934,6.82953760911598e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39512,-0.0299317958660252,0.00485064008885504,-0.039439050440181,-0.0204245412918693,7.0404920725712e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42063,0.0192900172759793,0.00312720658434172,0.0131606923706695,0.025419342181289,7.09372149537884e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41771,-0.0360764072381044,0.00585137342255426,-0.0475450991463107,-0.024607715329898,7.23321017666706e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42108,-0.0565438067411544,0.00917648397013854,-0.074529715322626,-0.0385578981596829,7.39587649685554e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39696,-0.0500745228731124,0.00815189265689242,-0.0660522324806215,-0.0340968132656033,8.3916804435113e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39872,-0.0245099966280915,0.00399122628872927,-0.0323328001540009,-0.0166871931021822,8.47818891947048e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41995,-0.0701316744043302,0.0114287031938084,-0.0925319326641947,-0.0477314161444657,8.67646294103077e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,39904,0.0334207006485655,0.00545805185760087,0.0227229190076678,0.0441184822894632,9.47638170033454e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39821,-0.0328718877341647,0.00536983408645795,-0.0433967625436223,-0.0223470129247071,9.57455872488354e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39575,-0.0494245386999641,0.00807491388850278,-0.0652513699214295,-0.0335977074784986,9.63161563465943e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,39597,-0.0216818023119505,0.00354436973648634,-0.0286287669954637,-0.0147348376284373,9.84404340780437e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,39500,-0.0374493004965064,0.00612574835667106,-0.0494557672755817,-0.0254428337174311,1.00853366615392e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,39526,-0.0366763507293086,0.00600046615793041,-0.0484372643988522,-0.024915437059765,1.01587861448205e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39597,-0.022689416067179,0.0037127446542025,-0.0299663955894159,-0.0154124365449421,1.02218747366082e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39675,0.0280553250030311,0.00459582200309145,0.0190475138769718,0.0370631361290903,1.06557457811904e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41929,-0.0313627234465388,0.00514275237568796,-0.0414425181028873,-0.0212829287901904,1.10075682912228e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,41771,-0.0380724283985347,0.00626785588840343,-0.0503574259398054,-0.025787430857264,1.28012177129105e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39869,-0.0327569973943217,0.00539265648646386,-0.0433266041077909,-0.0221873906808525,1.28490485659899e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39575,-0.0212779134741856,0.00350288195010013,-0.0281435620963818,-0.0144122648519893,1.28574934865296e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39575,-0.0343436883826489,0.00566170862758877,-0.0454406372927229,-0.0232467394725749,1.35492367415327e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39576,-0.0383489413868455,0.00632428007864879,-0.0507445303409971,-0.0259533524326939,1.37348242093599e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42050,-0.0357812444976913,0.00590846893392488,-0.0473618436081841,-0.0242006453871986,1.43333739713473e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39850,-0.0267881999117091,0.00442303604004358,-0.0354573505501945,-0.0181190492732237,1.4354258066569e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39696,-0.0494631722772644,0.00816729253102333,-0.0654710656380701,-0.0334552789164587,1.43843404039713e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39696,-0.0456179069103549,0.00753369138024405,-0.0603839420156332,-0.0308518718050765,1.44794513639979e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41771,-0.0385428116551185,0.00637150579040255,-0.0510309630043075,-0.0260546603059295,1.49468583989115e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39512,-0.037236299119048,0.00615875443753604,-0.0493074578166186,-0.0251651404214773,1.53272603198374e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,39597,-0.0325070142074316,0.00538431055761992,-0.0430602629003667,-0.0219537655144966,1.61714551178923e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,39872,-0.0194212594995379,0.00322207677832564,-0.0257365299850562,-0.0131059890140197,1.71661154338219e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,39836,-0.0613113702620778,0.0101826298174868,-0.0812693247043518,-0.0413534158198037,1.78569889566046e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41828,-0.0736587393819664,0.0122500825687916,-0.0976689012167979,-0.0496485775471349,1.87014908197243e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39868,-0.0150651929695678,0.00250809529194588,-0.0199810597417818,-0.0101493261973539,1.95269451342036e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41943,-0.0157366190692558,0.00262045092402991,-0.0208727028803544,-0.0106005352581572,1.95930574625905e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42048,-0.0653971443921147,0.0108903437651718,-0.0867422181718514,-0.044052070612378,1.96194756481503e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41995,0.0175925711374854,0.00293063154996813,0.0118485332995478,0.0233366089754229,1.98716013265114e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39868,-0.0201274337205074,0.0033542026004999,-0.0267016708174872,-0.0135531966235276,2.02557566369538e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41766,-0.0243186169741163,0.00405431267464343,-0.0322650698164174,-0.0163721641318152,2.04736328998304e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39519,-0.0367549718687222,0.00612891842338209,-0.0487676519785511,-0.0247422917588933,2.07392205271078e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,41828,0.0152613749402077,0.0025453962238759,0.010272398341411,0.0202503515390045,2.07918328394004e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42048,0.0326273696197724,0.00544343238534282,0.0219582421445004,0.0432964970950443,2.10115260273133e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,42010,-0.0528023841037913,0.00881008133529862,-0.0700701435209765,-0.035534624686606,2.10764981411874e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41842,-0.0472715646632308,0.00790615503994734,-0.0627676285415275,-0.031775500784934,2.30172592773126e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,39927,-0.0607610559239375,0.0101624231188385,-0.080679405236861,-0.040842706611014,2.31290538127128e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39872,-0.0432595796409595,0.0072394673642089,-0.057448935674809,-0.0290702236071101,2.36291154125647e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39802,0.0273662423321259,0.00458178843294963,0.0183859370035446,0.0363465476607072,2.40253816458468e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39675,-0.057335825933789,0.00960770734676975,-0.0761669323334577,-0.0385047195341203,2.4800196198439e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,42072,-0.0244753564493241,0.004107664350915,-0.0325263785771175,-0.0164243343215307,2.60979567471705e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,42048,-0.0225059540652622,0.00378065334118927,-0.0299160346139932,-0.0150958735165313,2.69949648992443e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,42236,0.0191607493979654,0.00322341086770399,0.0128428640972656,0.0254786346986652,2.84514023051533e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41771,-0.0369737879078772,0.00622081202078406,-0.0491665794686139,-0.0247809963471404,2.85943742630095e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,39863,-0.0202790317863667,0.00341187003173261,-0.0269662970485626,-0.0135917665241708,2.86965180891296e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,42072,0.045991546257052,0.00775267529838254,0.0307963026722222,0.0611867898418817,3.05963088566833e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39868,-0.0698071138531474,0.0117697555597103,-0.0928758347501796,-0.0467383929561151,3.09824519256199e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39675,-0.0821578790424466,0.0138762564929068,-0.109355341768544,-0.0549604163163493,3.2998203334242e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39597,-0.0553064121596451,0.00934829854915167,-0.0736290773159824,-0.0369837470033078,3.39279972107983e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42221,-0.0151149974892189,0.00255529334237209,-0.0201233724402682,-0.0101066225381696,3.39481518250868e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,41828,-0.0322280803532152,0.00544950014136428,-0.0429091006302892,-0.0215470600761413,3.42239743542084e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,41774,-0.0364180366540559,0.00615910612301991,-0.0484898846551749,-0.0243461886529368,3.44509499151867e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41842,-0.0280555392379889,0.00474724199471969,-0.0373601335476395,-0.0187509449283383,3.50816136728572e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39512,-0.0806042097205532,0.0136555465398022,-0.107369080938566,-0.0538393385025408,3.68306186509891e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,41842,-0.0736871690774534,0.0124863034998905,-0.0981603239372388,-0.049214014217668,3.6915358749169e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39904,-0.0543409399761545,0.00921950445369258,-0.072411168705392,-0.0362707112469171,3.87420318644994e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,41842,-0.0286479647108822,0.00486220023005089,-0.038177877161782,-0.0191180522599825,3.90877647852652e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,39895,-0.0466476714867178,0.00791952172424929,-0.0621699340662464,-0.0311254089071892,3.96690984194846e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42210,-0.0334460516953914,0.00568709976954948,-0.0445927672437084,-0.0222993361470744,4.17265973276908e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41995,-0.0446456253238755,0.0075923773095148,-0.0595266848505245,-0.0297645657972265,4.19226259034457e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,39597,-0.0282235856278715,0.00479924288631056,-0.0376301016850402,-0.0188170695707028,4.20065090695692e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,42092,-0.0369585273469353,0.00628615156790491,-0.049279384420029,-0.0246376702738417,4.21601272417186e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39858,-0.0279228581482874,0.00475070036251702,-0.0372342308588207,-0.018611485437754,4.2798398644998e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41943,0.072421619877537,0.0123265771014985,0.0482615287585999,0.0965817109964741,4.32293951565789e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39869,-0.0622736280541113,0.010602609193146,-0.0830547420726774,-0.0414925140355452,4.38941745346876e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41771,-0.0280203392296052,0.00477333635097799,-0.0373760784775221,-0.0186645999816884,4.45805365864008e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39512,-0.0242983574369528,0.0041391647870776,-0.0324111204196249,-0.0161855944542807,4.4753424390254e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42163,0.0161587225710555,0.00275561036857571,0.0107577262486471,0.0215597188934639,4.62542973180433e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,39869,-0.0224598986458358,0.00383429153178089,-0.0299751100481263,-0.0149446872435453,4.82614373655019e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42063,0.0340106098766872,0.00580950350940146,0.0226239829982604,0.0453972367551141,4.90166915743324e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39904,0.0141068883290348,0.0024095502279636,0.00938416988222619,0.0188296067758435,4.9153423797459e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41736,-0.0485026444874824,0.00828949407464444,-0.0647500528737855,-0.0322552361011793,4.99976181447937e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,42174,-0.0723830082856733,0.0123891828486217,-0.0966658066689719,-0.0481002099023748,5.26221517624263e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39872,-0.0427104481887568,0.00731286315076945,-0.057043659964265,-0.0283772364132487,5.34963934519466e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39872,-0.0555647331524503,0.00951678046797499,-0.0742176228696813,-0.0369118434352193,5.40915158508178e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,41995,-0.0528039574479526,0.00904758652414699,-0.0705372270352807,-0.0350706878606245,5.46246421933776e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39854,-0.0562944355276654,0.00964473514588767,-0.0751981164136052,-0.0373907546417255,5.4679954592778e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,39868,-0.0183811113708787,0.00315128513975458,-0.0245576302447976,-0.0122045924969597,5.59718155934371e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42072,-0.0368852127607531,0.00633323196169464,-0.0492983474056746,-0.0244720781158316,5.87402606919479e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,41828,-0.0298520435567011,0.00513076987912155,-0.0399083525197794,-0.0197957345936229,6.0847549405907e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42142,-0.0199721684673093,0.00343663503801601,-0.0267079731418206,-0.0132363637927979,6.32908039211624e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,42072,-0.0432880653330925,0.00745964495355526,-0.0579089694420608,-0.0286671612241242,6.66173430943773e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,42108,-0.0140538827558262,0.00242644907141496,-0.0188097229357995,-0.00929804257585288,7.11208612698315e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,42187,0.0381670652492902,0.0065898239586152,0.0252510102904044,0.051083120208176,7.11692134491212e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,39868,-0.0242521570787406,0.00418976928195896,-0.0324641048713801,-0.016040209286101,7.29455311860708e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,39512,-0.0372638242547015,0.00644203782677344,-0.0498902183951775,-0.0246374301142256,7.47368895367757e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41842,-0.0238302599466607,0.00412317028234963,-0.031911673700066,-0.0157488461932555,7.65667159376272e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42093,-0.0756609819636075,0.0130942566813883,-0.101325725059129,-0.0499962388680863,7.71800256364978e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,42063,-0.0771363319129084,0.0133518793780279,-0.103306015493843,-0.0509666483319737,7.76387626363671e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,42236,-0.0361234772281006,0.00625760103758548,-0.0483883752617681,-0.0238585791944331,7.96923526642841e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39581,-0.0229581776976675,0.0039769944221936,-0.0307530867651669,-0.015163268630168,8.01027516202358e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,39597,-0.0779516439644648,0.0135095256612838,-0.104430314260581,-0.0514729736683486,8.13518462775413e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39858,-0.045452965563341,0.00788522967889685,-0.0609080157339788,-0.0299979153927031,8.41423917189295e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39904,-0.038800851275993,0.00673300325359176,-0.0519975376530328,-0.0256041648989531,8.48988617547537e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,42072,-0.015466205587528,0.002684706085951,-0.020728229515992,-0.0102041816590641,8.55174331259104e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39590,-0.0408721736670178,0.00709794040929262,-0.0547841368692313,-0.0269602104648042,8.7234903329463e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39696,-0.0468399100632059,0.00816273581336956,-0.0628388722574102,-0.0308409478690016,9.81577793522782e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42072,-0.0425180377327866,0.00741599224608659,-0.0570533825351163,-0.0279826929304569,1.00613391580853e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41890,-0.073691142021796,0.0128646014692525,-0.0989057609015308,-0.0484765231420612,1.03695046373579e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42034,-0.0688484538889826,0.0120208941291312,-0.0924094063820797,-0.0452875013958855,1.04167018806884e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41828,-0.0222907392029754,0.00390755867163436,-0.0299495541993787,-0.014631924206572,1.19171847525536e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42048,0.0169686387051239,0.00298012956408304,0.0111275847595211,0.0228096926507266,1.2674698623903e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42201,0.0237434441459682,0.00417670612418078,0.0155571001425738,0.0319297881493625,1.33711827870729e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,42099,0.0162492018239255,0.00286486557230429,0.0106340653022091,0.021864338345642,1.4412879618148e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39734,0.00508293349838184,0.000897139009975404,0.00332454103883005,0.00684132595793364,1.50046689031627e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39575,-0.0546505006546717,0.00964810576759095,-0.0735607879591499,-0.0357402133501934,1.5127254356397e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,39917,0.0187805657483537,0.00331623041587423,0.0122807541332402,0.0252803773634672,1.52172569404429e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42236,0.0151898612973651,0.00268464625900194,0.00992795462972127,0.0204517679650089,1.56183134220257e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,42063,-0.0470725725141551,0.00832508062996268,-0.0633897305488819,-0.0307554144794282,1.59655613242324e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,39680,-0.0135291754302988,0.00239964128470384,-0.0182324723483183,-0.00882587851227927,1.76246034675492e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41766,-0.026659007205968,0.00473048492413593,-0.0359307576572745,-0.0173872567546616,1.78054338026767e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39869,-0.0311726613674455,0.00553979360700633,-0.0420306568371779,-0.0203146658977131,1.87699409842982e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39675,-0.0253270606408292,0.00450182443349203,-0.0341506365304736,-0.0165034847511848,1.88962125508311e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39872,-0.0619916053522311,0.0110216540083706,-0.0835940472086375,-0.0403891634958248,1.90446005255255e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42048,-0.0510490249387668,0.00908009081580641,-0.0688460029377473,-0.0332520469397862,1.92422587189982e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C3,Complement C3,39383,-0.0284443759042818,0.00506006619102638,-0.0383621056386935,-0.0185266461698701,1.94186099299475e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,41576,-0.0377873537022443,0.00672489779858735,-0.0509681533874755,-0.0246065540170131,1.95993522298291e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,42072,-0.0264098113019907,0.0047047795011168,-0.0356311791241796,-0.0171884434798018,2.02305404198754e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,42225,0.0272676840806686,0.00486482052037185,0.0177326358607398,0.0368027323005974,2.12204304849368e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39512,-0.0427928351693066,0.00763700218498619,-0.0577613594518795,-0.0278243108867337,2.15340230854599e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,42032,-0.0176023939198191,0.00314229597224337,-0.0237612940254161,-0.0114434938142221,2.16351389948031e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39597,-0.0395754225198197,0.00707561583127512,-0.0534436295491189,-0.0257072154905205,2.28231525443386e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41873,0.0236140208527582,0.00422386209776829,0.0153352511411324,0.0318927905643841,2.30718932429977e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39872,-0.047908608431391,0.00857774630357645,-0.0647209911864008,-0.0310962256763811,2.38811520814747e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39868,-0.0292936806567555,0.00525778162262187,-0.0395989326370944,-0.0189884286764167,2.58367251503382e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39513,0.0386734997268443,0.00694699818087841,0.0250573832923226,0.052289616161366,2.65383938559878e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39597,-0.0345691372579609,0.00622332068695479,-0.0467668458043923,-0.0223714287115295,2.8443537745481e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39575,-0.0621500800496362,0.0111948268137604,-0.0840919406046066,-0.0402082194946658,2.89517452656929e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,39904,-0.0157974921603727,0.00284938257716972,-0.0213822820116254,-0.01021270230912,3.0196273471941e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39895,-0.0197612937995906,0.0035651745560603,-0.0267490359294688,-0.0127735516697124,3.04234534510248e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,39869,-0.0205697663710089,0.00371764437572352,-0.0278563493474271,-0.0132831833945908,3.21812149706063e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,41943,0.0252843366678735,0.00457999051795383,0.016307555252684,0.034261118083063,3.44135808978774e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39675,-0.058067952231776,0.0105265796029828,-0.0787000482536222,-0.0374358562099298,3.53954678393363e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39895,-0.0430516994182842,0.00781506431227143,-0.0583692254703362,-0.0277341733662321,3.69183570411826e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,41995,-0.0257142560194456,0.00467166892909031,-0.0348707271204626,-0.0165577849184285,3.77458411046362e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,42063,-0.0439776045230526,0.00799108038421774,-0.0596401220761194,-0.0283150869699859,3.79483228604062e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,42070,-0.019665845535642,0.00357487551161243,-0.0266726015384023,-0.0126590895328816,3.84255086332195e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,42174,-0.0164349692774731,0.00299135087926428,-0.0222980170008311,-0.0105719215541151,3.99639302581189e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42044,0.029162046726415,0.00531076240474271,0.0187529524131193,0.0395711410397107,4.06636011103869e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,42226,-0.0203986977698844,0.00371862591782818,-0.0276872045688276,-0.0131101909709411,4.19542799805824e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39575,-0.0368792876278879,0.00672208786152911,-0.050054579836485,-0.0237039954192909,4.19585134558983e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42155,0.0115677483020579,0.00210892086155942,0.0074342634134014,0.0157012331907143,4.20522056033952e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42236,-0.0178350272672713,0.00325450909832417,-0.0242138650999867,-0.0114561894345559,4.32637711090406e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42108,0.0229090365495603,0.00418587988215647,0.0147047119805336,0.031113361118587,4.50542147085973e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41741,-0.0439366376386669,0.00803516892352256,-0.0596855687287712,-0.0281877065485627,4.63347740645852e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42048,-0.0496167895045552,0.00907557959421744,-0.0674049255092214,-0.031828653499889,4.65707115109038e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41943,-0.0346830930035848,0.00634660067067456,-0.0471224303181069,-0.0222437556890626,4.71667178131736e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42048,-0.0143607054384324,0.00262939346390975,-0.0195143166276955,-0.0092070942491693,4.80234948854894e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,39575,-0.0178544472727517,0.00327072371227589,-0.0242650657488125,-0.011443828796691,4.89609391270154e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42187,-0.0200449936720685,0.00367267130491852,-0.0272434294297088,-0.0128465579144282,4.90307051456514e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42070,0.0143012598135228,0.00262269144692811,0.00916078457754367,0.0194417350495018,5.04299645832807e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39590,-0.0374232476935044,0.00686827039449496,-0.0508850576667145,-0.0239614377202943,5.18296336267183e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39590,-0.035390666407141,0.00649650722539219,-0.0481238205689097,-0.0226575122453723,5.21413886351027e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39575,-0.0375567270965724,0.00689902851651064,-0.0510788229889332,-0.0240346312042115,5.32874367064809e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,39758,-0.0360367984240176,0.00663609830386675,-0.0490435510995964,-0.0230300457484387,5.74006166757422e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41766,-0.0377606223931136,0.00695932492685156,-0.0514008992497426,-0.0241203455364845,5.86822936105645e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42016,0.015443559137985,0.00284900709039861,0.00985950524080377,0.0210276130351663,6.03990753840675e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42111,-0.0161247391402859,0.00297835264675212,-0.02196231032792,-0.0102871679526517,6.2692612552234e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41906,0.0339297376191512,0.00627365753419435,0.0216333688521302,0.0462261063861721,6.47302006419607e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42111,-0.0522844252953532,0.00967443309335011,-0.0712463141583194,-0.033322536432387,6.61322413195525e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39675,0.0191132964232506,0.00353642001193285,0.0121819131998622,0.026044679646639,6.62625067088612e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39872,-0.0760101102120751,0.0140718924127921,-0.103591019341148,-0.0484292010830027,6.74083453540678e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,39895,-0.0161070567237934,0.00298773997121939,-0.0219630270673834,-0.0102510863802034,7.14571804540884e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,41828,-0.026337226931529,0.0048863683220952,-0.0359145088428356,-0.0167599450202224,7.16907396392451e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,39526,-0.0247760380550752,0.00459720694722276,-0.0337865636716318,-0.0157655124385186,7.21761653411954e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42187,-0.036786285641097,0.00682960232109613,-0.0501723061904454,-0.0234002650917485,7.31208104769089e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,42063,-0.0265229089841435,0.004926681105491,-0.0361792039509059,-0.0168666140173812,7.42665486360411e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39597,-0.0244724749835795,0.00454700458716716,-0.0333846039744271,-0.0155603459927318,7.51307962872212e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42083,-0.0565457590312279,0.0105094305087145,-0.0771442428283083,-0.0359472752341475,7.55299480522722e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42108,0.0248255653132331,0.00461618228406252,0.0157778480364705,0.0338732825899956,7.65962035743606e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,42174,0.0171266228726932,0.00318621435800954,0.0108816427309945,0.0233716030143919,7.775148943875e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41766,-0.0245467078900038,0.0045674565798267,-0.0334989227864642,-0.0155944929935435,7.82074611440281e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39868,-0.0197773610427134,0.0036817344072013,-0.0269935604808279,-0.0125611616045988,7.95273221419641e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42236,-0.013447764658968,0.00250449133876555,-0.0183565676829485,-0.00853896163498753,8.02675893614006e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2,Complement C2,42124,-0.0133121896610914,0.00247963102073611,-0.0181722664617342,-0.00845211286044865,8.06533346522357e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,42048,-0.0379135365625952,0.00708315025590301,-0.0517965110641651,-0.0240305620610253,8.81047514244615e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,41995,-0.0326435130820142,0.00610366882581586,-0.0446067039806132,-0.0206803221834151,9.03035918263718e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41865,-0.014071723824385,0.00263305127374754,-0.0192325043209302,-0.00891094332783983,9.22869678355923e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,42048,-0.0226442970157284,0.0042439717036027,-0.0309624815547897,-0.0143261124766671,9.6753324359934e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,39426,-0.0487675741264667,0.00914119453233714,-0.0666843154098475,-0.0308508328430859,9.75126571433426e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41903,-0.0172990807400241,0.00324403597636902,-0.0236573912537073,-0.0109407702263408,9.84113006079926e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42111,-0.0703243267547545,0.0132026929158194,-0.0962016048697606,-0.0444470486397485,1.01721031416002e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42054,-0.0182298602798725,0.00342459878497159,-0.0249420738984168,-0.0115176466613281,1.0358947095425e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42063,-0.0169525732021056,0.00318530312620964,-0.0231957673294765,-0.0107093790747347,1.04208746364922e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,39858,-0.0499553727060437,0.00939116137631362,-0.0683620490036184,-0.0315486964084691,1.06103960457068e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39869,-0.0177176525847739,0.00333636792595697,-0.0242569337196496,-0.0111783714498983,1.11428510280802e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39635,0.0200392458432054,0.00378043857355416,0.0126295862390392,0.0274489054473715,1.17538383178624e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,39897,-0.0130585658889402,0.00246545692748566,-0.017890861466812,-0.00822627031106828,1.20187871780255e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39500,-0.0389591621899601,0.00737402134695527,-0.0534122440299924,-0.0245060803499278,1.2932459826517e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42236,-0.0179775026432936,0.00340826954514208,-0.0246577109517721,-0.0112972943348151,1.35027905291024e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,39512,-0.0227543857799413,0.00431773765224231,-0.0312171515783362,-0.0142916199815464,1.39042029771194e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42174,-0.0272489509130964,0.00518280368636289,-0.0374072461383676,-0.0170906556878251,1.48186120194909e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39597,-0.0319863584960446,0.00608354018371473,-0.0439100972561255,-0.0200626197359637,1.48480839630286e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,39673,0.0179284817931283,0.00341127212093734,0.0112423884360911,0.0246145751501655,1.50238540260884e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39512,-0.0350785841948067,0.00668054565649555,-0.048172453681538,-0.0219847147080755,1.54240957506465e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39512,-0.0340099296871208,0.00648292851024618,-0.0467164695672033,-0.0213033898070383,1.58285158147513e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42048,-0.0697097021193532,0.0133275321457667,-0.095831665125056,-0.0435877391136504,1.71586266612983e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,42111,-0.0208136692895515,0.0039815652898897,-0.0286175372577353,-0.0130098013213677,1.74369629249586e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41719,-0.0333092336864,0.00637510377790351,-0.0458044370910909,-0.0208140302817092,1.76926217607171e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,41943,0.0149161993616929,0.00285945101747695,0.00931167536743805,0.0205207233559477,1.85109436652496e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42187,-0.0306775550860029,0.00588134933119778,-0.0422049997751505,-0.0191501103968552,1.85440529562166e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39575,-0.0301143354334216,0.0057735570921716,-0.0414305073340779,-0.0187981635327652,1.86252324170615e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39872,-0.0213782419504957,0.00409959170556951,-0.0294134416934119,-0.0133430422075794,1.87352054361113e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42048,0.0324574545546947,0.00623824829827432,0.020230487890077,0.0446844212193123,1.99006169285097e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,41842,-0.0463088819574668,0.00890473010160448,-0.0637621529566116,-0.0288556109583221,2.01736040319684e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41967,-0.0161734622416094,0.00311555997009348,-0.0222799597829927,-0.0100669647002262,2.12018749218627e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,42187,-0.023049929703172,0.00445606928762646,-0.0317838255069199,-0.0143160338994242,2.34012011789765e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40452,0.0176203370911305,0.00341125797257317,0.0109342714648871,0.0243064027173739,2.43886499537759e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42048,-0.0680110641745575,0.0131691887565688,-0.0938226741374323,-0.0421994542116827,2.44646360624028e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,41766,-0.0234307897494161,0.0045471308799529,-0.0323431662741238,-0.0145184132247084,2.60235914825065e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,42048,-0.0226036110951416,0.00439049660904486,-0.0312089844488695,-0.0139982377414136,2.66561577795478e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39869,0.017177387318877,0.00333928751667243,0.0106323837861991,0.023722390851555,2.73428830342284e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39512,-0.0197212030698776,0.00383707108323211,-0.0272418623930126,-0.0122005437467427,2.80012462866521e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,41766,-0.0252712056400062,0.00492337171971204,-0.0349210142106418,-0.0156213970693705,2.89367190467274e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,39869,-0.0368375679820824,0.00719090452875235,-0.050931740858437,-0.0227433951057278,3.06009035234058e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39858,-0.0294620188859531,0.00575324268056452,-0.0407383745398595,-0.0181856632320466,3.09039150792107e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41995,-0.0525331019347046,0.0102754351323743,-0.0726729547941583,-0.032393249075251,3.22316706723234e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41828,-0.034107224012346,0.00667650716744412,-0.0471931780605364,-0.0210212699641555,3.29172263167111e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39675,-0.0633319268745661,0.0124140672223923,-0.087663498630455,-0.0390003551186773,3.42324077093024e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42072,-0.0344382562108453,0.00675143612893503,-0.0476710710235579,-0.0212054413981326,3.42674435980271e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42048,-0.0511361891023898,0.0100403373773232,-0.0708152503619432,-0.0314571278428364,3.57070175276293e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,39575,-0.0129897491561155,0.00255173898389931,-0.0179911575645582,-0.00798834074767289,3.62946687476127e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39868,-0.0216558974522895,0.00425554405186012,-0.0299967637939353,-0.0133150311106436,3.66014277392878e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41943,-0.0257845443157856,0.00506889220618178,-0.0357195730399019,-0.0158495155916693,3.69059063061156e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41997,-0.0149942235238656,0.00294776324750522,-0.0207718394889758,-0.00921660755875536,3.69380790242162e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,41771,-0.0366176111625983,0.00720493352994782,-0.050739280881296,-0.0224959414439006,3.78008710725431e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42236,0.015073514255856,0.00296614361665022,0.00925987276722154,0.0208871557444904,3.78710359113421e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39858,-0.024553172188704,0.00483105471659767,-0.0340220394332354,-0.0150843049441726,3.78751792232658e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39696,-0.0395902908710308,0.00780847451429119,-0.0548949009190416,-0.0242856808230201,4.03874053366858e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39590,-0.0219284509522245,0.00432518325906837,-0.0304058101399985,-0.0134510917644505,4.04407615918808e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,39597,-0.0283900250243219,0.00560778114756497,-0.0393812760735493,-0.0173987739750946,4.20243087480569e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39869,-0.0240043218169194,0.00474436413309026,-0.0333032755177763,-0.0147053681160625,4.26880798799836e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39904,-0.0157692402779318,0.00312122564082316,-0.0218868425339452,-0.00965163802191838,4.43434889503815e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,39575,0.0237956695825585,0.0047189042871291,0.0145466171797854,0.0330447219853315,4.66520244126173e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,39895,-0.0212613370806233,0.00422730720343788,-0.0295468591993615,-0.012975814961885,4.99255434509842e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39869,-0.0221070580324954,0.0044179399439959,-0.0307662203227274,-0.0134478957422634,5.70213388835905e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39831,-0.0250085176816803,0.00500062115689975,-0.0348097351492039,-0.0152073002141568,5.78709267624748e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42136,0.0131410350783514,0.00262874485308444,0.00798869516630593,0.0182933749903969,5.83560333778397e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42069,-0.0341346340009452,0.00683105678646085,-0.0475235053024085,-0.0207457626994819,5.89667733291466e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41771,-0.0316461291356507,0.00634409312845163,-0.044080551667416,-0.0192117066038856,6.1694985984155e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,41828,-0.0398035587980565,0.0079854044910672,-0.0554549516005482,-0.0241521659955647,6.28957993399173e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41747,-0.0364629412072345,0.00732788148635103,-0.0508255889204825,-0.0221002934939865,6.57603535418599e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,42222,-0.0431219353687039,0.00868965969085746,-0.0601536683627845,-0.0260902023746233,7.04529960375137e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39868,-0.0376305767345709,0.00759594642986387,-0.0525186317371041,-0.0227425217320377,7.37459689930863e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,42069,-0.0195886877403093,0.00395546278570533,-0.0273413948002917,-0.0118359806803269,7.42255116897909e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,42149,-0.0388839912196813,0.00785257746874892,-0.0542750430584292,-0.0234929393809334,7.4435198309662e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39869,-0.0290505717080816,0.00586687731578558,-0.0405496512470213,-0.0175514921691418,7.46631366895605e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,41995,-0.0725230315816747,0.0146669364636797,-0.101270227050487,-0.0437758361128625,7.72004117251721e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39575,-0.0419875307521769,0.00849763471427614,-0.0586428947921581,-0.0253321667121957,7.88358904264228e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39904,-0.0257979152925055,0.00523252615647727,-0.0360536665592009,-0.01554216402581,8.32705205329943e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41981,-0.0339130208109466,0.00687967443398689,-0.0473971827015609,-0.0204288589203323,8.34489578440653e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,41995,0.0162213793962058,0.00329702671098632,0.00975920704267264,0.022683551749739,8.75714183622332e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39696,-0.0255521198400113,0.0051942269625646,-0.0357328046866379,-0.0153714349933847,8.8086825517298e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41842,-0.0350356494138991,0.00713563779851599,-0.0490214994989905,-0.0210497993288078,9.21843444081411e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,42222,-0.022930680523635,0.00467092787111257,-0.0320856991510157,-0.0137756618962544,9.24917276606209e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,39512,-0.0339706346793269,0.00692673831388987,-0.0475470417745511,-0.0203942275841027,9.51249762485437e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39500,-0.0195950521280915,0.00399571241415711,-0.0274266484598394,-0.0117634557963436,9.52503795897187e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39872,-0.021080557262225,0.0043040209291472,-0.0295164382833535,-0.0126446762410965,9.82239315182157e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39858,-0.0201524113209785,0.00411721450453941,-0.0282221517498757,-0.0120826708920812,9.98359527816414e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,42187,-0.0118580135933427,0.0024256260619727,-0.0166122406748092,-0.00710378651187626,1.0269496606413e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41771,-0.0247770792823739,0.0050760535986742,-0.0347261443357754,-0.0148280142289725,1.06694351825171e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39575,-0.0286259270614608,0.00586522756037646,-0.0401217730797987,-0.0171300810431229,1.07242794090234e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39887,-0.0122872523297447,0.00251888461882798,-0.0172242661826475,-0.00735023847684181,1.08600939364588e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,39895,-0.0355010158737432,0.0072810283154269,-0.0497718313719799,-0.0212302003755065,1.09830610994075e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,39590,-0.0350275314708771,0.00719644031380963,-0.0491325544859439,-0.0209225084558102,1.14682339512185e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41995,-0.0284769645826617,0.00585182001054955,-0.0399465318033388,-0.0170073973619846,1.14976641050967e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42070,-0.0185601993849263,0.00381438753065132,-0.0260363989450029,-0.0110839998248497,1.15261834037079e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41771,-0.0395567859638512,0.00814779710684576,-0.0555264682932689,-0.0235871036344335,1.21826505582596e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39927,0.0344369879889048,0.00710007539291499,0.0205208402187914,0.0483531357590182,1.24960251371595e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LXN,Latexin,41889,0.0363866868253084,0.00750441401497681,0.0216780353559538,0.0510953382946629,1.25676945228232e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41828,-0.0472307673396733,0.00975117412212294,-0.0663430686190342,-0.0281184660603123,1.28952877395158e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41771,-0.0158231121506953,0.00326794132997531,-0.0222282771574469,-0.00941794714394373,1.30050911141106e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41771,-0.0283729988260422,0.00586049613108065,-0.0398595712429603,-0.0168864264091242,1.30392278072273e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,39512,0.0165263328781524,0.00341830487893545,0.00982645531543895,0.0232262104408659,1.35194958994152e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,42072,-0.0185791502206712,0.00384390594696505,-0.0261132058767227,-0.0110450945646197,1.35698355845262e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,41686,0.0370404602538186,0.00768611865771198,0.0219756676847031,0.0521052528229341,1.45799091666065e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,42187,-0.0167673692316516,0.00347976582612231,-0.0235877102508513,-0.00994702821245187,1.46179757125714e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41771,-0.0255102495286651,0.00530063015096387,-0.0358994846245543,-0.015121014432776,1.50570307967474e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39500,-0.0401981913383476,0.00835719756723444,-0.0565782985701271,-0.0238180841065681,1.52945030718627e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39895,-0.0286975738764012,0.00597691130740499,-0.040412320038915,-0.0169828277138875,1.59577744636272e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39510,-0.0536698360648925,0.011184704372829,-0.0755918566356372,-0.0317478154941477,1.61975096575029e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42187,-0.0175933253584624,0.00367278323444318,-0.0247919804979711,-0.0103946702189538,1.68384366804483e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,42048,-0.0290513419365542,0.00607895609896465,-0.040966095890525,-0.0171365879825835,1.78030825038243e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,39895,-0.0519493097029993,0.0108770788884691,-0.0732683843243988,-0.0306302350815999,1.81032942609033e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39872,-0.0143109698278251,0.00299912974422374,-0.0201892641265036,-0.00843267552914653,1.84963858957929e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39696,-0.0207554329694377,0.00435473148667576,-0.0292907066833222,-0.0122201592555532,1.90135625216256e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,39927,-0.0390923648384034,0.00821886642117573,-0.0552013430239078,-0.0229833866528989,1.99489543746593e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39575,-0.0255666034739096,0.0053798690432781,-0.0361111467987347,-0.0150220601490845,2.03696249556994e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,39696,-0.0151054011180837,0.00318168723939368,-0.0213415081072953,-0.00886929412887209,2.0841168064122e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42072,-0.0257245920091362,0.00542324167543331,-0.0363541456929854,-0.0150950383252869,2.12318730565797e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,41828,-0.05967662322781,0.0125836963316955,-0.0843406680379332,-0.0350125784176868,2.13430618705834e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41842,-0.0221352761347154,0.00467166975456859,-0.0312917488536699,-0.012978803415761,2.17872433569541e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,41837,-0.0380174607175538,0.00804330941964542,-0.0537823471800589,-0.0222525742550488,2.30667899145952e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41771,-0.0245689582167293,0.00520233338933214,-0.0347655316598203,-0.0143723847736384,2.35157648398862e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41943,-0.0189111451343348,0.00400485696363609,-0.0267606647830616,-0.0110616254856081,2.35852583046903e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39869,-0.0513075437434576,0.0108818818460736,-0.0726360321617617,-0.0299790553251534,2.44667272722677e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41995,-0.0194380863875644,0.00412639988650739,-0.0275258301651189,-0.01135034261001,2.49390147157853e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,39590,-0.0255949545370501,0.0054379937083587,-0.0362534222054331,-0.014936486868667,2.54845266326183e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41924,-0.0371326365008296,0.00789372291656299,-0.0526043334172931,-0.0216609395843662,2.57585286460481e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41749,0.023481202392538,0.00499776160766881,0.0136855896415072,0.0332768151435689,2.64936528300455e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42047,-0.0376722010583497,0.00803096071488844,-0.053412884059531,-0.0219315180571684,2.74722426670354e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39927,0.0312941544356648,0.0066733494940165,0.0182143894273925,0.0443739194439371,2.7717766501182e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42149,-0.0155820376062652,0.00332652113356907,-0.0221020190280605,-0.0090620561844698,2.83808187693035e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,39858,-0.0231463181408368,0.00494498316057763,-0.0328384851355689,-0.0134541511461046,2.89137607428765e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42187,0.0271842503813758,0.00582858807193078,0.0157602177603914,0.0386082830023601,3.13150675036189e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41932,-0.0520986807955467,0.0111791806769725,-0.0740098749224129,-0.0301874866686806,3.18758265415172e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41771,-0.0364546506402905,0.00785551076153636,-0.0518514517329018,-0.0210578495476793,3.50669532667776e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41995,-0.0108991173371566,0.00234969503291426,-0.0155045196016685,-0.00629371507264461,3.54226878647762e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39858,-0.0227469321096073,0.00493158937663074,-0.0324128472878035,-0.013081016931411,4.02251052593974e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42056,-0.029268735781989,0.00634624537841602,-0.0417073767236844,-0.0168300948402936,4.02533336531491e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,39597,-0.0212005902904499,0.00460094776441194,-0.0302184479086973,-0.0121827326722025,4.11380960679201e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,42039,-0.0120878766821998,0.00262404971142915,-0.0172310141166009,-0.00694473924779864,4.13119471236911e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39590,0.0159638776063075,0.00346841804736097,0.00916577823348005,0.022761976979135,4.218442554347e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,41995,0.014033956589729,0.00304962328585032,0.00805669494946238,0.0200112182299956,4.22567029860222e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,41766,-0.0413424193964256,0.00898632833492529,-0.0589556229328792,-0.023729215859972,4.25224972231988e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39575,-0.0165918955171722,0.0036068468076149,-0.0236613152600974,-0.00952247577424701,4.26993656986563e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39904,-0.011713501127931,0.00254702019645763,-0.016705660712988,-0.00672134154287409,4.29331150118502e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41995,-0.0185077912488454,0.00402669634656112,-0.0264001160881052,-0.0106154664095856,4.34047238281522e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,38447,-0.0537918988648727,0.0117285395860043,-0.0767798364534411,-0.0308039612763043,4.56496682238546e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,41945,-0.0353476350372431,0.00771213564092855,-0.050463420893463,-0.0202318491810231,4.61674141402583e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,39858,-0.0201498057808011,0.00439876959415037,-0.0287713941853358,-0.0115282173762664,4.68214148732511e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39861,-0.0100820924602459,0.0022011368473686,-0.0143963206810883,-0.0057678642394034,4.69062543115e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,42222,0.00461836806293515,0.00100997843716753,0.0026388103260868,0.00659792579978351,4.85629253075842e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,42048,0.0221589002229931,0.00485083015439099,0.0126512731203867,0.0316665273255994,4.96625862022227e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42072,0.0552099180315786,0.0121232914049629,0.0314482668778512,0.0789715691853059,5.30874857495153e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39512,-0.0193093085422586,0.00423977129527972,-0.0276192602810069,-0.0109993568035104,5.31227860174205e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,42071,-0.0272377256134842,0.00600005256076772,-0.038997828632589,-0.0154776225943795,5.68543052694988e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,39792,-0.0214420728024299,0.00472324889133878,-0.0306996406294539,-0.0121845049754059,5.69255239508417e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,42065,-0.0203422247578467,0.00448154887044889,-0.0291260605439266,-0.0115583889717669,5.69826191099824e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42072,-0.0435593393354075,0.00959661508508365,-0.0623687049021715,-0.0247499737686436,5.70023972576193e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39742,-0.0279801034986737,0.00616586973191417,-0.0400652081732255,-0.015894998824122,5.74116155645071e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42050,-0.0146341361332528,0.00322531928183244,-0.0209557619256444,-0.00831251034086125,5.7481238229704e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39675,-0.0348413782333114,0.00770240319087465,-0.0499380884874258,-0.0197446679791971,6.1474584072503e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39895,-0.0143233330750367,0.00316659113736942,-0.0205298517042808,-0.00811681444579261,6.1513514589132e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42055,-0.047298513030713,0.0104657736190444,-0.0678114293240401,-0.026785596737386,6.2558013238148e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39652,0.0243888027270541,0.00539709863274576,0.0138104894068724,0.0349671160472357,6.28150899676203e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,39904,-0.0417262800912642,0.00923535182391951,-0.0598275696661464,-0.0236249905163819,6.30286610206988e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39869,-0.0596260696194593,0.0132006353402921,-0.0854993148864318,-0.0337528243524867,6.33865736892435e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42051,-0.029582850116615,0.00655731396625484,-0.0424351854904745,-0.0167305147427555,6.49380191023174e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,39732,-0.0162284150624768,0.00359728569505811,-0.0232790950247907,-0.00917773510016296,6.50929876106216e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,42003,-0.012389276322046,0.00275295184729045,-0.0177850619427353,-0.00699349070135677,6.8409473146019e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39904,-0.0252974324230104,0.0056424249300418,-0.0363565852858923,-0.0142382795601285,7.41750080541632e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,42174,-0.0317966674947206,0.00714018004438375,-0.0457914203817127,-0.0178019146077284,8.52743963627329e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39858,-0.0236635150249299,0.00532929288621234,-0.034108929081906,-0.0132181009679537,9.07007454307817e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39696,-0.0425391447902523,0.00959338675372611,-0.0613421828275555,-0.0237361067529492,9.32966784628733e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,42048,-0.0154828555594801,0.00349418792283847,-0.0223314638882435,-0.00863424723071672,9.45250713307543e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39575,-0.0210957797815015,0.00477821197979233,-0.0304610752618945,-0.0117304843011086,1.01978340425853e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,42034,-0.01946493994961,0.00441204835031444,-0.0281125547162263,-0.0108173251829937,1.03327371798968e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41766,-0.0356505072485921,0.0080877142964382,-0.051502427269611,-0.0197985872275732,1.05163758899462e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,42108,0.0132980220259789,0.00301822686755328,0.00738229736557451,0.0192137466863834,1.06154285899908e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,42070,-0.0115679321295857,0.00262656222509716,-0.0167159940907761,-0.00641987016839527,1.06988788239403e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42236,-0.0132899393471421,0.00301765530166956,-0.0192045437384145,-0.00737533495586978,1.07052110524359e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,39872,-0.03351848177427,0.00762893011159813,-0.0484711847930023,-0.0185657787555377,1.12506523281742e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,41771,-0.0296966586037902,0.00676153500342992,-0.0429492672105129,-0.0164440499970676,1.13189488435278e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39675,-0.0180146860904052,0.0041061179461213,-0.0260626772648029,-0.00996669491600745,1.15838907927682e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,39417,-0.0190912094507784,0.00435366803958779,-0.0276243988083705,-0.0105580200931863,1.17035719369525e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39512,0.0224572928687935,0.00512275959947282,0.0124166840538268,0.0324979016837603,1.17703647402445e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,39825,-0.0137241607639092,0.00313095318029336,-0.0198608289972842,-0.00758749253053426,1.17914064647672e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39850,-0.0338206262277796,0.00771611568845,-0.0489442129771416,-0.0186970394784176,1.18055315173677e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,42174,-0.0144421574205648,0.00329831203164756,-0.0209068490025941,-0.0079774658385356,1.20309922907035e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39869,-0.0372873469854754,0.00854486289258646,-0.0540352782549448,-0.0205394157160059,1.2901057170073e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,42092,0.0100908063130522,0.00231457573832881,0.00555423786592775,0.0146273747601767,1.31218252472074e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,42041,-0.0420900076505877,0.00965822276417631,-0.0610201242683732,-0.0231598910328021,1.32263640703442e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,42046,0.0320701002412053,0.00737413896567282,0.0176167878684866,0.046523412613924,1.37769082038299e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41360,-0.0200248904313744,0.00460633951490201,-0.0290533158805823,-0.0109964649821665,1.38925615740635e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39872,-0.0139121150945713,0.00320722819872412,-0.0201982823640706,-0.00762594782507206,1.45209090886102e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39872,0.0122191090622587,0.00282503130717101,0.00668204770020353,0.0177561704243139,1.53634813342455e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41995,-0.040333171565474,0.00934072051141843,-0.0586409837678542,-0.0220253593630939,1.58586148670603e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,42174,0.0142351638698268,0.00329674007508698,0.00777355332265628,0.0206967744169972,1.58601367548862e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,41741,-0.0172762804165521,0.00401616389884212,-0.0251479616582827,-0.00940459917482154,1.70727145364966e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42072,-0.00827151986034281,0.00192481773955636,-0.0120441626298733,-0.00449887709081234,1.74104445597014e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39575,0.010197215019249,0.00237396430930519,0.00554424497301087,0.0148501850654872,1.7584987132493e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41766,-0.0180353780355897,0.00420541201233406,-0.0262779855797644,-0.00979277049141492,1.81075050982333e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39512,-0.0239294616391208,0.00558453411954294,-0.034875148513425,-0.0129837747648166,1.84346062469448e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39858,-0.029419871464736,0.0068674334790963,-0.0428800410837648,-0.0159597018457073,1.85113216329093e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41842,0.0185141077356055,0.00432495952426982,0.0100371870680366,0.0269910284031743,1.87567980055678e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41995,0.0321583088776328,0.00755123054289816,0.0173578970135524,0.0469587207417131,2.0703589599024e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,41919,0.0153533127314348,0.00361162524765419,0.00827452724603257,0.022432098216837,2.14190213771664e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,39512,-0.0280536987534231,0.00660214052003301,-0.0409938941726878,-0.0151135033341584,2.16334294640656e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,42111,0.0310374872874121,0.00730721165697844,0.0167153524397344,0.0453596221350899,2.17602182029715e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39868,-0.0170427785909568,0.00401265930247011,-0.0249075908237982,-0.00917796635811542,2.1814518337715e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39512,-0.0215103033817905,0.00506966865466294,-0.0314468539449299,-0.0115737528186511,2.22431862754876e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42072,0.0182575682852235,0.00430641316283872,0.00981699848605962,0.0266981380843874,2.25388000738129e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39675,-0.0297573723247656,0.00702985407016559,-0.0435358863022902,-0.0159788583472411,2.32454218379147e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39869,0.0335898256743314,0.00794800363126396,0.0180117385570541,0.0491679127916088,2.39546582474664e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,39590,-0.0228750057817181,0.00542194574416602,-0.0335020194402835,-0.0122479921231527,2.47394620805763e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41995,-0.0207985721967404,0.00493132848853062,-0.0304639760342604,-0.0111331683592204,2.48494324607714e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,42174,-0.0170073654612467,0.00403655298420872,-0.0249190093102958,-0.00909572161219757,2.53248824290892e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41842,-0.0165909812686851,0.00396014432765275,-0.0243528641508845,-0.00882909838648571,2.81395347733971e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39597,-0.0186518945993179,0.00445488357941767,-0.0273834664149765,-0.00992032278365927,2.85065663839685e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,39597,-0.0293055898837976,0.00702142219649101,-0.04306757738892,-0.0155436023786752,3.01946134916171e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39872,0.0192745482472434,0.00461856728734917,0.010222156364039,0.0283269401304478,3.02506583326544e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42175,-0.0142269705001454,0.00341208424144398,-0.0209146556133756,-0.0075392853869152,3.07051151950035e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,41686,-0.0336416299162741,0.00806983047948458,-0.0494584976560638,-0.0178247621764843,3.08158155872268e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39590,-0.0247297362046108,0.00594003133257147,-0.0363721976164509,-0.0130872747927707,3.16165987464703e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42027,-0.0217441595917539,0.00523265677266128,-0.03200016686617,-0.0114881523173378,3.26627877565634e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42142,0.0162570933254981,0.00393141357781484,0.00855152271298102,0.0239626639380152,3.56818999992829e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41842,-0.0269930263162586,0.00653080100038087,-0.0397933962770051,-0.0141926563555121,3.59968635942522e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42104,0.0220811743931366,0.00534578002326748,0.0116034455475324,0.0325589032387409,3.64027340747034e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,41741,-0.0416463719452519,0.0100901328127671,-0.0614230322582753,-0.0218697116322284,3.69094817777705e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39725,-0.00606660948812832,0.00147051515596821,-0.00894881919382601,-0.00318439978243063,3.72623558768269e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41943,-0.0474581077157636,0.0115160815395552,-0.0700296275332918,-0.0248865878982354,3.79462223327349e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,39872,-0.0115033659927294,0.00280725913601892,-0.0170055938993265,-0.00600113808613229,4.20157957368882e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCT,Secretin,39590,-0.0217086083113778,0.00530102204369648,-0.0320986115170229,-0.0113186051057327,4.24873364171244e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39927,-0.0329879996895373,0.00806647065741517,-0.048798282178071,-0.0171777172010036,4.35253915677748e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41995,-0.0155037558755458,0.00379500739266396,-0.0229419703651671,-0.0080655413859244,4.42755483678439e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42142,-0.0192942901918906,0.00473373573910923,-0.0285724122405447,-0.0100161681432365,4.60959736895542e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41771,-0.0210178059744272,0.00516029932713345,-0.0311319926556088,-0.0109036192932457,4.66866912576078e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41882,0.026748384227639,0.00657418794937115,0.0138629758468716,0.0396337926084065,4.75499086999663e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39869,-0.0195678288569892,0.00481624949661473,-0.029007677870354,-0.0101279798436243,4.88001808084319e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41771,-0.0165841075036034,0.00408461460352379,-0.02458995212651,-0.00857826288069678,4.93269073524599e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39675,-0.0397750188514598,0.00981413973143532,-0.059010732725073,-0.0205393049778465,5.09480223375954e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39675,-0.0146780232538852,0.00362397443034439,-0.0217810131373602,-0.00757503337041019,5.15104525913403e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41542,-0.0143554031761639,0.00354750949136126,-0.0213085217792319,-0.00740228457309581,5.22657143639366e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42063,-0.0108783634650964,0.00269136142765521,-0.0161534318633006,-0.0056032950668922,5.33020829869085e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,42048,-0.01521869733834,0.00376965491385483,-0.0226072209694954,-0.00783017370718453,5.4402226277356e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,39917,-0.0134768243504516,0.00334091023072539,-0.0200250084026734,-0.00692864029822982,5.52242000663669e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,41766,-0.013010763812366,0.00323218064599291,-0.0193458378785121,-0.0066756897462199,5.72012642612704e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,42142,-0.020585325214915,0.00511530647391264,-0.0306113259037838,-0.0105593245260462,5.74654586239693e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42048,0.0195658108101777,0.00486437927380315,0.0100316274335236,0.0290999941868319,5.79567975245338e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,39869,-0.0276271056077921,0.00686827902215929,-0.0410889324912243,-0.0141652787243599,5.79790473176521e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,42072,-0.0155898637518467,0.00387728622669539,-0.0231893447561696,-0.00799038274752371,5.83123027031019e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42003,-0.0193197857115335,0.00482299541747854,-0.0287728567297915,-0.00986671469327562,6.21508813751865e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39512,0.0163584586441354,0.00408388439935634,0.00835404522139702,0.0243628720668739,6.22673135484018e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,39512,-0.033101113903908,0.00828762923388547,-0.0493448672023235,-0.0168573606054925,6.53833924087141e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39675,0.0130548205365691,0.00327310298758719,0.00663953868089816,0.0194701023922399,6.69157482739814e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41747,-0.0178703536127177,0.00448286900014156,-0.0266567768529951,-0.00908393037244024,6.74557608087783e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39696,-0.0155112818330184,0.00389100734638583,-0.0231376562319347,-0.0078849074341022,6.7500671592508e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39904,-0.0276021722669339,0.00693282912033565,-0.0411905173427917,-0.014013827191076,6.89473435871335e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,42114,-0.0198050662560493,0.00498282205039434,-0.0295713974748223,-0.0100387350372764,7.08437317619084e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39575,-0.0190839000475055,0.00480543697787916,-0.0285025565241487,-0.00966524357086233,7.19335412567492e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39512,-0.0425164473041515,0.0107426728053329,-0.063572086002604,-0.0214608086056991,7.61494576914616e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41995,-0.0141890547939927,0.00359098845109617,-0.0212273921581412,-0.00715071742984418,7.81281247490133e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39904,-0.027909855685359,0.00706474774256631,-0.041756761260789,-0.0140629501099291,7.84355117318396e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39869,0.0218432071992073,0.00553126357077878,0.0110019306004809,0.0326844837979337,7.89412114267527e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,42063,0.0101396175629769,0.00257526318973882,0.0050921017110888,0.015187133414865,8.28139536666724e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,42174,-0.0151602509411168,0.00385527348649525,-0.0227165869746475,-0.00760391490758609,8.45406357434781e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42039,-0.0102749289700523,0.00261513051587814,-0.0154005847811735,-0.00514927315893117,8.57156322753455e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42142,0.0141110912974985,0.00359300499185193,0.00706880151346872,0.0211533810815283,8.63024951561617e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,39639,-0.0191870052552731,0.00488822139704598,-0.0287679191934832,-0.00960609131706298,8.72017545798011e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,41943,-0.0241637630728583,0.00616719724888282,-0.0362514696806686,-0.0120760564650479,8.96907349146401e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41995,-0.0104476499736931,0.00267296751126606,-0.0156866662957746,-0.00520863365161166,9.32766312153857e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42048,-0.0208631592161928,0.00534348474583465,-0.0313363893180288,-0.0103899291143569,9.49164961925943e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42139,-0.0358066573684072,0.00917091515587417,-0.0537816510739206,-0.0178316636628938,9.49288745960741e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39869,-0.0361646398139496,0.00927016549112029,-0.0543341641765454,-0.0179951154513539,9.62788314795416e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39597,-0.0133467482968951,0.00342121722373561,-0.0200523340554169,-0.00664116253837332,9.62991719719189e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39512,-0.031131978752719,0.00799038153262891,-0.0467931265566716,-0.0154708309487663,9.83047204708656e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39597,0.0111111787886994,0.00286712574254901,0.00549161233330335,0.0167307452440955,0.000107080219764288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,42063,0.0111044377697659,0.00286794680823934,0.00548326202561683,0.0167256135139151,0.000108495267574805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,41766,0.0137049020015596,0.00354173073587641,0.0067631097592418,0.0206466942438773,0.00010956243607333
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,42063,0.0103912098336277,0.00269233278617126,0.00511423757273203,0.0156681820945234,0.000114123510683435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42042,-0.0140959060720728,0.00365770802472536,-0.0212650138005345,-0.00692679834361105,0.000116861486513096
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41859,-0.0143826315752811,0.00373380853921694,-0.0217008963121463,-0.00706436683841595,0.000117708260261433
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41771,-0.0200774946226623,0.00521311783677713,-0.0302952055827455,-0.00985978366257914,0.000118028978168869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,39895,-0.0226101723081552,0.00587355281481537,-0.0341223358251933,-0.0110980087911171,0.000119017379069163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,42236,-0.01304503228393,0.00339007206951323,-0.0196895735401759,-0.00640049102768406,0.000119623825674918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39696,-0.029835053420688,0.00776685599939947,-0.045058091179511,-0.014612015661865,0.000123050912184977
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,39927,-0.0114135405826465,0.00297214673883339,-0.0172389481907599,-0.00558813297453301,0.000123620213276883
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42111,-0.0120360159019471,0.00314558446187493,-0.018201361447222,-0.00587067035667227,0.000130658393777434
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,42008,-0.0457684178517994,0.0119623588432154,-0.0692146411845016,-0.0223221945190972,0.000130813920741358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42108,0.0119730991311781,0.00313448704926811,0.00582950451461261,0.0181166937477436,0.000134160160300734
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41995,-0.0171843917636851,0.00450110916686328,-0.0260065657307372,-0.0083622177966331,0.000135246529596051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39675,-0.0149628866076312,0.00392547341239773,-0.0226568144959307,-0.00726895871933163,0.000138739106934385
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42005,-0.0147921498536919,0.00388335174193302,-0.0224035192678806,-0.0071807804395032,0.000140085021333739
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42174,-0.0121840335642379,0.00320439755602963,-0.018464652774056,-0.00590341435441983,0.000143995035472253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,39675,0.0404856334956217,0.0106620418033735,0.0195880315610097,0.0613832354302337,0.000147136174778772
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,39675,-0.0164016356902062,0.0043251424652779,-0.0248789149221509,-0.00792435645826149,0.000150135569364098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41995,-0.0221044994827554,0.00583857227629448,-0.0335481011442926,-0.0106608978212182,0.000153795280512621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI3,Elafin,41894,-0.0233075299948986,0.00616611966309803,-0.0353931245345707,-0.0112219354552265,0.000157555143536788
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,39512,0.0143867988050181,0.00381032407119516,0.00691856362547555,0.0218550339845606,0.000160378625434967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,42072,-0.0315464387246095,0.00837889235737837,-0.0479690677450711,-0.0151238097041479,0.000167264065873932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39858,-0.0119789784111277,0.00318358237988197,-0.0182187998756963,-0.00573915694655899,0.000168917844789155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,39872,-0.0124866336752019,0.00332087185504533,-0.0189955425110908,-0.0059777248393131,0.000170740302179158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,39904,0.0132486096753746,0.00352960422032467,0.00633058540353823,0.0201666339472109,0.000175208236026572
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39895,-0.0309018154884019,0.00823927418749692,-0.0470507928958959,-0.014752838080908,0.000177328302441602
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42111,-0.0110777399696647,0.00295709211262068,-0.0168736405104012,-0.00528183942892817,0.000180308715131995
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39858,-0.0267460809723239,0.00716360624760003,-0.0407867492176199,-0.0127054127270278,0.000189688234134657
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,41842,-0.0196740991455691,0.00527848976010932,-0.0300199390753833,-0.00932825921575479,0.000194408306995284
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39575,-0.0148160279572494,0.00397928194943905,-0.02261542057815,-0.00701663533634889,0.000197625892369224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39500,-0.0149167085327128,0.00401175344412478,-0.0227797452831973,-0.00705367178222822,0.000201611943995626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,39869,-0.0178487106006933,0.00481520279080157,-0.0272865080706644,-0.00841091313072219,0.000210949262037647
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39526,-0.0128949817905916,0.00349152111349041,-0.0197383631730328,-0.00605160040815035,0.000222505200696779
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,41766,-0.0296210200744885,0.00805767296417433,-0.0454140590842702,-0.0138279810647068,0.000237743882382039
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39526,0.0251093948579418,0.00683451207181641,0.0117137511971816,0.0385050385187019,0.0002400068948198
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39872,-0.0241027923744312,0.00656108085081739,-0.0369625108420333,-0.0112430739068291,0.000240263816032516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39575,-0.0156095994009097,0.00425452153921232,-0.0239484616177659,-0.00727073718405359,0.000244707890634516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39364,-0.0436929446595497,0.0119198499692151,-0.0670558505992112,-0.0203300387198881,0.000247983588519375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39868,0.0123254469119553,0.00336330059602027,0.00573337774375554,0.018917516080155,0.000248777299344065
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39675,0.0085236241257541,0.00233787046275277,0.00394139801875867,0.0131058502327495,0.000267686342994292
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,41995,-0.0114952285094981,0.00315508097264963,-0.0176791872158914,-0.00531126980310483,0.000270074420947557
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,42074,-0.0378111977693303,0.0103784534065647,-0.0581529664461971,-0.0174694290924636,0.000270238332276914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42087,-0.00911029409461052,0.00250225881327384,-0.0140147213686273,-0.00420586682059379,0.000272779454200499
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41771,-0.0209597915895317,0.00577327856256777,-0.0322754175721645,-0.00964416560689886,0.000283963397069211
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39675,-0.0298648308499518,0.00822795502324307,-0.0459916226955082,-0.0137380390043954,0.000285053125461004
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41771,-0.0295383396754397,0.00815844670095331,-0.0455288952093082,-0.0135477841415712,0.000295042018095683
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42063,-0.0146387282175074,0.00404602315176474,-0.0225689335949663,-0.00670852284004855,0.000297913799313031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,41812,-0.035165518996266,0.0097363900437555,-0.0542488434820268,-0.0160821945105052,0.00030525143422737
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,42048,-0.0201737165384313,0.00558587416025954,-0.03112202989254,-0.00922540318432264,0.000305469397415676
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,41766,-0.0197545633799234,0.00547752090970209,-0.0304905043629395,-0.0090186223969073,0.000311528290734154
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,41924,-0.0140872012538286,0.00391075024372951,-0.0217522717315384,-0.00642213077611871,0.000316715851523038
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41943,-0.0242069507270695,0.00674174603003658,-0.0374207729459412,-0.0109931285081978,0.000331095053379231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,39858,-0.0177489910546207,0.00494517938701258,-0.0274415426531654,-0.00805643945607609,0.000333167647737709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41943,0.020111223346521,0.00561076507497765,0.00911412379956478,0.0311083228934772,0.000339059813218604
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,42063,-0.0148858046590422,0.00415602785788845,-0.0230316192605036,-0.00673999005758083,0.000342518726490832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,41766,-0.0193016194355964,0.00539021508709852,-0.0298664410063095,-0.00873679786488334,0.000343695218537318
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,41842,-0.0194645269649992,0.00543771724807577,-0.0301224527712277,-0.00880660115877066,0.000345430311114105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,39590,-0.017891471346107,0.00499826625579851,-0.0276880732074721,-0.00809486948474189,0.000345689013090976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39526,-0.0189448388595237,0.00530344985738971,-0.0293396005800076,-0.00855007713903989,0.000355554787317704
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42063,-0.0147934965841417,0.00416335236776438,-0.0229536672249599,-0.00663332594332355,0.00038178203475032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39858,-0.0137564113350841,0.00387138917234092,-0.0213443341128723,-0.0061684885572959,0.000381910897111498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39512,-0.0142824018459927,0.00402675247516862,-0.0221748366973232,-0.00638996699466223,0.000391459352793244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39917,0.00751478500234917,0.00212111011220192,0.0033574091824334,0.0116721608222649,0.000397414601345969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41967,0.0129704715633494,0.0036620719096517,0.0057928106204321,0.0201481325062668,0.000398699872101468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,41766,-0.0267786338046956,0.00757457326038794,-0.041624797395056,-0.0119324702143353,0.00040866086871181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41747,-0.0187493715757187,0.00531984876779886,-0.0291762751606045,-0.00832246799083297,0.000425856403843575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39575,-0.0130136656796185,0.00369340135307394,-0.0202527323316434,-0.00577459902759355,0.000427634586653479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,42072,-0.026234077805035,0.00748204238425542,-0.0408988808781756,-0.0115692747318943,0.000455908529527268
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,41942,-0.0226575086878744,0.00647285145674661,-0.0353442975430978,-0.00997071983265107,0.000466093450809925
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41771,-0.0179012792083499,0.00511478565717131,-0.0279262590964056,-0.00787629932029411,0.000466957117469265
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,39512,-0.0216123954729946,0.00618298664618999,-0.033731049299527,-0.00949374164646224,0.000475121155080758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41828,0.013200579184209,0.00378570702907431,0.00578059340722335,0.0206205649611946,0.000490144561719415
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41766,-0.0192643981890407,0.00552879982846466,-0.0301008458528314,-0.00842795052524995,0.000494896627397505
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,42072,-0.0317602004462402,0.00911799454732912,-0.0496314697590053,-0.0138889311334751,0.000496948997586741
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42222,-0.0251640998099776,0.0072401052561881,-0.0393547061121063,-0.0109734935078489,0.000511196431756724
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,42048,0.0235500417406856,0.00680751144041992,0.0102073193174625,0.0368927641639086,0.000543017859915627
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,42048,0.0247770471322401,0.00716722208757793,0.0107292918405874,0.0388248024238929,0.000547924760967755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42149,0.0133327883527551,0.00386179197380622,0.00576367608409486,0.0209019006214153,0.000557139388017738
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42222,-0.0278598390704381,0.00807564767442061,-0.0436881085123025,-0.0120315696285737,0.000562579831618841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,39512,0.0158406329126066,0.00459465381730207,0.00683511143069458,0.0248461543945187,0.000567676923293761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39872,-0.011903816709311,0.00345357746643888,-0.0186728285435312,-0.00513480487509077,0.000569322327414563
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41842,-0.011852030095749,0.00344545477077608,-0.0186051214464702,-0.00509893874502794,0.000583716385006187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42210,-0.01442035196776,0.00420077626871784,-0.0226538734544469,-0.00618683048107301,0.000599198540600303
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41943,-0.0112899684849584,0.00330366402478453,-0.0177651499735361,-0.00481478699638075,0.000634091291413128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,41771,-0.0274869298800068,0.00806027964163398,-0.0432850779776094,-0.0116887817824042,0.000651170048409706
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41828,-0.0102554067634882,0.00301666158820535,-0.0161680634763706,-0.00434275005060566,0.000676867311495816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,41895,-0.0393059677148093,0.0115789480854853,-0.0620007059623605,-0.0166112294672582,0.000689282361025621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42072,0.0119895766907407,0.00353618357642215,0.00505865688095328,0.0189204965005281,0.000699549845155969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,41842,-0.0285098052889615,0.00842824537346446,-0.0450291662209518,-0.0119904443569711,0.000719979027810958
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,39512,0.0215924293625228,0.00640483261872683,0.00903895742981824,0.0341459012952274,0.000750817858850093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,39868,-0.0363214563577822,0.0107808101305826,-0.0574518442137241,-0.0151910685018403,0.000756712779714352
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,39575,-0.0114605363956125,0.00340958963908017,-0.0181433320882096,-0.00477774070301535,0.000778509753015029
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41842,-0.0241578229865525,0.00719248262121259,-0.0382550889241292,-0.0100605570489758,0.000785138428402717
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,41954,-0.0170778472967284,0.005088324809994,-0.0270509639243166,-0.00710473066914015,0.000792186190990341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41807,-0.0196832869045953,0.00586708434934708,-0.0311827722293156,-0.00818380157987501,0.000796267614011499
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39868,-0.0100675766939826,0.00300831836962504,-0.0159638806984476,-0.0041712726895175,0.000820827825412785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39575,-0.0148091857528633,0.00442550032396404,-0.0234831663878328,-0.00613520511789381,0.000821636912860878
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39590,-0.0123759570880549,0.00370091320718459,-0.0196297469741367,-0.0051221672019731,0.000828475337132252
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39927,0.0531324163091869,0.0159435944233534,0.0218829712394143,0.0843818613789595,0.000863376052316861
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39869,-0.0420361154718042,0.0126190903124154,-0.0667695324841383,-0.01730269845947,0.000867652015221012
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41919,-0.0147941727355262,0.0044442032702164,-0.0235048111451503,-0.00608353432590205,0.000874357816491392
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,41942,-0.0183196016355635,0.00554666677707434,-0.0291910685186292,-0.00744813475249785,0.000959720443548881
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39705,-0.0144076233722781,0.00437275256230491,-0.0229782183943957,-0.00583702835016047,0.000987778931240862
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41771,-0.0181012863237143,0.00550728252646605,-0.0288955600755877,-0.0073070125718408,0.00101601203072428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42108,0.00995386954186048,0.00303102896713938,0.00401305276626729,0.0158946863174537,0.00102608776458812
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,39575,-0.0263698348769938,0.00805743494757657,-0.0421624073742439,-0.0105772623797437,0.00106842236610149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,41771,-0.0112413203805668,0.0034427142942451,-0.0179890403972872,-0.0044936003638464,0.00109647085093374
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,42063,0.00711697997955812,0.00218259029043812,0.00283910301029941,0.0113948569488168,0.00111376421543861
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39597,-0.0136333458026426,0.00418581706134956,-0.0218375472428878,-0.00542914436239751,0.00112924415750511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39500,0.0111595608599813,0.00342769665884402,0.00444127540864707,0.0178778463113156,0.00113457520286778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,42072,-0.040926827435153,0.0125802675584093,-0.0655841518496352,-0.0162695030206707,0.00114371775993664
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42164,-0.0108703995064177,0.00335689307953436,-0.0174499099423051,-0.00429088907053037,0.00120562075561699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,39675,-0.0108673244011309,0.00335770195942603,-0.0174484202416059,-0.00428622856065586,0.00121345531120758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41747,-0.0166844635198087,0.00515979175394076,-0.0267976553575326,-0.0065712716820848,0.0012256209042603
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42172,-0.0239422023250494,0.00742599489827429,-0.038497152325667,-0.00938725232443181,0.00126665001408335
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41919,-0.00906365638528731,0.00281446440287112,-0.0145800066149147,-0.00354730615565991,0.00128326139775735
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,41903,-0.0197021238404641,0.00612012523365017,-0.0316975692984185,-0.00770667838250978,0.00128841307648943
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41895,-0.0151413841036322,0.00470517072869216,-0.0243635187318688,-0.00591924947539558,0.00129383422529434
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,39590,-0.0111263759907143,0.00346365829338675,-0.0179151462457524,-0.00433760573567629,0.00132047429881764
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,39590,-0.0132531315875797,0.0041263221738992,-0.0213407230484222,-0.00516554012673728,0.00132262645830117
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39858,-0.0140102342873342,0.0043695979404734,-0.0225746462506621,-0.00544582232400638,0.00134830163604809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39597,-0.0226344708960015,0.00706928376572047,-0.0364902670768136,-0.00877867471518935,0.00136957799334731
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39868,-0.00969428755445974,0.00303609589715974,-0.0156450355128928,-0.00374353959602665,0.00141184605382482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,42030,-0.017494139016278,0.00548100223449967,-0.0282369033958974,-0.00675137463665867,0.00141725860717222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39597,-0.00979806749989356,0.00307428242037353,-0.0158236610438257,-0.00377247395596145,0.00144105517376609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41995,-0.0252811257668848,0.00793827082792863,-0.0408401365896249,-0.00972211494414468,0.00145228710629377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,41842,-0.0118880967703093,0.00373605559639153,-0.0192107657392367,-0.00456542780138191,0.00146603904562015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,39904,0.00890400699679635,0.00280144452563188,0.00341317572655787,0.0143948382670348,0.00148508304181138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42219,-0.0209325529966438,0.00659528470317976,-0.0338593110148761,-0.00800579497841144,0.00150757426875168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39868,-0.0194078893409376,0.00612571328610831,-0.0314142873817099,-0.00740149130016532,0.00153760731793764
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42039,-0.0150040474437608,0.00473713265736771,-0.0242888274522015,-0.00571926743532007,0.00154191428828232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42174,0.00968211630124903,0.0030609580580445,0.00368263850748182,0.0156815940950162,0.00156442721265674
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,39675,-0.0127026180113492,0.00402003478679802,-0.0205818861934733,-0.00482334982922509,0.00158287183269803
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,42063,-0.0149402305156342,0.00473731659696997,-0.0242253710456953,-0.00565508998557307,0.00161550900580494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,39512,0.0241643278629868,0.00768673913337691,0.00909831916156808,0.0392303365644056,0.00167308736355701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39556,-0.0129603330074147,0.00412342067022453,-0.0210422375210548,-0.0048784284937746,0.00167613356501393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,39512,0.0223244001174176,0.00711013409943697,0.0083885372825211,0.036260262952314,0.00169514207719721
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39597,-0.0101765865347663,0.0032455635457852,-0.0165378910845053,-0.00381528198502728,0.00171991322207651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41943,-0.0138609662868924,0.00442140650859876,-0.022526923043746,-0.0051950095300388,0.0017224593567331
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39575,0.0137751218414812,0.00439749052705193,0.00515604040845937,0.0223942032745029,0.00173782621703511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39696,-0.0197283708186503,0.00629958726909858,-0.0320755618660835,-0.00738117977121709,0.00174253462424145
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,39675,0.0178960095966674,0.00573804176629866,0.00664944773472201,0.0291425714586128,0.00182032864138113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39895,0.0137668380174746,0.0044146956900872,0.00511403446490369,0.0224196415700455,0.00182285760214923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,41828,-0.0269024166688445,0.0086311752543126,-0.0438195201672971,-0.00998531317039177,0.00183161808014274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42063,-0.0142542236245532,0.00457669965233446,-0.0232245549431287,-0.00528389230597761,0.00184631046955012
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39917,0.00526461394341254,0.00169189145765666,0.00194850668640549,0.00858072120041958,0.00186493080191396
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39869,0.0148850099140313,0.00480004224203104,0.00547692711965052,0.0242930927084122,0.00193333591759071
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42027,0.00591763109778197,0.00190915782015645,0.00217568177027533,0.0096595804252886,0.00194180960650989
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39575,-0.00939992518295522,0.00303427677868213,-0.0153471076691722,-0.00345274269673824,0.00195380802232709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,39869,-0.0104846093721857,0.00338697517852224,-0.0171230807220893,-0.0038461380222821,0.00196918559443789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,41943,0.00413012048016133,0.00133513395004357,0.00151325793807593,0.00674698302224673,0.0019827740105756
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42089,-0.0174183816295295,0.00563098760031085,-0.0284551173261387,-0.00638164593292021,0.00198342664002934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42063,-0.0150320035672528,0.0048658959251971,-0.0245691595806392,-0.00549484755386652,0.00201066473873328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,42236,-0.00854082725421823,0.0027777975177466,-0.0139853103890016,-0.00309634411943489,0.00211147919863016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39512,0.00894525094358804,0.00291017854272766,0.00324130099984182,0.0146492008873343,0.00211886278131038
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41967,0.00732354181955956,0.00238274379728285,0.00265336397688518,0.0119937196622339,0.0021193644620784
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39512,0.0156385892835237,0.00509235300079562,0.00565757740196426,0.0256196011650831,0.00213871663789873
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42222,-0.0118430069795209,0.00386013731111233,-0.0194088761093011,-0.00427713784974079,0.00215899867932386
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39904,0.0137458667518801,0.0044832203562027,0.00495875485372281,0.0225329786500374,0.00217404585228135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39512,-0.0294030848342895,0.00960745268674654,-0.0482336921003127,-0.0105724775682662,0.002215448045625
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,42190,-0.00691363523152469,0.0022600232256366,-0.0113432807537724,-0.00248398970927694,0.00222435825148031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39869,-0.0297184121559892,0.00973271726078301,-0.0487945379871239,-0.0106422863248545,0.00226750400833971
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39500,-0.0318776345001846,0.0104431268313121,-0.0523461630895563,-0.0114091059108129,0.00227491047742121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,41995,-0.0151319465259749,0.0049630564374644,-0.0248595371434052,-0.00540435590854471,0.00230116145462441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39675,-0.00823068275774325,0.00270525204001503,-0.0135329767561727,-0.00292838875931379,0.00235184754986427
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42155,-0.0166247625180409,0.00548066409278093,-0.0273668641398915,-0.00588266089619025,0.00242314041531682
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39575,-0.0212609514101421,0.00701040704491993,-0.0350013492181852,-0.00752055360209906,0.0024288632737789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41995,-0.00775652464646461,0.00256917782240849,-0.0127921131783852,-0.00272093611454397,0.0025403017147345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42048,0.0147394731126392,0.00488450011579875,0.00516585288567366,0.0243130933396048,0.00255260824060693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39868,-0.0155828238782786,0.00517500657478706,-0.0257258367648612,-0.00543981099169593,0.00260820019959317
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41943,-0.0140809414245122,0.00468917331397285,-0.023271721119899,-0.00489016172912538,0.00267949003851697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42187,-0.0197643279240681,0.00659453006797922,-0.0326896068573073,-0.00683904899082878,0.00273072489769569
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,42072,-0.0221310823256969,0.00738804244295967,-0.0366116455138978,-0.0076505191374959,0.00274469104816212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42024,-0.012588510036449,0.00420352853488335,-0.0208274259648204,-0.00434959410807769,0.00275172226162826
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39872,0.0125154987507134,0.00418714247900086,0.00430869949187175,0.0207222980095551,0.00280467297835165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39845,-0.0125788044993402,0.0042128837144154,-0.0208360565795944,-0.00432155241908606,0.00283451817169096
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42050,-0.0979972663740258,0.0328367299494304,-0.162357257074909,-0.0336372756731423,0.00284664661212628
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41771,-0.01314936269161,0.00441259236141914,-0.0217980437199915,-0.00450068166322849,0.0028880923421562
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41766,-0.00910162158614355,0.00305722125807036,-0.0150937752519615,-0.00310946792032565,0.00291528438239552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,41766,-0.0125945161302508,0.00423316486289736,-0.0208915192615296,-0.00429751299897194,0.00293328192495546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,39927,0.00790115530004356,0.00265590308883198,0.00269558524593288,0.0131067253541542,0.00293662979728428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39597,-0.0191580979823469,0.00644610511687574,-0.0317924640114234,-0.0065237319532705,0.00296466298041466
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,39917,-0.0048439377283592,0.00163383027286802,-0.00804624506318052,-0.00164163039353787,0.00303536854455467
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,41599,-0.0118904727937769,0.0040209347826457,-0.0197715049677625,-0.00400944061979133,0.00311064048384119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39675,0.00918206188602343,0.00310651002730156,0.00309330223251236,0.0152708215395345,0.00312568744163695
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,42172,0.0099030826182271,0.00335578043108023,0.00332575297330984,0.0164804122631444,0.00317234946696011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42048,-0.0222223786735875,0.00753301667108061,-0.0369870913489055,-0.00745766599826951,0.0031832425023579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41547,-0.0123155533259159,0.00418575551858234,-0.0205196341423373,-0.00411147250949449,0.00326410783960947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,41794,-0.0240589596889331,0.00817768537008778,-0.0400872230143051,-0.00803069636356103,0.0032663999370184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,41842,-0.0227421134250379,0.00776609842359533,-0.0379636663352847,-0.00752056051479102,0.00341310103164089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39500,-0.0198568446942915,0.00678107470483361,-0.0331477511157654,-0.00656593827281764,0.00341554931165849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42051,-0.0299990989304828,0.0102648526651608,-0.050118210154198,-0.00987998770676763,0.00347804434529042
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,42092,-0.0263765282976013,0.00903121377876594,-0.0440777073039825,-0.00867534929122004,0.00349940865353917
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,39576,-0.0143162385761011,0.00492247854913561,-0.0239642965324069,-0.0046681806197953,0.00364082132808845
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,39512,0.010801510197375,0.00371816682303456,0.00351390322422729,0.0180891171705227,0.00367916169716337
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,39858,-0.016659022154046,0.00573926976963846,-0.0279079909025374,-0.0054100534055546,0.00370752272367919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,42174,-0.0071943720350545,0.00248446021790407,-0.0120639140621465,-0.00232483000796252,0.00378858905401327
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,42048,-0.0284782209737545,0.00985110411711762,-0.047786385043305,-0.00917005690420397,0.00384796970074461
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,41989,-0.0102040643962115,0.00353499145127264,-0.0171326476407058,-0.0032754811517171,0.00390066421982516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,39500,0.0126690575894484,0.00439581385060185,0.00405326244226882,0.0212848527366281,0.00395839561001619
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,42092,-0.00970917135232338,0.00337057368340163,-0.0163154957717906,-0.00310284693285619,0.00397582758721469
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,42187,0.0197344945724481,0.00686977954946456,0.00626972665549761,0.0331992624893987,0.00407670863189703
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,39660,-0.0183133816650611,0.00637897607265183,-0.0308161747674587,-0.00581058856266349,0.00410086118194479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,42048,-0.0156128723583107,0.00545680987083885,-0.0263082197051548,-0.00491752501146651,0.00422728601596184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39872,-0.0144269839285464,0.00504509491940477,-0.0243153699705797,-0.00453859788651302,0.00424946349491343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39512,-0.0126439520214461,0.00442340368769165,-0.0213138232493218,-0.00397408079357051,0.00426560769362564
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41771,-0.0245999370550706,0.00863944131502576,-0.0415332420325211,-0.00766663207762015,0.00441462607092988
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41828,-0.0175738737749563,0.00617420740960923,-0.0296753202977904,-0.00547242725212226,0.00442934228649917
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39858,-0.0162818644503831,0.00572258506055199,-0.027498131169065,-0.00506559773170125,0.00444644992937849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42124,0.00863722192223432,0.0030391473767507,0.00268049306380294,0.0145939507806657,0.00449001912744945
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39858,-0.0124457083367353,0.00439382713585551,-0.0210576095230121,-0.00383380715045846,0.0046261240120149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42173,-0.00877787935683608,0.00310738285133522,-0.0148683497454531,-0.00268740896821905,0.00473722794313086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42070,-0.0107514817801688,0.00380740835426816,-0.0182140021545344,-0.00328896140580318,0.00475228974600358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39500,-0.00919467188038434,0.00325712784504776,-0.0155786424566779,-0.00281070130409073,0.00476719132911076
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,41937,0.0152268452235414,0.00539849041491274,0.00464580401031246,0.0258078864367704,0.00480084908900544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,39597,-0.0143925321781279,0.00511791296123186,-0.0244236415821423,-0.00436142277411342,0.00492929374182592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',39512,-0.013304673181677,0.00473809710208554,-0.0225913435017647,-0.00401800286158936,0.00499355884339613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39526,0.0177450080813743,0.00632569526523575,0.00534664536151222,0.0301433708012364,0.00503700820366351
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,39869,-0.0192558420971918,0.00686460194027608,-0.0327104619001329,-0.0058012222942507,0.00503883386878293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,39858,0.0323093433012307,0.0115345659815888,0.0097015939773167,0.0549170926251447,0.00510173853738027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39479,-0.0266360501104884,0.00951568291074723,-0.0452867886155529,-0.00798531160542379,0.00513237751356442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,39897,-0.00443855388768594,0.00158650786127397,-0.00754810929578292,-0.00132899847958896,0.00515569289947668
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41842,-0.011347972679543,0.00406025827387432,-0.0193060788963367,-0.00338986646274937,0.00519921683081163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42097,-0.00825638892643803,0.0029575991757713,-0.0140532833109498,-0.00245949454192628,0.00525243256879747
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,42037,-0.00902679638645084,0.003236536310326,-0.0153704075546898,-0.00268318521821187,0.00529405768321326
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,39526,-0.0325803483386331,0.011683185700325,-0.0554793923112701,-0.00968130436599598,0.00530193246456823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42072,-0.0140927111376294,0.00505610019785914,-0.0240026675254333,-0.00418275474982548,0.00532287684343486
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39696,-0.019371672048107,0.00695435829921983,-0.0330022143145778,-0.00574112978163609,0.0053528612245022
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,39858,-0.0215957506653907,0.00775375960540531,-0.0367931194919852,-0.00639838183879634,0.00535845539522029
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,39917,0.00690036181236817,0.00248139301752396,0.0020368314980212,0.0117638921267151,0.00543077533304186
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39597,-0.0111125374312407,0.00399745844296621,-0.0189475559794545,-0.00327751888302695,0.0054467919127901
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,42157,-0.0127197166590133,0.00458190304996438,-0.0217002466369435,-0.00373918668108309,0.00550945918401352
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39869,-0.00797059236609242,0.0028805880285652,-0.0136165449020802,-0.00232463983010463,0.00566666846310114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39590,-0.0121580483044042,0.00439864438244645,-0.0207793912939992,-0.00353670531480911,0.00571848588563172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39597,-0.0169932656283693,0.00615188752120811,-0.0290509651699372,-0.00493556608680143,0.00574936994039266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,39858,-0.0160166807639068,0.00582756961068349,-0.0274387172008464,-0.00459464432696716,0.0059976387300407
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39512,0.0062828806969577,0.00229365914939806,0.0017873087641375,0.0107784526297779,0.00616815832369504
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39597,-0.013414079949619,0.00491068800857197,-0.0230390284464201,-0.00378913145281798,0.00631264176457073
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,39526,-0.0245681736615128,0.00901326766935076,-0.0422341782934403,-0.00690216902958534,0.00642521939286305
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39869,-0.00887340474070411,0.00325936670897816,-0.0152617634903013,-0.00248504599110692,0.00649030083647138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39590,-0.0255871991000064,0.00942357941137814,-0.0440574147463075,-0.0071169834537052,0.00663329307617776
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39221,0.0330502744115382,0.0121732780434151,0.00919064944644455,0.0569098993766319,0.0066385758351832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39872,0.0136768737976802,0.00505590579738386,0.00376729843480783,0.0235864491605525,0.00683806265184329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,39526,0.0138817666903766,0.00515306937242308,0.00378175072042738,0.0239817826603259,0.00707327993562252
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,41766,-0.0195686584356142,0.00726811048221127,-0.0338141549807483,-0.00532316189048015,0.00710296113425119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,41998,-0.0196596117579885,0.00730654878867025,-0.0339804473837822,-0.00533877613219483,0.00713942026854808
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,42149,-0.0180299667716821,0.00671488578024311,-0.0311911429009586,-0.00486879064240564,0.00726019704413128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39869,-0.00726708765080847,0.00270656918976543,-0.0125719632627487,-0.00196221203886822,0.00726400182471027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39597,-0.0312626499192028,0.0116857385872856,-0.0541666975502827,-0.008358602288123,0.00747768781493114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,41995,-0.0218319878605991,0.00816756722552877,-0.0378404196226355,-0.0058235560985627,0.00752651188116691
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,39869,-0.035405177719962,0.0132714431822572,-0.0614172063571862,-0.00939314908273788,0.00764653752063355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39872,-0.0344812679554164,0.0129603025656399,-0.0598834609840706,-0.00907907492676218,0.00781283520211442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42072,0.00996656728777148,0.00375298035358353,0.00261072579474776,0.0173224087807952,0.00792510717716555
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39791,-0.0197195922844167,0.00742707436184207,-0.0342766580336272,-0.00516252653520629,0.00793981966203134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42149,-0.0199611884180599,0.00751833692677498,-0.0346971287945389,-0.00522524804158098,0.00794010159838292
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,42015,-0.0210684217245823,0.00795775907416307,-0.036665629509942,-0.00547121393922274,0.0081176478128658
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39868,-0.0162340890454735,0.00615458927051172,-0.0282970840156764,-0.00417109407527049,0.00835798774532588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39512,-0.0182449120693562,0.00693163637814402,-0.0318309193705184,-0.0046589047681939,0.00849728514629725
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39872,-0.0142608644684722,0.00542121581977739,-0.0248864474752359,-0.00363528146170849,0.00853588028740568
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42013,-0.0552092889118915,0.0210879536092611,-0.0965416779860433,-0.0138768998377397,0.00885335410778302
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,41900,-0.0117238913671122,0.00447868535921653,-0.0205021146711766,-0.00294566806304782,0.00886227171636304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,42041,0.0211221154051957,0.00807386628418904,0.00529733748818521,0.0369468933222063,0.00890375689886301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,39675,-0.00996431845473191,0.00380995322115667,-0.017431826768199,-0.00249681014126483,0.00892598308993706
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,39872,-0.017442239292978,0.00668945666871482,-0.030553574363659,-0.00433090422229691,0.00913469451475524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42236,0.018048048873923,0.00694097855615573,0.0044437309038578,0.0316523668439883,0.00932653647829409
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39858,-0.00989083703287423,0.00381690779895344,-0.017371976318823,-0.00240969774692548,0.00957313790483459
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,39512,0.0114776554013796,0.00443784158097273,0.00277948590267302,0.0201758249000861,0.00971365595649275
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,39512,-0.0317661704322512,0.0122827664946145,-0.0558403927616955,-0.00769194810280685,0.00971578987631535
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39512,0.0121594031519697,0.00470735320311521,0.00293299087386394,0.0213858154300756,0.00980555513773432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,42174,-0.0208820186086486,0.00808448947043883,-0.0367276179707087,-0.00503641924658849,0.00980566081117575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39927,-0.0115809345343692,0.00448424068137537,-0.0203700462698649,-0.00279182279887343,0.00981873662812799
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39597,-0.0103144604543119,0.00399404440375248,-0.0181427874856668,-0.00248613342295707,0.00982267280277405
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,42092,-0.00925206043563745,0.00358279824912192,-0.0162743450039164,-0.00222977586735848,0.00982326813340182
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41842,-0.0151421768085723,0.00586425718094556,-0.0266361208832256,-0.00364823273391896,0.00983037027238574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39512,-0.0167821498935141,0.00651364281778623,-0.0295488898163751,-0.0040154099706531,0.00999475337906218
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42236,0.00843395501523591,0.00328277255961249,0.00199972079839543,0.0148681892320764,0.0102051883062956
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41771,-0.0144549877193067,0.00563774336417603,-0.0255049647130917,-0.00340501072552165,0.0103593315006696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39696,-0.0148070868155533,0.00577766947433179,-0.0261313189852436,-0.00348285464586298,0.0103958640708071
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42149,-0.0115419690084614,0.00450480334533287,-0.0203713835653138,-0.00271255445160894,0.0104134379909162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39869,0.0100985538906686,0.00394212330079834,0.00237199222110385,0.0178251155602334,0.010428889678137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39847,-0.0102177777956953,0.00399220215239282,-0.0180424940143852,-0.00239306157700534,0.010497237456908
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42048,-0.00937624193881155,0.00367234618005512,-0.0165740404517196,-0.00217844342590351,0.0106846940916764
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,39500,-0.0210389301094797,0.00824467555042085,-0.0371984941883046,-0.00487936603065484,0.0107297036859168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39868,-0.0675793394953652,0.0265409074889032,-0.119599518173615,-0.0155591608171148,0.0109024335863045
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,39696,0.0464127330180586,0.0182851114691035,0.0105739145386158,0.0822515514975015,0.0111534346729458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42048,-0.04172541218806,0.0164459289667189,-0.073959432962829,-0.00949139141329095,0.0111878379036823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39597,-0.0113538404389854,0.00448039099730654,-0.0201354067937062,-0.00257227408426461,0.011286828106693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,39868,-0.00842002866553261,0.00332793175672641,-0.0149427749087164,-0.00189728242234886,0.0114162297801671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42020,-0.0113801311825647,0.00450019569523277,-0.020200514745221,-0.0025597476199085,0.0114564208848608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,42008,0.00794672568144093,0.00314589104571973,0.00178077923183026,0.0141126721310516,0.0115462261433639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39500,0.0220995053631389,0.00874992087137527,0.00494966045524339,0.0392493502710344,0.0115614934342372
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39675,-0.00809052578895332,0.00320880559225064,-0.0143797847497646,-0.00180126682814208,0.0117044277849525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41945,-0.0162379237035162,0.00644249926230005,-0.0288652222576243,-0.0036106251494081,0.0117324331724871
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,39597,-0.00912450117190073,0.00362676848614033,-0.0162329674047358,-0.00201603493906569,0.0118878080090799
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39590,-0.0227300123643822,0.00904994425572984,-0.0404679031056127,-0.0049921216231517,0.0120320954500933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,39590,0.0104749963734685,0.00417617113401415,0.00228970095080078,0.0186602917961362,0.0121464213246387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39575,-0.00866302879366649,0.00345756904404443,-0.0154398641199936,-0.00188619346733941,0.0122413086786576
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41766,-0.00970623535527148,0.00388167663069698,-0.0173143215514375,-0.0020981491591054,0.0124129432745834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39597,-0.0287578738368011,0.0115179885174356,-0.0513331313309748,-0.00618261634262734,0.0125472112620694
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39597,-0.0121336760399767,0.00486996630877547,-0.0216788100051766,-0.00258854207477682,0.0127339780798746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41900,-0.00939647788810933,0.00377538922767735,-0.0167962407743569,-0.00199671500186173,0.0128268773668693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,39696,0.0091965810236665,0.00369889084814576,0.00194675496130081,0.0164464070860322,0.012922224937168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39500,-0.0228814458977316,0.00921719226416855,-0.040947142735502,-0.00481574905996125,0.0130622742603411
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RETN,Resistin,42034,-0.0115863514457858,0.00469241210913183,-0.0207834791796842,-0.00238922371188744,0.0135551254026005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,39863,0.0129853601877515,0.00527667787235987,0.00264307155792614,0.0233276488175768,0.0138739095863847
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42236,0.0109942761314211,0.00446894141523247,0.00223515095756547,0.0197534013052767,0.0139001213951479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39858,0.0104228011211731,0.00423891074303393,0.00211453606482656,0.0187310661775196,0.0139536311400805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,42021,-0.0117964731311232,0.00481779493644751,-0.0212393512065603,-0.00235359505568608,0.014357104360465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,39512,0.0106427704364773,0.00435127751894651,0.00211426649934213,0.0191712743736124,0.0144649677485119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42207,-0.0139273452867266,0.00571393115716486,-0.0251266503547697,-0.0027280402186835,0.0148045242893382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41771,-0.00964913709918054,0.00396860935596566,-0.0174276114368732,-0.00187066276148785,0.0150553068304651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39675,-0.0223569297582188,0.00919651605467869,-0.0403821012253891,-0.00433175829104861,0.0150720745974561
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,42187,-0.0124429541937988,0.00512673416962009,-0.0224913531662542,-0.00239455522134341,0.0152341374451369
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39512,-0.0174423885967422,0.00720186487193934,-0.0315580437457433,-0.00332673344774105,0.0154546529796408
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,42236,0.0196500152115294,0.00811879743533645,0.00373717223827,0.0355628581847889,0.015520216198418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,41828,0.0138008721402199,0.00570624338999756,0.00261663509582465,0.0249851091846151,0.0155956362020833
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,42050,-0.00620937883073192,0.00256983895413272,-0.0112462631808321,-0.00117249448063178,0.0156944286309804
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41903,-0.0108060578602708,0.00447421182963082,-0.0195755130463472,-0.00203660267419444,0.0157405309824453
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,41842,0.012351640274793,0.00511920892504901,0.00231799078169691,0.022385289767889,0.0158438909189559
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,39590,-0.0195882474219687,0.00812334622276245,-0.0355100060185831,-0.00366648882535435,0.0159097937287977
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39512,-0.0113034398286499,0.00469143094963097,-0.0204986444899266,-0.00210823516737316,0.0159961032234645
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39500,0.00690855626536534,0.00286786670019006,0.00128753753299283,0.0125295749977378,0.0160148350339838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42108,0.012079603086057,0.00501693152002403,0.0022464173068099,0.0219127888653041,0.0160637304726302
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39868,-0.00742526687255841,0.00308955338905864,-0.0134807915151134,-0.00136974223000347,0.0162618485577512
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,39590,-0.00592415104741028,0.00246511683553578,-0.0107557800450604,-0.00109252204976016,0.0162690814421162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39869,-0.00568715966615305,0.00236709949284521,-0.0103266746721297,-0.00104764466017644,0.016295684744413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,42108,-0.0112253620070847,0.00468176138175455,-0.0204016143153236,-0.00204910969884574,0.0165127973475904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42236,-0.00859906095348767,0.0035914710193577,-0.0156383441514288,-0.00155977775554658,0.0166655193987094
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42175,-0.0109897925885881,0.00459118324182993,-0.0199885117425747,-0.0019910734346014,0.0166940926701884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39677,0.0139290668491996,0.00582504472453073,0.00251197918911932,0.0253461545092798,0.0168082612834147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,42070,0.00862743763793609,0.00365136195475536,0.00147076820661559,0.0157841070692566,0.0181515891169686
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,42236,0.010808224843364,0.00457971033959579,0.0018319925777562,0.0197844571089717,0.0182877729624789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,41903,-0.0168513844110371,0.00714378382934737,-0.0308532007165579,-0.00284956810551626,0.0183441723729219
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41766,-0.0385632137372125,0.0163485055224838,-0.0706062845612807,-0.00652014291314423,0.0183475749037714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,42063,0.0115705950819155,0.00490620351284816,0.00195443619673311,0.0211867539670979,0.0183700854588458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39512,0.0217165406012067,0.00923068081262801,0.00362440620845584,0.0398086749939576,0.0186579399348788
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,41943,0.00877054919623812,0.00372874370036232,0.00146221154352797,0.0160788868489483,0.018679901392481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39500,-0.03784909469506,0.016106647339347,-0.0694181234801801,-0.00628006590993992,0.0187959278641766
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,39526,-0.01107721074973,0.00474909276186896,-0.0203854325629932,-0.00176898893646688,0.0196930000014343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42174,0.00725931147100153,0.00311692685598725,0.00115013483326653,0.0133684881087365,0.0198738557945895
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39500,0.0123627011801222,0.00530930446172669,0.00195646443513789,0.0227689379251065,0.0199039047133367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42016,-0.0220653244957546,0.00948135189591941,-0.0406487742117566,-0.00348187477975254,0.0199676170280187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39526,0.0148625374588666,0.00640956908117859,0.00229978205975651,0.0274252928579766,0.0204239966663715
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,41997,0.00885692760025199,0.00383213764837464,0.0013459378094377,0.0163679173910663,0.0208356000705468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39512,0.00983887223273913,0.00426320241294843,0.00148299550336019,0.0181947489621181,0.0210255646561189
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",42187,-0.0183138182126122,0.00798470020968069,-0.0339638306235864,-0.0026638058016381,0.021827886339615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39597,-0.00514149826925022,0.0022449712292248,-0.00954164187853083,-0.000741354659969614,0.0220268851274327
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39512,0.00787505340140488,0.00343931804713348,0.00113399002902327,0.0146161167737865,0.0220569220796999
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERVV_1,,39512,0.010990828026489,0.00480100139550765,0.001580865291294,0.020400790761684,0.0220821995764457
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42108,0.00741979738217651,0.00325531581439978,0.00103937838595293,0.0138002163784001,0.0226655665575141
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39895,-0.0131831762252219,0.00578581185246769,-0.0245233674560586,-0.00184298499438523,0.0227132913420134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39696,-0.0112953941138559,0.00497581740092143,-0.0210479962196619,-0.00154279200804987,0.0232231583756886
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,41676,0.0167535629952955,0.00739594511051652,0.00225751057868315,0.0312496154119079,0.0235144735073769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41842,-0.00700240410383793,0.00310422486687881,-0.0130866848429204,-0.000918123364755456,0.0241015548214544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39872,-0.00745807187829105,0.00330710358600488,-0.0139399949068606,-0.000976148849721476,0.0241419305253165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42048,-0.0210262517616898,0.00934563114129264,-0.0393436887986234,-0.00270881472475621,0.0244746818945276
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39872,-0.00892196303841138,0.00396601868323027,-0.0166953596575427,-0.00114856641928006,0.0244934446342484
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,41842,-0.00757147599771417,0.00336820088550792,-0.0141731497333097,-0.000969802262118643,0.0245971112418305
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,39897,0.0095071180174367,0.00423131412067005,0.00121374234092341,0.01780049369395,0.0246689963021986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39869,-0.0119080738460034,0.00530483486256776,-0.0223055501766362,-0.00151059751537056,0.0248029506274083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39858,-0.0133374307073975,0.00594421501083794,-0.0249880921286399,-0.00168676928615515,0.0248667846791557
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,42133,-0.0275448159059604,0.012285793554676,-0.0516249712731254,-0.0034646605387953,0.024977154439716
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39500,-0.0139884216516386,0.00625137566194026,-0.0262411179490415,-0.00173572535423569,0.0252636881045157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,39652,0.00706993843358492,0.00318164991249998,0.000833904605084957,0.0133059722620849,0.0262968398623869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39872,-0.0226108008102915,0.0102073443532312,-0.0426171957426247,-0.00260440587795833,0.0267696716286948
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,39500,0.00828522015343355,0.00376322797911057,0.000909293314376834,0.0156611469924903,0.0277126210234193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39895,0.00932611697957892,0.0042414920630622,0.001012792535977,0.0176394414231808,0.0279136196384952
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39858,-0.011115110178105,0.00507492061279155,-0.0210619545791764,-0.00116826577703354,0.0285299036317126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,39696,-0.0169557803169555,0.00774816783944614,-0.0321421892822699,-0.00176937135164104,0.0286641683007379
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42063,0.00874572828501564,0.00401210743850221,0.0008819977055513,0.01660945886448,0.0292870325289819
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39682,0.0128727789922507,0.00590639373979786,0.00129624726224688,0.0244493107222545,0.0293181175705097
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39500,-0.0104326257354351,0.00480177717887646,-0.019844109006033,-0.00102114246483725,0.0298274433109643
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,39512,0.0109458604448488,0.00504276450412674,0.00106204201676044,0.0208296788729373,0.0299823755375468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,39597,-0.00407219332322669,0.0018763704120955,-0.00774987933093387,-0.000394507315519503,0.0300092263773871
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,39512,0.0121544447354147,0.00560500410740084,0.00116863668490901,0.0231402527859203,0.0301422888117468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,42121,-0.00835773779338896,0.00385633481473895,-0.0159161540302773,-0.000799321556500626,0.0302312947923387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39597,-0.00720333360997025,0.00332566939027367,-0.0137216456149067,-0.000685021605033854,0.0303341283060108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39500,-0.014155898580785,0.00654142916872619,-0.0269770997514883,-0.00133469741008166,0.0304831133235115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,39597,-0.00844167703243976,0.00391539937738592,-0.0161158598121162,-0.000767494252763365,0.0311037687439067
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41766,-0.0158365511449544,0.00734648173926001,-0.030235655353904,-0.00143744693600476,0.0311279215966248
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,39590,-0.0216449955105784,0.0100429463165327,-0.0413291702909825,-0.00196082073017441,0.0311644268324902
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39590,-0.0147309187068014,0.00685453030010305,-0.0281657980950033,-0.0012960393185994,0.0316500070502683
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42063,-0.00847866645449774,0.00395022583391901,-0.016221109088979,-0.000736223820016481,0.0318608787817926
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39895,-0.00789592867289656,0.00369527040345738,-0.015138658663673,-0.000653198682120102,0.0326384397305133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39500,-0.0134725774562474,0.00631110481291907,-0.0258423428895688,-0.00110281202292601,0.0328043688531706
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39512,0.015455453947586,0.00724866020586493,0.00124807994409069,0.0296628279510812,0.0330142537485463
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,39696,0.00969833759647579,0.00456048411966595,0.000759788721930523,0.0186368864710211,0.033475117787789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42072,-0.0106808812380899,0.00502303404422371,-0.0205260279647684,-0.000835734511411433,0.0334897244604116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39512,0.013424799082775,0.00631900192241806,0.00103955531483562,0.0258100428507144,0.0336497229919506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39575,-0.021458348722896,0.0101312946494373,-0.0413156862357931,-0.00160101120999881,0.034195255140915
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,39597,-0.0102157830197019,0.00482348154634143,-0.0196698068505311,-0.000761759188872703,0.0342036026883149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,39872,-0.00525772784324459,0.00248789024388158,-0.0101339927212525,-0.000381462965236699,0.0345946282298962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,41995,0.00349195871177279,0.00165714940658137,0.000243945874873314,0.00673997154867227,0.0351180811744709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39597,-0.0200291912320924,0.00951168333299143,-0.0386720905647556,-0.00138629189942915,0.0352490129311374
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,39869,-0.0267866496197101,0.0127384742602924,-0.0517540591698832,-0.00181924006953691,0.0355040993791729
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41995,-0.0109158419209868,0.00519133687949732,-0.0210908622048015,-0.00074082163717201,0.0355103117176908
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39597,0.0104791913792331,0.00498730393412894,0.000704075668340408,0.0202543070901258,0.0356484283071224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41968,-0.00913901323010028,0.00436184852981608,-0.0176882363485398,-0.000589790111660774,0.036170594873533
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,39526,0.0121343983667602,0.00579619158019843,0.000773862869571271,0.0234949338639491,0.0363264414789853
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39526,0.019393190971542,0.0092997169158615,0.00116574581645347,0.0376206361266305,0.0370604362118655
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39512,-0.00755556533296252,0.00362912089947636,-0.0146686422959362,-0.000442488369988861,0.0373723703989681
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39597,0.0200350010982541,0.00962513347173431,0.0011697394936549,0.0389002627028534,0.0374085232195677
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39512,-0.0211802530333128,0.0101770924120115,-0.0411273541608554,-0.0012331519057702,0.0374416662893509
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41842,-0.0127322190654176,0.0061253997238592,-0.0247380025241816,-0.00072643560665353,0.0376738915159123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39512,0.00835046640654077,0.00401831190262637,0.000474575077393083,0.0162263577356885,0.0377231833886263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39597,0.00970531497302556,0.00467548736669541,0.000541359734302551,0.0188692702117486,0.03793685569537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42156,0.00509491346967481,0.00245644653856848,0.000280278254080587,0.00990954868526902,0.0380889429629306
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,39872,0.00791816804336082,0.00382093867048217,0.000429128249215757,0.0154072078375059,0.0382592542751231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42108,-0.00839305012947018,0.00405079876831813,-0.0163326157153737,-0.000453484543566642,0.0382890904640971
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39512,-0.0109038361887143,0.00527467913906216,-0.0212422073012761,-0.000565465076152429,0.0387384893946625
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,41911,0.00794209457469151,0.00384760600759843,0.000400786799798591,0.0154834023495844,0.0390213837260516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,42187,-0.00780935838645585,0.00379323499290842,-0.0152440989725564,-0.000374617800355342,0.0395363080638478
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,41842,0.00613565568625177,0.00299243111093505,0.000270490708819079,0.0120008206636845,0.0403458733794892
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,39858,-0.00897478825489002,0.00439172738752015,-0.0175825739344295,-0.000367002575350526,0.0410195896891237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39597,-0.00662034313735605,0.00324766994897926,-0.0129857762373554,-0.000254910037356697,0.04152481122732
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41771,0.00674546996023931,0.0033131810768782,0.000251635049558042,0.0132393048709206,0.0417753766984191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41995,0.00878699698717732,0.00431668437139378,0.000326295619245512,0.0172476983551091,0.0418112420724384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_DRA,,41989,0.00813437763829249,0.00399776447012181,0.000298759276853747,0.0159699959997312,0.0418975495900737
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39872,0.00811678019576027,0.00399142732805139,0.000293582632779538,0.015939977758741,0.0420200296993285
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39526,0.0124894527006516,0.00614325760473265,0.000448667795375597,0.0245302376059276,0.0420731941214588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42222,0.00619653198366407,0.00305303466777888,0.00021258403481747,0.0121804799325107,0.0424135209554354
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,42111,-0.00924577172791257,0.00455967712086672,-0.0181827388848113,-0.000308804571013808,0.0426078987647669
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,39597,-0.00596089309726397,0.00294259198213534,-0.0117283733822492,-0.000193412812278699,0.0428166908274598
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,42048,0.0132213638997368,0.00654364476445038,0.000395820161414042,0.0260469076380595,0.0433524468518766
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42077,0.00691041249200987,0.00342241363267831,0.000202481771960374,0.0136183432120594,0.0434899938572778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42187,0.0136175250608071,0.00674834184294944,0.000390775048626233,0.026844275072988,0.0436205833299289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42174,0.0099394040937186,0.00492946616970008,0.000277650401106442,0.0196011577863308,0.0437856986504839
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39500,-0.00835921593635188,0.00414817228364251,-0.0164896336122912,-0.000228798260412555,0.043912766072863
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,39597,-0.00879654393275678,0.00437698021032012,-0.0173754251449842,-0.000217662720529338,0.0444842628173023
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42111,-0.00635957417387932,0.00317819616891232,-0.0125888386649475,-0.000130309682811177,0.0454122335373142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39868,0.0130362643993496,0.00652175256934704,0.000253629363429446,0.0258188994352698,0.0456442606731443
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41842,-0.0253779848692423,0.0127119164435491,-0.0502933410985985,-0.000462628639886033,0.045911567404488
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,39858,-0.00756564146785959,0.00379169919563531,-0.0149973718913048,-0.00013391104441439,0.0460323865875065
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39590,-0.0112289479030944,0.00562988330666773,-0.0222635191841631,-0.000194376622025632,0.0461192741122999
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41842,0.0133921818638569,0.0067168327062254,0.000227189759655114,0.0265571739680587,0.0461917728563923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41943,-0.0133109649623979,0.00670238486591944,-0.0264476392996,-0.000174290625195781,0.0470532786166183
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42048,-0.00794486461662435,0.00401489481373852,-0.0158140584515518,-7.56707816968599e-05,0.0478535444795725
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,39590,-0.00781917187854105,0.00395891417421454,-0.0155786436600015,-5.97000970805409e-05,0.0482840648153175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,41766,-0.00986793228892784,0.00500216123782333,-0.0196721683150616,-6.369626279412e-05,0.0485467929094278
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,41766,-0.00838736787594722,0.00426725695715517,-0.0167511915119714,-2.35442399230783e-05,0.0493753685911403
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39500,0.0100848716112317,0.00514610565103068,-1.49546478840634e-06,0.0201712386872519,0.0500552109522375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,39597,0.0064438175233288,0.00329657247868199,-1.74645348878892e-05,0.0129050995815455,0.0506435295269361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39590,-0.0117672995580557,0.00602501730883446,-0.0235763334833712,4.17343672598613e-05,0.0508362705958438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41732,-0.00623900492589092,0.00319959860963083,-0.0125102182007673,3.22083489855025e-05,0.0512052813333174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,39629,-0.0182938415510394,0.00938310936104538,-0.0366847358986884,9.70527966095286e-05,0.0512423641855969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,39512,-0.00835613883058949,0.00428737313890637,-0.016759390182846,4.7112521666998e-05,0.0513196607507159
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39590,0.0127730399969819,0.0065690564591263,-0.000102310662905657,0.0256483906568694,0.0518696576522919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,39696,0.00715204941529681,0.00368148963008319,-6.36702596662451e-05,0.0143677690902599,0.0520770388152543
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42048,0.0103184450771826,0.00531570551818299,-0.000100337738456037,0.0207372278928213,0.0522640689090344
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39512,-0.0212652340677383,0.0109641714054154,-0.0427550100223525,0.000224541886875974,0.0524637427881328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41863,0.0359223605761768,0.0185239069095604,-0.000384496966561607,0.0722292181189153,0.0524929114240815
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,39917,0.00704407211764796,0.00364501496167783,-0.000100157207240584,0.0141883014425365,0.0533200152574073
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41995,-0.00669273386829175,0.00347971461290531,-0.0135129745095862,0.000127506773002651,0.0544563871722324
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,42004,-0.0124318264244796,0.00646818244232375,-0.0251094640114341,0.000245811162474975,0.0546273251675033
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41842,-0.00905328176068113,0.00471240646893863,-0.0182895984398009,0.000183034918438586,0.0547331177326746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,42009,-0.00740011557643558,0.00385517072157746,-0.0149562501907274,0.000156019037856239,0.0549384988377404
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39834,-0.00571793524011016,0.0029790458364978,-0.0115568650796459,0.000120994599425528,0.0549609579223788
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,42048,-0.0142594600286045,0.00744962369923419,-0.0288607224791035,0.00034180242189456,0.0556262599878112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39526,0.0148826158019848,0.0078013893474423,-0.000408107319002064,0.0301733389229718,0.056457760450872
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,42108,0.00639361458362537,0.00336631739060429,-0.000204367501959039,0.0129915966692098,0.0575475757947525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39481,0.00554027132363327,0.0029238042328479,-0.000190384972748606,0.0112709276200151,0.0581341891637513
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,39696,-0.00901956755405525,0.00476673901416868,-0.0183623760218259,0.000323240913715368,0.0584919121032773
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,39512,0.00724079682866457,0.00383707354728739,-0.000279867324018714,0.0147614609813479,0.0591784665928775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,42174,-0.00576640733753669,0.00307355621633997,-0.011790577521563,0.000257762846489655,0.0606581431429485
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41766,-0.0141217957274932,0.00753014664358789,-0.0288808831489254,0.000637291693939083,0.0607642339483327
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39590,-0.0104186826744443,0.00555763054084932,-0.021311638534509,0.00047427318562031,0.0608656433214427
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39500,0.0168140318305201,0.00897929021681446,-0.000785376994436239,0.0344134406554764,0.061159426021891
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,41828,-0.0079988372536625,0.00427413941143227,-0.0163761505000698,0.000378475992744758,0.0613048187935271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39526,-0.0120725772408034,0.0064716509907037,-0.0247570131825827,0.000611858700975833,0.0621443585252551
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39512,0.00652272532672508,0.00349683693192577,-0.000331075059849428,0.0133765257132996,0.062163161745082
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,39590,-0.0159168639175906,0.00854569314733293,-0.0326664224863632,0.000832694651181905,0.062550897697089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,39512,0.0114019323575835,0.00613055159565697,-0.000613948769904112,0.0234178134850712,0.0629330408370786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39696,-0.00822123583635467,0.00442592610735457,-0.0168960510067696,0.000453579334060291,0.063264016789254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39696,0.0161105535739437,0.00869581857215744,-0.000933250827484858,0.0331543579753723,0.0639550303627248
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,39760,-0.00638139868602074,0.00345076851150031,-0.0131449049685614,0.000382107596519871,0.064445428284743
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,39597,0.0116879580729783,0.00632117427525141,-0.000701543506514494,0.024077459652471,0.0644821927433611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39597,0.00871697667638338,0.00471670294101336,-0.000527761088002806,0.0179617144407696,0.0646135454210373
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39526,0.016870264548727,0.00917680576365276,-0.00111627474803244,0.0348568038454864,0.0660366334312295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39526,-0.00899946276425931,0.00490275628067625,-0.0186088650743848,0.000609939545866141,0.0664451063387518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,39597,-0.00671384098270298,0.00365791586216533,-0.013883356072547,0.00045567410714107,0.0664692957030123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41842,0.0073059968449199,0.00398575588734765,-0.000506084694281503,0.0151180783841213,0.0668210423168846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39674,0.0101920836233627,0.00556259420900572,-0.000710601026288567,0.0210947682730139,0.0669404763621553
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39526,0.00593714425983966,0.00324035696629781,-0.000413955394104043,0.0122882439137834,0.0669413760949215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,39814,0.0146609406995159,0.00802672049716738,-0.00107143147493213,0.030393312873964,0.0677990083030475
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42063,-0.00687848483532387,0.0037783079518217,-0.0142839684208944,0.000526998750246665,0.0687020577527689
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39590,0.0137360685247832,0.0075500722047687,-0.00106207299656347,0.0285342100461298,0.0688883838737188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42187,0.00528587042824267,0.00291295685967461,-0.000423525016719564,0.0109952658732049,0.0696064466495387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39872,0.0156033097228911,0.00861343388650086,-0.00127902069465056,0.0324856401404328,0.0700887599321542
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,39500,0.0154327565326152,0.0085581990208268,-0.00134131354820531,0.0322068266134357,0.0713731876289831
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,39500,-0.0140806609499226,0.00782118808411699,-0.0294101895947919,0.00124886769494669,0.0718373653395369
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39575,-0.0190203923480378,0.010588123139686,-0.0397731137018224,0.00173232900574683,0.0724600959533119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39526,-0.00692024129370456,0.0038558822533639,-0.0144777705102978,0.000637287922888688,0.0727254452881456
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42111,-0.00673488728899171,0.00375463771694272,-0.0140939772141994,0.00062420263621602,0.0728751835530382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41771,0.00624223939674037,0.00349018562856546,-0.000598524435247928,0.0130830032287287,0.0737163933808736
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,41828,-0.0095445842804931,0.00534083670636215,-0.0200126242249629,0.000923455663976707,0.0739449729696054
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41766,-0.00658380258821523,0.00369474222796914,-0.0138254973550347,0.000657892178604291,0.0747823391512544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39872,-0.00531268717725697,0.00299280548273385,-0.0111785859234153,0.000553211568901384,0.0758996314532099
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42236,-0.00534346014442783,0.00301105601320543,-0.0112451299303105,0.000558209641454805,0.075984060133204
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,41468,-0.00551583894761607,0.00311007281333721,-0.011611581661757,0.000579903766524855,0.0761628940618561
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,39526,-0.00952423933092859,0.00540340968680353,-0.0201149223170635,0.00106644365520633,0.0779900147572466
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,41754,-0.0109035315203989,0.0061862952475763,-0.0230286702056484,0.00122160716485068,0.0780029970862639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,39526,0.00808398562538861,0.00458813446601539,-0.000908757928001547,0.0170767291787788,0.0781085751248497
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39858,-0.00931191624968908,0.00530480900287271,-0.0197093418953196,0.00108550939594143,0.0792227945419506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39858,-0.0193514719089489,0.0110288742826056,-0.0409680655028558,0.00226512168495804,0.0793517079959919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39696,0.0067249703588486,0.00383395854337744,-0.000789588386171194,0.0142395291038684,0.0794488567200027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39512,-0.00979169511431704,0.00558870719784214,-0.0207455612220876,0.00116217099345356,0.0797932775291024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39895,0.00681917351173005,0.0039137081332527,-0.000851694429445239,0.0144900414529053,0.0814688893544867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39872,-0.0129399567639277,0.00743669484403216,-0.0275158786582308,0.00163596513037529,0.0818837663646024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,41943,0.0199637411204755,0.0114796687095805,-0.00253640955030237,0.0424638917912533,0.0820486749333126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,39500,0.0057891329993805,0.00332885496984567,-0.000735422741517001,0.012313688740278,0.0820495630106251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,39872,-0.00701092828412896,0.00403195022851119,-0.0149135507320109,0.000891694163752971,0.0820896908509756
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,42072,-0.00770307722038629,0.00444699840681429,-0.0164191940977423,0.00101303965696972,0.0832613842074187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39526,0.00630501782158567,0.00366077031527177,-0.000870091996346998,0.0134801276395183,0.0850398718833328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39575,0.00446591622553848,0.00259956199870337,-0.000629225291920115,0.00956105774299708,0.0858340343602944
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,41759,-0.016158955042886,0.009416620380357,-0.0346155309883858,0.00229762090261367,0.0861849098463059
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39512,-0.00730323521737598,0.00426978483811908,-0.0156720135000894,0.00106554306533743,0.0872119070675605
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,39512,-0.0122654487859505,0.00719147547727615,-0.0263607407214118,0.00182984314951074,0.088119635421247
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39512,0.00668533041777681,0.00392722174027508,-0.00101202419316234,0.014382685028716,0.088726632587506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,42187,-0.00524283184408332,0.00308317938247423,-0.0112858634337328,0.00080019974556617,0.0890667929990797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39696,0.0134666938660474,0.00795497411917528,-0.00212505540753611,0.029058443139631,0.0905093200670859
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42063,0.00658237320483395,0.00389011323497527,-0.00104224873571759,0.0142069951453855,0.0906543322715864
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41766,-0.00561433717501234,0.00332098244513569,-0.0121234627674783,0.00089478841745361,0.0909435566798851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,39907,0.00659087360789984,0.00389931568438382,-0.00105178513349244,0.0142335323492921,0.0910049899228048
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39858,0.00785168573926517,0.0046471373544482,-0.0012567034754533,0.0169600749539836,0.0911370364501495
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39500,0.0124441019987781,0.00738297610591723,-0.00202653116881971,0.0269147351663758,0.0919182673390014
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39526,-0.0139424431498451,0.00828998994079163,-0.0301908234337967,0.00230593713410646,0.0926282958219289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41828,-0.0154397276401558,0.00919395111727995,-0.0334598718300245,0.00258041654971288,0.0931103105073579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42072,0.0052156432309603,0.00310747492223351,-0.000875007616617388,0.011306294078538,0.0932886319474204
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39597,-0.00917506538374746,0.00547211402167029,-0.0199004088662212,0.00155027809872632,0.0936305913477259
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,39904,-0.0170519476553787,0.0102047738400423,-0.0370533043818617,0.0029494090711042,0.0947538003607198
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39590,-0.00929089999499605,0.00556214894675728,-0.0201927119306403,0.00161091194064821,0.0948727638949158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42114,-0.00631052716556712,0.00377943494719151,-0.0137182196620625,0.00109716533092823,0.0950016514435697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,39597,0.0100125272843446,0.00601752081613218,-0.00178181351527447,0.0218068680839637,0.0961617572282098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41766,-0.0095852647985728,0.00576724639521206,-0.0208890677331884,0.00171853813604284,0.0965330590802029
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,42222,-0.00881769325209564,0.00531093307918293,-0.0192271220872942,0.0015917355831029,0.0968789846710013
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,41227,0.00907375365834131,0.00548981310292252,-0.00168628002338684,0.0198337873400695,0.0983893682619495
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,39904,0.0206827640479859,0.0125588660377259,-0.00393261338595685,0.0452981414819286,0.099613477135467
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,39479,0.00743749724627291,0.0045302979554667,-0.00144188674644182,0.0163168812389876,0.100676194761386
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,39853,0.00443981201236143,0.00270448770929349,-0.000860983897853813,0.00974060792257666,0.100691288129197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41924,-0.00588269921638524,0.00358421517105183,-0.0129077609516468,0.00114236251887635,0.100762992162509
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41741,-0.00969134427009432,0.00591523667812188,-0.0212852081592132,0.00190251961902457,0.101368545879264
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSND,Barttin,39500,-0.00603666171971774,0.00369142795752213,-0.0132718605164611,0.00119853707702564,0.10201109856863
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39696,0.00488995357241021,0.00301362384087682,-0.00101674915570835,0.0107966563005288,0.10469997580128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41766,-0.0153239498017955,0.00945188953731796,-0.0338496532949388,0.00320175369134766,0.104986303576193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39597,0.00612044102829727,0.00377767444541628,-0.00128380088471864,0.0135246829413132,0.105226356458742
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39500,0.0121164961997098,0.0075028019966459,-0.00258899571371615,0.0268219881131358,0.106354908577579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,39696,-0.0153476432604166,0.00950764335468689,-0.0339826242356029,0.0032873377147697,0.106503241603198
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,39597,0.00985064041645702,0.00612293322833498,-0.00215030871107955,0.0218515895439936,0.107686448066705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42063,-0.00935390106036735,0.00582571655883577,-0.0207723055156855,0.00206450339495076,0.10838035217634
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,42213,-0.0103148418332017,0.00644477978461252,-0.0229466102110422,0.00231692654463888,0.109511882105511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,39526,0.016313466783156,0.0102112264967108,-0.0037005371503972,0.0363274707167092,0.110160697016991
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41828,-0.00760720317742295,0.00478316487339857,-0.0169822063292842,0.00176779997443825,0.111765846743736
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39696,-0.0078184198485405,0.00491911636803893,-0.0174598879298968,0.00182304823281581,0.111999691921149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,39868,-0.00853564481881183,0.00537523922346222,-0.0190711136967978,0.00199982405917412,0.112324285719177
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,39696,0.00675221989737153,0.00425304091520713,-0.00158374029643443,0.0150881800911775,0.112400409104992
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,41771,-0.0093763509943887,0.00590638714566612,-0.0209528697998943,0.00220016781111689,0.112424930136642
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,39590,-0.0122591518186839,0.00772349703961213,-0.0273972060163237,0.00287890237895585,0.112483889945848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39590,-0.017961008239246,0.0114051034660269,-0.0403150110326587,0.00439299455416663,0.115326313268574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,39868,-0.0120720239633649,0.00766745141012496,-0.0271002287272098,0.00295618080048004,0.115411373377692
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,39597,0.0175167937951997,0.011152568528148,-0.00434224051997038,0.0393758281103698,0.116292488059366
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C5,Complement C5,39917,-0.00258636594738141,0.00165015391099806,-0.0058206676129376,0.000647935718174784,0.117061257091045
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39696,0.0131680074630988,0.00840298688975884,-0.00330184684082852,0.0296378617670261,0.117128548420326
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39858,0.00758735624827087,0.00485299448057875,-0.00192451293366347,0.0170992254302052,0.117977702479128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42108,0.00424286907070612,0.00271452127206334,-0.00107759262253803,0.00956333076395027,0.118069753951454
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39868,-0.00659401299471087,0.00422742207959725,-0.0148797602707215,0.00169173428129973,0.118830759749415
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,41766,-0.0101036962119754,0.00648072991439131,-0.0228059268441824,0.00259853442023158,0.119011713631241
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42072,0.00485361049943345,0.00312788891846751,-0.00127705178076287,0.0109842727796298,0.120752517726747
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41842,0.0108644913013484,0.00700950084756745,-0.00287413035988375,0.0246031129625806,0.121173461070587
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39895,-0.00513465592322834,0.00331806351530389,-0.011638060413224,0.00136874856676727,0.121774180517826
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39590,-0.0131654651676874,0.00851751594231162,-0.0298597964146182,0.00352886607924335,0.122207510578678
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41828,0.00574173469578607,0.00372923836887313,-0.00156757250720527,0.0130510418987774,0.123668770123743
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39526,0.00533004292624473,0.00346852052413548,-0.00146825730106081,0.0121283431535503,0.124398047668679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39526,-0.00820390597437238,0.0053435182842972,-0.0186772018115949,0.00226938986285014,0.124739001325673
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTN,Titin,39512,-0.0116615043418222,0.00760470642095461,-0.0265667289268932,0.00324372024324886,0.125191829557787
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39526,0.00511530238084638,0.00334342541793063,-0.00143781143829766,0.0116684161999904,0.126055933352044
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,39500,0.00785258955435062,0.0051392701820468,-0.00222038000246111,0.0179255591111623,0.126551955357622
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41943,-0.0097270719083662,0.00636988933947942,-0.0222120550137459,0.00275791119701347,0.126774920622104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,39590,-0.0101042813284616,0.00661838552354212,-0.0230763169546042,0.00286775429768094,0.126864699768891
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39590,0.00601062881790509,0.00394298177374316,-0.0017176154586315,0.0137388730944417,0.127440924543299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39526,0.00626866231868237,0.00412687190907143,-0.00182000662309765,0.0143573312604624,0.128794852742163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,39590,-0.010283106951209,0.00678798810488565,-0.0235875636367848,0.0030213497343669,0.129827094547068
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39590,0.00681274292768521,0.00449979650778467,-0.00200685822757274,0.0156323440829432,0.130051721042011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42222,-0.00755078408030649,0.00499749343460542,-0.0173458712121331,0.00224430305152013,0.130833493663435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,39526,0.00806095990373361,0.00533679200754702,-0.00239915243105854,0.0185210722385258,0.130957441344829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39917,-0.00303946397034217,0.0020167686578165,-0.00699233053966251,0.000913402598978175,0.131813964927804
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39526,0.0123998323012924,0.008237014725968,-0.0037447165616049,0.0285443811641896,0.132255468732746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41842,-0.00939028118958729,0.00625034135524565,-0.0216409502458688,0.00286038786669418,0.133027248310225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,39597,-0.0101647024541272,0.00679360961141164,-0.0234801772924941,0.00315077238423958,0.134626263123312
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41842,-0.0093552974870608,0.00627000520000024,-0.0216445076790613,0.00293391270493967,0.135704164990378
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41766,-0.00471240501833329,0.00319257636249564,-0.0109698546888247,0.00154504465215818,0.139954159810387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41828,0.00477078485463898,0.00323233648993999,-0.0015645946656434,0.0111061643749214,0.139979638478684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,39917,-0.00417858891558898,0.00283821963747459,-0.00974149940503917,0.00138432157386122,0.140979280607005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,39500,0.00853288876722961,0.00580215027675516,-0.00283932577521049,0.0199051033096697,0.141416690396565
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39500,0.00424758717276355,0.00289318690122776,-0.00142305915364286,0.00991823349916996,0.142096578261208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39512,0.0042485271305276,0.00289735245677941,-0.00143028368476005,0.00992733794581524,0.142582306913266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41771,-0.00628015490250275,0.00429297127460911,-0.0146943786007366,0.00213406879573111,0.143520694849841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41590,-0.0100148085536973,0.00685198448585507,-0.0234446981459732,0.00341508103857864,0.143877123191381
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39675,0.00420913862871785,0.00288605876155461,-0.00144753654392919,0.00986581380136489,0.144748128272936
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,42157,-0.00671478954153586,0.00460756100964483,-0.0157456091204397,0.00231603003736801,0.145045318313495
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,39590,0.0107600475217081,0.00739488214547704,-0.00373392148342692,0.0252540165268431,0.145679329593602
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39512,0.0169459386176885,0.0116606628984838,-0.00590896066333974,0.0398008378987167,0.146181200470675
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39590,-0.012335323037007,0.00850666770842472,-0.0290083917455194,0.00433774567150547,0.14706559006818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,41766,-0.00876464272858176,0.00607018263772952,-0.0206622006985316,0.0031329152413681,0.148795256570971
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39512,-0.00755274868072361,0.00523408759852551,-0.0178115603738336,0.0027060630123864,0.149051313395566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39696,-0.0109493712836998,0.0076119837232623,-0.0258688593812939,0.00397011681389435,0.150337848099453
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39512,0.00757900500643913,0.00527520265296804,-0.00276039219337824,0.0179184022062565,0.150825385326668
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39479,0.00847746264769365,0.00590886433565034,-0.00310391145018101,0.0200588367455683,0.151400626368171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39512,0.00815426445129315,0.00568772765438374,-0.00299368175129899,0.0193022106538853,0.151698123939919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39512,-0.00726328371044818,0.00510848662150131,-0.0172759174885907,0.00274935006769439,0.155110771966266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_A,,39872,-0.00514174921619653,0.00361732988471832,-0.0122317157902444,0.00194821735785138,0.15522202549852
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,41567,-0.00366718540097354,0.00258885732754596,-0.00874134576296362,0.00140697496101655,0.156645388746854
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42236,-0.00390371990021316,0.00277599917704978,-0.00934467828723073,0.00153723848680441,0.159675783519262
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,39500,0.0180654716116216,0.0128579208119039,-0.00713605317971002,0.0432669964029532,0.160047628301127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,39917,-0.00289990240912307,0.00206697303377716,-0.0069511695553263,0.00115136473708016,0.160653038088178
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,39500,-0.00955042510436421,0.00680911495884989,-0.02289629042371,0.00379544021498159,0.160766364666729
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39526,-0.00953151059483362,0.00679623764873269,-0.0228521363863497,0.00378911519668246,0.160803741925164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39590,-0.0125032399700374,0.00892754683145689,-0.0300012317596929,0.0049947518196181,0.161384815349432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39696,-0.00817512569480268,0.00584196775175734,-0.0196253824882471,0.0032751310986417,0.161727381368739
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39696,0.012612545163359,0.00902796710978574,-0.00508227037182109,0.030307360698539,0.162425683104392
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39590,-0.00462852457754183,0.00331806951479864,-0.0111319408265472,0.00187489167146351,0.163060607298542
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39590,0.0103038711335344,0.00742378082556252,-0.00424673928456814,0.0248544815516369,0.165178990615213
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,39696,0.00857684091831116,0.00618851415853936,-0.00355264683242598,0.0207063286690483,0.165796452020933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,41724,-0.0071982409747799,0.00520311494882466,-0.0173963462744762,0.00299986432491643,0.16655095434541
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39904,0.00520222449152174,0.00376187495887698,-0.00217105042787715,0.0125754994109206,0.166728746732287
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42174,0.0194956251986609,0.014109382558028,-0.00815876461507389,0.0471500150123958,0.167071524104744
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39895,-0.00521713897556858,0.0037772867629185,-0.0126206210308888,0.00218634307975167,0.167248826621385
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39500,-0.00787081015215304,0.00570651195310128,-0.0190555735802315,0.00331395327592547,0.16784039212426
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,39872,-0.00563632662046686,0.00412721776143247,-0.0137256734328745,0.00245302019194078,0.172076726802904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41592,0.00724752227498979,0.00536140013032639,-0.00326082198044994,0.0177558665304295,0.176463936868992
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,39597,0.00567216224325796,0.00419772245713187,-0.00255537377272051,0.0138996982592364,0.176643940099978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,39868,0.00595421061642329,0.00440705143393582,-0.00268361019409092,0.0145920314269375,0.176701908117231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,41943,0.00706934726077,0.00526178472568261,-0.00324375080156791,0.0173824453231079,0.179124396101806
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39927,0.00388281961141354,0.00290040185833897,-0.00180196803093084,0.00956760725375792,0.180689424620227
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,42072,-0.00430905275687352,0.00324375674096949,-0.0106668159691737,0.00204871045542668,0.184063788497983
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,39597,-0.00683699686515816,0.0051523356456254,-0.0169355747305839,0.00326158100026763,0.18454602706712
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41967,0.00591723380200707,0.00447087515452418,-0.00284568150086032,0.0146801491048745,0.185689522038261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39512,0.00501397004512323,0.00379317087207162,-0.00242064486413716,0.0124485849543836,0.186248700874894
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,39500,0.00775469405049447,0.00586715916706287,-0.00374493791694875,0.0192543260179377,0.186291845534728
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42056,-0.00474706863802583,0.00359343393581296,-0.0117901991522192,0.00229606187616758,0.186510614308398
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39858,0.0059312115539937,0.00449424296194681,-0.00287750465142205,0.0147399277594094,0.18695021047326
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,39500,0.00613700530357969,0.0046681949957371,-0.00301265688806503,0.0152866674952244,0.188657900391596
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,41771,0.0127580782349215,0.00972854240394399,-0.00630986487680871,0.0318260213466517,0.189743168202811
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39696,-0.0074128297773022,0.00567385719684873,-0.0185335898831257,0.00370793032852131,0.191413530362524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39526,0.0088397366251281,0.00677544179340127,-0.00444012928993839,0.0221196025401946,0.19203166521468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,39917,-0.00301730492537004,0.00231729330749852,-0.00755919980806713,0.00152458995732705,0.192915000211294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39512,0.00727354804392189,0.0055961859259407,-0.00369497637092189,0.0182420724587657,0.193719919546699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42149,-0.00907413784681367,0.0069915283825434,-0.0227775334765987,0.00462925778297139,0.194351995544006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,42174,0.0045620206953988,0.00352584608252673,-0.00234863762635359,0.0114726790171512,0.19572898954549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39597,0.00651661347479653,0.00505106593488172,-0.00338347575757164,0.0164167027071647,0.197027032318784
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39597,-0.00882842275183721,0.00684914037825931,-0.0222527378932255,0.00459589238955104,0.197431250007541
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41766,-0.00831112847870157,0.00645542059257301,-0.0209637528401447,0.00434149588274152,0.19795487023258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39575,0.00800111599559493,0.00624777152380553,-0.00424451619106392,0.0202467481822538,0.200348900704366
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39500,0.00688539898417319,0.00537972306140557,-0.00365885821618173,0.0174296561845281,0.200614645041355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39590,-0.00515556924832512,0.00404703404157474,-0.0130877559698116,0.00277661747316137,0.2027211925556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,39512,0.00814984569476679,0.00640908757106535,-0.00441196594452129,0.0207116573340549,0.203539608503746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39526,0.0065327608400275,0.00513923612532019,-0.00354014196560006,0.0166056636456551,0.203700909050616
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39512,-0.00534075278167173,0.00420654841398717,-0.0135855876730866,0.00290408210974311,0.20424415026894
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39872,0.0068687672216151,0.00544514609431364,-0.00380371912323963,0.0175412535664698,0.207173682529027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,41842,-0.00590901031275566,0.00469567378195741,-0.0151125309253922,0.00329451029988086,0.208271287064218
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,39696,0.00736316750914238,0.00586396063806905,-0.00413019534147295,0.0188565303597577,0.20926405656997
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39590,0.00432297615786342,0.00344891783693106,-0.00243690280252147,0.0110828551182483,0.210076021367141
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39526,-0.0113486324489705,0.00906188749048813,-0.0291099319303273,0.0064126670323862,0.21047006080444
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39590,0.00499525078887472,0.00399299182771354,-0.00283101319344383,0.0128215147711933,0.21095946230838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42102,-0.00699444973921132,0.00559942342522197,-0.0179693196526464,0.00398042017422374,0.211636444423072
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39575,-0.00859637658095885,0.00690085113884125,-0.0221220448130877,0.00492929165117,0.212901874218415
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39842,-0.00777237646549126,0.00626725784497588,-0.020056201841644,0.00451144891066146,0.214943639069946
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39895,-0.0104935384367094,0.00848448275962213,-0.0271231246455688,0.00613604777214995,0.216190113511484
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39512,0.00837573554634631,0.00678027175159103,-0.00491359708677211,0.0216650681794647,0.216741855990195
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,39500,0.00635803430692791,0.00515300915445726,-0.00374186363580831,0.0164579322496641,0.217285843886764
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,39597,-0.00401362967803682,0.00325723068524298,-0.0103978018211131,0.00237054246503942,0.217892699125724
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42142,0.00368289171193288,0.00298980978051944,-0.00217713545788522,0.00954291888175098,0.218039690484663
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42069,0.0051513340968609,0.00419077543627853,-0.00306258575824501,0.0133652539519668,0.219015356898269
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,41995,-0.0257422767274347,0.020946611411031,-0.0667976350930555,0.0153130816381862,0.219113240506872
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41943,0.00934552315157201,0.00763702407231712,-0.00562304403016955,0.0243140903333136,0.221082245275261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39858,0.0101175926815132,0.00833673439824007,-0.00622240673903735,0.0264575921020637,0.224919926540993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39597,0.00398267189013473,0.00328294857068221,-0.00245190730840241,0.0104172510886719,0.225102861398134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41771,-0.011230411914532,0.00926478238297993,-0.0293893853851727,0.00692856155610864,0.225472333957074
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41766,0.00721047928890942,0.00595084308606878,-0.00445317315978539,0.0188741317376042,0.225659105533285
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,39696,-0.0055294767624552,0.0045792160670307,-0.0145047402538354,0.00344578672892498,0.227259217029093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FST,Follistatin,42092,0.00642369205514846,0.00535058888265445,-0.00406346215485427,0.0169108462651512,0.229943795943802
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42187,0.00545017058490569,0.00454994130243451,-0.00346771436786595,0.0143680555376773,0.230994311142934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39858,-0.00791352082858615,0.00662204667048352,-0.0208927323027339,0.00506569064556156,0.232101875378291
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,42049,0.0168458220872212,0.0141360143339417,-0.0108607660073046,0.044552410181747,0.233401763312541
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,39575,-0.0115387594650495,0.00972063046336151,-0.030591195173238,0.00751367624313908,0.23523825444835
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39858,-0.00473082037951787,0.00398570655801103,-0.0125428052332195,0.00308116447418374,0.235273775902619
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39525,0.00450105120975086,0.00379263459085976,-0.00293251258833426,0.011934615007836,0.235337268332369
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39500,0.00508423472486192,0.00429525359118503,-0.00333446231386074,0.0135029317635846,0.236562902835548
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,39590,-0.00771114750918712,0.00655075128007446,-0.0205506200181331,0.00512832499975883,0.23916535938671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,39590,0.00630842096261749,0.00536119438606015,-0.00419952003406041,0.0168163619592954,0.239347937686563
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,39597,0.00381030501983818,0.00324938578515963,-0.00255849111907471,0.0101791011587511,0.240972358886086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39904,-0.0047482744605677,0.0040526081013253,-0.0126913863391653,0.0031948374180299,0.241358713883163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41771,-0.00594149684867643,0.00507415931370285,-0.015886849103534,0.00400385540618115,0.241647189307043
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39526,-0.00932542634574973,0.00802570491385229,-0.0250558079769002,0.00640495528540076,0.245283255932781
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39597,0.00878591717709063,0.00761560431691536,-0.00614066728406347,0.0237125016382447,0.248659324625769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39597,0.00368480752187169,0.00319824078553687,-0.00258374441778058,0.00995335946152396,0.24929034308248
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39590,-0.013329995652675,0.0116086994946956,-0.0360830466622784,0.00942305535692833,0.250879471712429
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,42112,-0.00343159507675034,0.00299040370107618,-0.00929278633085965,0.00242959617735898,0.251180594599088
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39597,-0.0115630494748182,0.0100871538427115,-0.0313338710065328,0.00820777205689638,0.251690038122726
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41828,-0.00413170307087154,0.00362937293809161,-0.0112452740295311,0.00298186788778801,0.254971245458679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39597,-0.00387001074945869,0.00340718149079358,-0.0105480864714141,0.00280806497249673,0.256048565294967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39696,0.00524190718680578,0.00461988444315275,-0.00381306632177361,0.0142968806953852,0.256550560216879
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41409,0.0037285499459493,0.00328737148130998,-0.00271469815741825,0.0101717980493169,0.256730204214922
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,41943,-0.00453949333306256,0.00400447819369059,-0.0123882705926961,0.003309283926571,0.256980974059882
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,39597,-0.00321741300203903,0.00283931562000084,-0.00878247161724069,0.00234764561316262,0.257169685280927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,42085,-0.00383051125306873,0.00338542495962271,-0.0104659441739293,0.00280492166779178,0.257876888175384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,41995,-0.00236408789504443,0.00209692396482384,-0.00647405886609916,0.0017458830760103,0.259590405764746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,39858,-0.0138729274939849,0.0123510299078733,-0.0380809461134166,0.0103350911254469,0.261367895589028
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39869,0.00541181548456946,0.00481818548227385,-0.00403182806068727,0.0148554590298262,0.261373886410879
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39500,0.00372456966314891,0.00334702715613269,-0.00283560356287116,0.010284742889169,0.265819152700328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,41708,-0.00372113747297437,0.00334418814454896,-0.0102757462362903,0.00283347129034158,0.265850079801912
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,39927,-0.00278663603162576,0.00251004393237434,-0.00770632213907946,0.00213305007582794,0.266938950458775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41842,0.00777504239639593,0.00700761946821634,-0.0059598917613081,0.0215099765540999,0.267229241853907
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,39500,0.00509846123798445,0.00460812928621335,-0.00393347216299371,0.0141303946389626,0.268575308501501
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39696,0.00803292426396515,0.00727013236348738,-0.00621653516847012,0.0222823836964004,0.269217640349699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41919,0.00572524666746602,0.00518351292659155,-0.00443443866865342,0.0158849320035855,0.269391519037689
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,42072,0.00471229158688996,0.00427357592877295,-0.00366391723350502,0.013088500407285,0.270195521326556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,39500,0.00366061568542571,0.0033376182784375,-0.00288111614031178,0.0102023475111632,0.272764069907321
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,39904,0.0102515483174793,0.00934967187207311,-0.008073808551784,0.0285769051867426,0.272900544861149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42063,0.00709223223031076,0.00648043312388127,-0.00560941669249654,0.0197938811531181,0.273796036686168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,39858,-0.00514409502434226,0.00470404968251768,-0.0143640324020769,0.0040758423533924,0.274177512470329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,39450,0.00413126490492251,0.0037794722969215,-0.00327650079704362,0.0115390306068886,0.27438302284906
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,41766,0.00557955828026049,0.00510738784495632,-0.00443092189585391,0.0155900384563749,0.274655996423351
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39526,0.00343986730231112,0.00315411657160821,-0.00274220117804097,0.00962193578266321,0.275474686996913
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,39564,-0.00793974248075111,0.00738961560407286,-0.0224233890647339,0.0065439041032317,0.28264650685979
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42106,0.00573783122746528,0.00535133806859593,-0.00475079138698275,0.0162264538419133,0.283638749209689
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,42063,-0.00629225945189691,0.00592135187870014,-0.0178981091341492,0.00531359023035536,0.287964752954296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,39917,0.00348789926507827,0.00329390930558174,-0.00296816297386193,0.00994396150401847,0.289670869289481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,39512,0.00958073120796124,0.00907088938345089,-0.0081982119836025,0.027359674399525,0.290897321066648
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39590,0.00326838104585756,0.00310519626610581,-0.00281780363570982,0.00935456572742494,0.292569432883111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,41642,-0.00303714388028784,0.00289827673604365,-0.0087177662829334,0.00264347852235771,0.294697791611581
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39526,-0.00631635790320739,0.00604507807078269,-0.0181647109219415,0.00553199511552669,0.296103329878635
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39526,0.00476107961617126,0.00456092595303698,-0.00417833525178122,0.0137004944841237,0.296561954972868
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39526,0.00829306152932647,0.00794762038078858,-0.00728427441701915,0.0238703974756721,0.296756195432645
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39590,-0.00735529977679083,0.00707169587998837,-0.021215823701568,0.00650522414798638,0.298314426899662
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,41842,0.00552623233329882,0.00531915098947851,-0.00489930360607906,0.0159517682726767,0.298855668059936
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42009,-0.0038521418755644,0.00370899432407037,-0.0111217707507423,0.00341748699961353,0.299011995570971
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42092,-0.0101989402160893,0.00985982949855661,-0.0295242060332602,0.00912632560108169,0.300970939384841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39500,-0.00875224210401372,0.00849320646263494,-0.0253989267707782,0.00789444256275077,0.302798612478392
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39526,0.00553846299330435,0.0053894350779635,-0.00502482975950412,0.0161017557461128,0.304136368607224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,42236,0.00630700227228859,0.00614990658979443,-0.00574681464370849,0.0183608191882857,0.305124577982806
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,39526,-0.00641119992529628,0.00627339237170975,-0.0187070489738474,0.00588464912325482,0.30681915051579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39526,0.00386522657115398,0.00379552890198167,-0.0035740100767301,0.0113044632190381,0.308527981035592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,39590,-0.00450299778213021,0.00442636278942081,-0.013178668849395,0.00417267328513457,0.30902680130643
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,39590,-0.00308699516786254,0.00304401787771159,-0.00905327020817726,0.00287927987245219,0.31054848615341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39500,0.00445123175372347,0.0044067876973466,-0.00418607213307587,0.0130885356405228,0.31247681527575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,41741,-0.00674031916261104,0.00668991034862533,-0.0198525434459167,0.0063719051206946,0.313696274005494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39858,0.00986803385329085,0.009827689353977,-0.00939423728050407,0.0291303049870858,0.315349496488144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39500,-0.00620289439291488,0.00617846318363487,-0.0183126822328392,0.00590689344700946,0.315422950441301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,41842,-0.0151467119324186,0.0151457009527475,-0.0448322857998037,0.0145388619349665,0.317296479566147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,39689,-0.0109344642195813,0.0109356532825836,-0.0323683446534451,0.0104994162142826,0.317384948903368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42222,-0.00403029272926959,0.0040326876266632,-0.0119343604775295,0.00387377501899027,0.317615744485906
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,39526,-0.00427243322128794,0.00430054816177671,-0.0127015076183703,0.00415664117579442,0.320506629252813
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41842,-0.00401107454559303,0.0040396586236307,-0.0119288054479092,0.00390665635672313,0.320765069839583
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,39590,-0.00661495002682974,0.00668259148357516,-0.019712829334637,0.00648292928097757,0.322255566197056
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39512,0.00370865017228481,0.00374754692812799,-0.00363654180684604,0.0110538421514157,0.32238147063872
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,42236,-0.00213198104363868,0.00215653614978988,-0.00635879189722685,0.00209482980994948,0.322869753627973
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39500,-0.00848862349281426,0.00860368875468634,-0.0253518534519995,0.00837460646637096,0.323847892264093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39512,0.00810625154621359,0.00823204891608876,-0.00802856432932039,0.0242410674217476,0.324784154861633
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41828,-0.0051556194752421,0.00523719690862105,-0.0154205254161394,0.00510928646565516,0.324925355173615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39927,-0.00574041406959377,0.00583707586993386,-0.0171810827746641,0.00570025463547659,0.325411922094139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39597,-0.00288139112957514,0.00293333823780016,-0.00863073407566345,0.00286795181651318,0.325978221276164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,39696,0.00623809593107533,0.00637042968815275,-0.00624794625770406,0.0187241381198547,0.327489243303624
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,39904,0.00513272042007194,0.00526483899013147,-0.00518636400058574,0.0154518048407296,0.329628005695286
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41771,-0.0135154907678182,0.0138829995693813,-0.0407261699238055,0.0136951883881692,0.330308759408573
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,39512,-0.00507885924868228,0.0052384467240641,-0.0153462148278479,0.00518849633048336,0.332299643213837
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,39590,0.00365522020454682,0.00377087684797255,-0.00373569841747938,0.011046138826573,0.332402406666679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41771,-0.00324862296172204,0.00335505362019707,-0.0098245280573083,0.00332728213386423,0.332923573683975
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42187,0.00352039042505788,0.00364832834650985,-0.00363033313410142,0.0106711139842172,0.334595818449611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,39575,0.00434045037976625,0.00451370620085198,-0.00450641377390363,0.0131873145334361,0.336263908353976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39500,-0.0067788886694617,0.00705865758082567,-0.02061385752788,0.00705608018895661,0.3368927790696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,39696,-0.00422866446316157,0.00440533016784383,-0.0128631115921355,0.00440578266581233,0.337127828741612
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41842,-0.00654928244653984,0.00683464679935909,-0.0199451901732836,0.00684662528020397,0.33795552116626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42039,-0.0035878835230032,0.00374622618964041,-0.0109304868546984,0.00375471980869201,0.338214764887137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,39590,0.00680962984369488,0.00712963805672915,-0.00716446074749426,0.020783720434884,0.339540155479972
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39872,-0.00437159429955943,0.00458284308104857,-0.0133539667384146,0.00461077813929576,0.340152477974525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41771,0.00397884276390967,0.00417819625115312,-0.00421042188835044,0.0121681074161698,0.340968828075301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39696,0.0064111926128236,0.00674179182957676,-0.00680271937314685,0.0196251045987941,0.341644019827192
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,39673,0.00401595079423219,0.00422653837521455,-0.00426806442118833,0.0122999660096527,0.342044113933172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39032,-0.00591308295470867,0.0062349769813507,-0.0181336378381561,0.00630747192873871,0.342961638936746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39526,-0.00474003842604396,0.00499889646304519,-0.0145378754936125,0.0050577986415246,0.343039984358568
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41766,-0.00783253804567026,0.00832175868916878,-0.0241431850764411,0.00847810898510055,0.346613564201357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,42091,-0.00549738729535858,0.00587638594982352,-0.0170151037570127,0.00602032916629551,0.349544952517849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42236,-0.00713414559035454,0.00768379623220286,-0.0221943862054721,0.00792609502476306,0.353182193297169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39500,-0.00632586746606467,0.00682677382293594,-0.0197063441590191,0.00705460922688977,0.354141164357989
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,39847,-0.00621471001563419,0.00672997679441663,-0.0194054645326908,0.0069760445014224,0.355799293800957
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,39858,-0.00358083196696947,0.00388356405331412,-0.0111926175114651,0.0040309535775262,0.356523365118562
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,42032,0.00705700575797068,0.00766067298856331,-0.00795791329961341,0.0220719248155548,0.356962985322795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41766,0.00513932965072096,0.00560455100579853,-0.00584559032064416,0.0161242496220861,0.35916351501344
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39597,-0.00247253385853112,0.00270065508927392,-0.00776581783350802,0.00282075011644577,0.359932932137557
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39512,0.00493545559417037,0.00539921879970209,-0.00564701325324572,0.0155179244415865,0.360681610664998
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,39868,0.00903300677854277,0.00989347341610076,-0.0103582011170147,0.0284242146741003,0.361247959465446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,41730,0.00481230202590625,0.0052797197774065,-0.0055359487378105,0.015160552789623,0.362064933841267
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,39744,0.00356163264525803,0.00392173602449062,-0.0041249699627436,0.0112482352532597,0.363804057754925
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,42044,0.00783302851718875,0.00863263714362478,-0.00908694028431582,0.0247529973186933,0.364225438373409
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39512,0.00677334020571577,0.0074761879252778,-0.00787998812782873,0.0214266685392603,0.36496194893545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39526,-0.0108256904519044,0.0119513137043639,-0.0342502653124577,0.0125988844086489,0.365053257116263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39597,-0.00291796016487636,0.00322867170280654,-0.00924615670237718,0.00341023637262446,0.366139873016297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,41771,-0.0098068421238824,0.010858848969358,-0.0310901861038241,0.0114765018560593,0.366478802877458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42236,0.00159506341216064,0.00176723516971264,-0.00186871752047613,0.00505884434479742,0.36676710341799
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39895,0.00307227998402374,0.00340800108790421,-0.0036074021482685,0.00975196211631598,0.36734690132171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,39512,0.00317808328644368,0.00352583302208217,-0.00373254943683737,0.0100887160097247,0.367411041634168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39696,-0.00550577482078936,0.00611024354369435,-0.0174818521664303,0.00647030252485157,0.36756912169015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,39917,0.00199939391744564,0.00222233035719429,-0.00235637358265517,0.00635516141754645,0.368307858201832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42050,0.00231366867018886,0.00257199622395747,-0.00272744392876779,0.00735478126914551,0.36836978117787
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39597,0.00414725288484049,0.00461050142300925,-0.00488932990425763,0.0131838356739386,0.368393752624128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,39526,0.00517896803476023,0.00575954463488016,-0.00610973944960487,0.0164676755191253,0.36856729740221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39526,0.00495598804826491,0.00551299023870965,-0.00584947281960601,0.0157614489161358,0.368690845913028
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39512,0.00547593045507535,0.00609781554921391,-0.00647578802138392,0.0174276489315346,0.369197311304499
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,39872,-0.00463107988972545,0.00516622706161506,-0.014756884930491,0.00549472515104006,0.370050668351292
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39927,-0.00279502856212402,0.00312309042780641,-0.00891628580062459,0.00332622867637654,0.370829618231073
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,39526,0.00960899144926687,0.0107591545500909,-0.0114789514689112,0.030696934367445,0.371823764870361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39590,0.00358049913911042,0.00402143066934636,-0.00430150497280844,0.0114625032510293,0.373295022770961
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39526,-0.00426595723442676,0.00481102678918656,-0.0136955697412324,0.00516365527237889,0.375257740553481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,39839,-0.00510557349577867,0.0057907423823959,-0.0164554285652746,0.00624428157371729,0.377969504959513
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39512,0.0038241544491403,0.0043381037697178,-0.0046785289395066,0.0123268378377872,0.378052206990418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39500,-0.00879186921405948,0.0100701402043804,-0.0285293440146451,0.0109456055865262,0.382647842595173
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39590,0.00403430949318577,0.00462269107937777,-0.00502616502239467,0.0130947840087662,0.382835425081359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,39858,-0.00746527022760372,0.00855680949121156,-0.0242366168303784,0.00930607637517093,0.382989073714147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42111,0.00418602116369351,0.00480041971905933,-0.00522280148566278,0.0135948438130498,0.383217603316652
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39526,-0.00708069767264794,0.00812977629408696,-0.0230150592090584,0.0088536638637625,0.383795955108418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42072,-0.00302550549449162,0.00347789863770867,-0.00984218682440062,0.00379117583541738,0.384357752106369
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,42213,0.00286261828178662,0.00331544668481879,-0.00363565722045821,0.00936089378403145,0.387922577006877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,39658,-0.00345090350250999,0.0040109435215909,-0.0113123528048281,0.00441054579980817,0.389602667940755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39500,-0.00397987361567165,0.0046271678194429,-0.0130491225417797,0.00508937531043643,0.389747290320578
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42008,-0.00251098704029711,0.0029284503912003,-0.0082507498070497,0.00322877572645547,0.391213966924383
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,41842,0.00684931720618454,0.00802903934860971,-0.00888759991709049,0.0225862343294596,0.393636979307337
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,41842,0.00386421723670467,0.00453639727669101,-0.0050271214256097,0.012755555899019,0.394326556402424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,39597,-0.00805627320967696,0.00945849662905265,-0.0265949266026201,0.0104823801832662,0.394371486266264
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,39500,0.00561815295567609,0.00660229615406901,-0.00732234750629916,0.0185586534176513,0.394821791174409
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,39872,-0.00491158725777051,0.00577925242907744,-0.0162389220187623,0.00641574750322126,0.39541791845898
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39915,-0.0105920897162366,0.0125331904447275,-0.0351571429879025,0.0139729635554294,0.398059939117524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41857,-0.00380651554392515,0.0045224572350849,-0.0126705317246916,0.00505750063684125,0.399975625689032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39858,0.00565497849747078,0.00676188165367981,-0.00759830954374165,0.0189082665386832,0.403002499867341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39590,0.00337240498482969,0.00404526652886927,-0.00455631741175407,0.0113011273814135,0.404486808806148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39512,-0.00456025477126569,0.005475487485841,-0.0152922102435141,0.00617170070098267,0.404948072484069
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41771,0.00322057524224072,0.00388636197186928,-0.00439669422262306,0.0108378447071045,0.407296909982381
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39895,-0.0025492557870211,0.00308113625294926,-0.00858828284280164,0.00348977126875945,0.408041900232458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42108,-0.00993676173881936,0.0120554332533034,-0.0335654109152941,0.0136918874376553,0.409808735737025
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39896,0.00178092989705129,0.00216793940969973,-0.00246823134596017,0.00603009114006275,0.411387351789769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39696,0.00616320722154943,0.00750576843955858,-0.00854809891998539,0.0208745133630843,0.411590199782457
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39590,-0.00409769382217616,0.00500953492943996,-0.0139163822838785,0.00572099463952616,0.41338697512623
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41771,0.00486648916713112,0.00595459752811657,-0.00680452198797736,0.0165375003222396,0.4137913050277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,41806,-0.00384366364654458,0.0047079635839017,-0.0130712722709919,0.00538394497790276,0.414276143089886
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,39597,-0.00538480265132136,0.00662602483456269,-0.0183718113270642,0.00760220602442152,0.416422190882943
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39481,-0.00430901393918919,0.00532238226716955,-0.0147408831828415,0.00612285530446313,0.418186379831841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39512,0.00360203311800969,0.00445000636390405,-0.00511997935524226,0.0123240455912616,0.418277171332608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39597,0.00195134546956218,0.00241346305284954,-0.00277904211402293,0.00668173305314728,0.418805849936712
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42106,-0.00507248107068201,0.00635010080141195,-0.0175186786414494,0.00737371650008541,0.424418560114896
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39500,0.00348550050446748,0.00438361835455642,-0.0051063914704631,0.0120773924793981,0.4265612961846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,41943,-0.00369781404659892,0.0046587094456413,-0.0128288845600559,0.00543325646685804,0.427359672532974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39526,-0.00511377594253491,0.00648065653532845,-0.0178158627517787,0.00758831086670885,0.430080615334544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,41766,0.00458194835524045,0.00581149244516332,-0.00680857683727965,0.0159724735477606,0.430460091491534
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42034,0.00262854768089831,0.00333683715953505,-0.00391165315179038,0.009168748513587,0.430864879615251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39500,0.00219691227721781,0.00279358064008181,-0.00327850577734254,0.00767233033177817,0.431641797065958
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39868,0.00377985608339791,0.00480762118479249,-0.00564308143879537,0.0132027936055912,0.431754150646064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39872,-0.00208302910779881,0.0026606666019298,-0.00729793564758122,0.00313187743198361,0.433703780229528
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39927,-0.00226895403296777,0.0029063092261237,-0.00796532011617021,0.00342741205023468,0.434995595169933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,39512,-0.00339394190001439,0.00435086655726655,-0.0119216403522568,0.00513375655222806,0.435371811332421
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39512,-0.00576302976869318,0.00739641489067082,-0.020260002954408,0.00873394341702162,0.435899249574001
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39512,-0.0047325759365119,0.00608051115100205,-0.0166503777924759,0.00718522591945211,0.436397990937138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39696,-0.00586029242126872,0.00753503566126215,-0.0206289623173425,0.00890837747480509,0.436739374104831
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39696,-0.00351176839858331,0.00451704826940415,-0.0123651830066154,0.00534164620944882,0.436911304950823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,41944,0.0108793210516652,0.0140410617356801,-0.0166411599502679,0.0383998020535982,0.438458681127411
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39597,-0.00531712546553333,0.00688512705709708,-0.0188119744974436,0.00817772356637694,0.439975563974898
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39500,-0.00441947523932701,0.00573028768105352,-0.0156508390941919,0.00681188861553789,0.440576425558987
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39500,0.00424494288078436,0.0055052469611471,-0.00654534116306397,0.0150352269246327,0.440680851784828
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,41842,-0.00508748636998689,0.0066475822358831,-0.0181167475523178,0.00794177481234399,0.44409835259836
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39512,0.00407897209886721,0.00533031675010765,-0.00636844873134378,0.0145263929290782,0.444145137998465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,42135,-0.0131068932320245,0.0171978883408715,-0.0468147543801326,0.0206009679160836,0.446000328791086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41842,0.00400512856873293,0.0052566534190963,-0.00629791213269582,0.0143081692701617,0.44612368437156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39526,0.00476785921107659,0.00629596203905523,-0.00757222638547165,0.0171079448076248,0.448893411400173
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39869,-0.00467062918083177,0.00620545608333379,-0.016833323104166,0.00749206474250246,0.451667009930532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39597,-0.00333661477405349,0.00448970952717114,-0.0121364454473089,0.00546321589920195,0.457394997429681
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39512,-0.00346571839426441,0.00467136429634848,-0.0126215924151074,0.00569015562657861,0.458159584298172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,39872,-0.00359854548444257,0.00485973296400176,-0.013123622093886,0.00592653112500088,0.45902291528321
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41995,0.00210520311649482,0.00284668823309368,-0.0034743058203688,0.00768471205335844,0.459599944777092
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41842,-0.00357322797841977,0.00486919613089029,-0.0131168523949647,0.00597039643812521,0.463057111689105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,39512,0.00359558044795998,0.00491034152512596,-0.00602868894128689,0.0132198498372069,0.464033847351399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39868,0.00326553934736483,0.00447054781603767,-0.00549673437206901,0.0120278130667987,0.465126566211822
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39872,0.00276582909466196,0.00381716453541925,-0.00471581339475976,0.0102474715840837,0.46872669809268
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39590,-0.00405332334841884,0.00559484847643656,-0.0150192263622345,0.00691257966539681,0.46879008625313
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39917,0.00145196038034203,0.00201591051257817,-0.00249922422431118,0.00540314498499524,0.471385704545416
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39927,0.0029038152800496,0.0040559927393047,-0.00504593048898762,0.0108535610490868,0.474048053013169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42108,0.00624742683463126,0.00872918953173991,-0.010861784647579,0.0233566383168415,0.474192810232171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42072,-0.00198269940657083,0.00277052981031851,-0.0074129378347951,0.00344753902165345,0.474226638496296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39575,0.0208655190959611,0.0293124886656041,-0.0365869586886229,0.0783179968805451,0.476584965837159
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39590,-0.00397941300166653,0.00559670008557304,-0.0149489451693897,0.00699011916605663,0.477081694098518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39590,0.00421247358009264,0.00593658439576316,-0.00742323183560315,0.0158481789957884,0.477980512763345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39512,0.00786293628133916,0.0111426533369216,-0.0139766642590271,0.0297025368217054,0.480414022019403
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39864,-0.00476196072980347,0.00675267459609361,-0.0179972029381469,0.00847328147854001,0.480702703208992
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41874,0.00216347172996578,0.00306971309176638,-0.00385316592989633,0.00818010938982789,0.480959656456331
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,41766,-0.00392681906080884,0.00557737959246159,-0.0148584830620336,0.00700484494041588,0.481406835365931
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39590,-0.00536755022832438,0.00762498836423773,-0.0203125274222303,0.00957742696558158,0.481483753923336
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41766,-0.00366346294119382,0.00520934261753493,-0.0138737744715623,0.00654684858917464,0.48191326725304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,39526,0.00260303008276165,0.00372768567151452,-0.00470323383340682,0.00990929399893012,0.485006611180984
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,39526,0.00356799119808405,0.00512734522960767,-0.00648160545194698,0.0136175878481151,0.486521936025412
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39500,-0.0041104389068278,0.0059628727742823,-0.0157976695444211,0.00757679173076551,0.490624829541042
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39590,-0.00419030601062394,0.00610649958037676,-0.0161590451881624,0.00777843316691451,0.492598789600271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39858,-0.00333606653670925,0.00486468596358562,-0.0128708510253371,0.00619871795191856,0.492870872379393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39858,-0.00404436342205423,0.00590191702345647,-0.0156121207880289,0.00752339394392044,0.493192292026366
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39597,-0.00165103475633186,0.00241925436091311,-0.00639277330372156,0.00309070379105784,0.494965003876518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39597,-0.00660232157850083,0.00976353171821138,-0.0257388437461951,0.0125342005891935,0.498913496508153
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39696,-0.00487635666375464,0.00722887242078947,-0.019044946608502,0.00929223328099272,0.499965145029578
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39696,-0.00468352929118444,0.0069697939455233,-0.0183443254244101,0.00897726684204124,0.501613419515214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39575,-0.00562538947270328,0.00842238168343886,-0.0221332575722435,0.0108824786268369,0.504205352078875
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,39575,0.0013366920270376,0.00200688322432029,-0.00259679909263016,0.00527018314670537,0.505390766601012
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39500,0.00245061260673003,0.00368858949886478,-0.00477902281104494,0.009680248024505,0.506463349758717
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39669,0.00453197700345777,0.00683091262200922,-0.00885661173568029,0.0179205657425958,0.507055456766356
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,42135,-0.00307583664877702,0.00463627196571492,-0.0121629297015783,0.00601125640402421,0.507067223132656
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,39868,-0.00278437360343544,0.00420109775405857,-0.0110185252013902,0.00544977799451937,0.507489589985872
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41995,-0.00248991153419196,0.00375735350479349,-0.0098543244035872,0.00487450133520328,0.507548881774145
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,39500,0.00478390296142111,0.00728604475322355,-0.00949674475489705,0.0190645506777393,0.511462075227417
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41943,0.00206465219485777,0.00315906156775987,-0.00412710847795158,0.00825641286766711,0.513403337052079
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42063,0.00172617221827119,0.00264220382521509,-0.00345254727915038,0.00690489171569277,0.513569058170884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39512,0.0029156895426166,0.00446757129506053,-0.00584075019570204,0.0116721292809352,0.514005919889115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,41842,-0.00412494181752915,0.00635658039612504,-0.0165838393939342,0.00833395575887594,0.516398323685242
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,39858,0.00330728401528495,0.00510557781042491,-0.00669964849314786,0.0133142165237178,0.517141372024932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39512,0.00302731756007775,0.0046978283552079,-0.00618042601612973,0.0122350611362852,0.519324528501682
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41766,-0.00277049902080914,0.0043858217329073,-0.0113667096173074,0.00582571157568916,0.527597556576509
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39897,0.00126423625427016,0.00203297601830114,-0.00272039674160008,0.0052488692501404,0.534043312446035
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCN,Decorin,41828,0.00156695785066685,0.00252227318267895,-0.0033766975873839,0.0065106132887176,0.534446989255317
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,42172,-0.00298072449385117,0.00480110271158836,-0.0123908858085644,0.00642943682086202,0.534714246680109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41842,0.00273927174308166,0.00443205346513184,-0.00594755304857675,0.0114260965347401,0.536546896863465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39512,-0.0031641854091692,0.0051291780346587,-0.0132173743571003,0.00688900353876185,0.537314138833226
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39512,0.00240304543956825,0.00389688713229987,-0.00523485333973949,0.010040944218876,0.537473395024954
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,41766,0.0030747286389141,0.00499806569400301,-0.00672148012133179,0.01287093739916,0.538444031434973
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,39526,-0.00452379650969242,0.00735363123405542,-0.018936913728441,0.00988932070905619,0.538449596197294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39512,0.00335454985651984,0.0054549592527603,-0.00733717027889035,0.01404626999193,0.538597820400577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41886,-0.00204284572459386,0.00334006919361679,-0.00858938134408277,0.00450368989489506,0.540801132893867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42175,-0.00232042022428181,0.00379481091244413,-0.0097582496126723,0.00511740916410869,0.540897457664461
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39895,-0.00192153959004058,0.00314749302469062,-0.00809062591843419,0.00424754673835303,0.541543958047208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,41842,-0.00302124891877895,0.00495780857936134,-0.0127385537343272,0.00669605589676928,0.542275090002611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39590,0.00272125205493029,0.00447832165848454,-0.0060562583956994,0.01149876250556,0.543432201728277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,39872,-0.00232969604375723,0.00383535416664555,-0.0098469902103825,0.00518759812286804,0.54358009294456
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39479,0.00515863527928994,0.00850343614401325,-0.011508099562976,0.0218253701215559,0.544093860363214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39526,-0.00394101944944955,0.00656097412003857,-0.0168005287247251,0.00891848982582604,0.548068291216704
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,41995,0.00215147962118185,0.00358768571038229,-0.00488038437116743,0.00918334361353113,0.548726643085617
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41766,-0.00559772104863382,0.00935303407207093,-0.0239296678298928,0.0127342257326252,0.549521635901128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42063,0.00403992157053438,0.00678037638439679,-0.00924961614288333,0.0173294592839521,0.551301781423483
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,39597,-0.00200915292170349,0.00339026061767226,-0.00865406373234113,0.00463575788893414,0.553444384308055
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42222,-0.00159950990521483,0.00270433209984575,-0.0069000008209125,0.00370098101048285,0.554220666068332
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39512,-0.00287540586190253,0.00488899448489373,-0.0124578350522942,0.00670702332848919,0.556451507674099
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39696,-0.00239225852964612,0.00408112460742735,-0.0103912627602037,0.00560674570091148,0.557768968467552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,39597,-0.00642944809066366,0.0110356343222351,-0.0280592913622445,0.0152003951809172,0.560169209582658
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,41771,0.0103314899146739,0.0178104766811109,-0.0245770443803035,0.0452400242096512,0.561871024781545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39512,-0.00397451175107695,0.00691030940860287,-0.0175187181919386,0.00956969468978467,0.565197085253523
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41771,-0.00202446502854767,0.0035431668668676,-0.00896907208760817,0.00492014203051283,0.567757505141708
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,41842,0.00302113372071673,0.00529174101760007,-0.00735067867377941,0.0133929461152129,0.568067027782604
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,39675,0.00282223901634515,0.00499242252969478,-0.00696290914185663,0.0126073871745469,0.57187810677812
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41828,-0.00194635995986395,0.00344365531562942,-0.0086959243784976,0.00480320445876971,0.57194614195834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39868,-0.00154689250973197,0.00279142160561593,-0.00701807885673919,0.00392429383727524,0.579480761461862
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39590,-0.00424540337873201,0.00767875085598056,-0.0192957550564539,0.0108049482989899,0.580359003971206
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39512,-0.00197920096698323,0.00361019568551236,-0.00905518451058746,0.00509678257662099,0.583548359563525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39278,0.0031143028297864,0.00569182716831972,-0.00804167842012025,0.014270284079693,0.584284753384015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39927,0.00169748434642587,0.00313931470467948,-0.00445557247474591,0.00785054116759764,0.58871251918258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,41842,0.00172533179467929,0.00319373435205003,-0.00453438753533877,0.00798505112469736,0.589051681254633
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,42039,-0.00173797800757876,0.00322265729642433,-0.00805438630857045,0.00457843029341294,0.589689032621189
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39500,-0.00371160824561801,0.0068951867076049,-0.0172261741925236,0.00980295770128759,0.590388026332343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39575,-0.0024387380930357,0.00453649846827008,-0.011330275090845,0.00645279890477365,0.590876837426435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39526,-0.00295170811871677,0.00550751593430655,-0.0137464393499576,0.00784302311252406,0.592009669651541
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39833,0.00222831133395194,0.0042239803960226,-0.00605069024225236,0.0105073129101562,0.597830262977264
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39869,-0.006011093206065,0.0114536931896143,-0.028460331857709,0.016438145445579,0.599720717785422
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39895,0.00613005624462279,0.0118289743721775,-0.0170547335248452,0.0293148460140908,0.604312270375752
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39696,-0.00306062247027103,0.00592962402671349,-0.0146826855626295,0.00856144062208741,0.605754394998613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39590,-0.00208069978409115,0.00404855690725346,-0.0100158713223079,0.00585447175412562,0.607306959157247
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39597,0.00231577544105817,0.00455127462071219,-0.00660472281553772,0.0112362736976541,0.610889240354432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39590,-0.00226894802064323,0.00446161241397897,-0.011013708352042,0.00647581231075555,0.611078673075476
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,41842,-0.00265332271297067,0.00530102136588808,-0.0130433245901113,0.00773667916416996,0.616709925666593
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,41842,0.00333446053212015,0.00666795851501683,-0.00973473815731283,0.0164036592215531,0.617032565912352
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39500,-0.00344921173301354,0.0069660029354708,-0.0171025774865363,0.0102041540205092,0.620504690972385
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,39869,0.0141254605001932,0.0285901565052351,-0.0419112462500676,0.0701621672504541,0.621268303722876
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,39696,-0.00316066484394863,0.00642319484209768,-0.0157501267344601,0.00942879704656283,0.622679224460386
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39696,-0.00259374844954683,0.00527440481775932,-0.0129315818923551,0.00774408499326144,0.622897787927872
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,41702,0.00341184223517865,0.0069936779498548,-0.0102957665465368,0.0171194510168941,0.625666641294857
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39696,0.00329086136899998,0.00675133417445691,-0.00994175361293556,0.0165234763509355,0.625957122963869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39575,-0.00137243084871752,0.00281903997084729,-0.00689774919157821,0.00415288749414317,0.626379073053676
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42174,-0.0037316319327571,0.00770273712698515,-0.018828996701648,0.0113657328361338,0.62807058712851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39696,0.00198041986285438,0.00409417375369925,-0.00604416069439615,0.0100050004201049,0.628596546588155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39904,-0.00737330495452564,0.0152452753234516,-0.0372540445884909,0.0225074346794396,0.628647025361929
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41828,-0.00308677227380644,0.00640019053360835,-0.0156311457196788,0.00945760117206593,0.62960522436415
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42198,-0.0025171855792638,0.00523069357040139,-0.0127693449772505,0.00773497381872293,0.630358215338949
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41916,-0.00146546264484323,0.00304778583427886,-0.00743912288002979,0.00450819759034334,0.630646210093104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,39500,0.0031959910210152,0.00673833820024347,-0.010011151851462,0.0164031338934924,0.635295787539708
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,39904,-0.00224179198631564,0.00474868634328364,-0.0115492172191516,0.0070656332465203,0.636873969753191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41995,-0.00106765050445024,0.00229003076945557,-0.00555611081258315,0.00342080980368267,0.641068004252955
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39526,0.00310917131122721,0.00668531315735209,-0.00999404247718288,0.0162123850996373,0.641887092339161
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,42050,-0.00181239732308778,0.00392563191256042,-0.00950663587170621,0.00588184122553065,0.644316166170572
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39526,0.00383157199609984,0.00833658769318765,-0.0125081398825479,0.0201712838747476,0.645805933712664
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39869,-0.00864550671188514,0.0189357865249734,-0.0457596483008331,0.0284686348770628,0.647989148719288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39526,0.00482998190490011,0.0105933176329413,-0.0159329206556649,0.0255928844654651,0.648437796734083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,42072,-0.00236066181452898,0.00519400226532254,-0.0125409062545612,0.00781958262550318,0.649478006930283
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39696,-0.00431007828001189,0.00949784821832865,-0.022925860787936,0.0143057042279123,0.649985087440166
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39526,0.00324535773434447,0.00717224695531337,-0.0108122462980697,0.0173029617667587,0.650926241598751
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,39458,-0.00218811966771886,0.00483611960776243,-0.0116669140989332,0.0072906747634955,0.65095128872044
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41995,-0.00412762361945378,0.00918515454458699,-0.0221305265268443,0.0138752792879367,0.653164915805583
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,39858,0.00281316559530261,0.00630421772563127,-0.00954310114693468,0.0151694323375399,0.655435741965438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39696,-0.00193430525484408,0.00434503706416917,-0.0104505779006157,0.00658196739092748,0.656201414024452
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,39868,0.00106842989487561,0.00240700582741129,-0.00364930152685052,0.00578616131660174,0.657135420958466
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39500,0.00312684215955596,0.0070846710910998,-0.0107591131789996,0.0170127974981116,0.65896608187619
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,39597,0.00209436630832856,0.00474577584266676,-0.0072073543432983,0.0113960869599554,0.658996048067105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39575,0.00187023289210759,0.00425649009589847,-0.00647248769585341,0.0102129534800686,0.660392096702356
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,39927,0.0025595512468987,0.0058736951161992,-0.00895289118085172,0.0140719936746491,0.663015483010211
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42174,-0.00221394628140517,0.00513375615961081,-0.0122761083542424,0.00784821579143203,0.666291476371965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,39512,0.00236367804971766,0.00553156397325863,-0.00847818733786925,0.0132055434373046,0.669163897290393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,39895,0.00141139616391779,0.00331027371216075,-0.00507674031191729,0.00789953263975286,0.669847536297884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,41792,-0.00229497252777029,0.00545262839606973,-0.012982124184067,0.00839217912852639,0.673840153225932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,42187,-0.0019997911131008,0.00483393477967213,-0.0114743032812582,0.00747472105505656,0.679101524155549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39526,-0.00337986446984189,0.00822742720718108,-0.0195056217959168,0.012745892856233,0.681223918220993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39526,0.00313275567292507,0.00764254001895774,-0.0118466227642321,0.0181121341100822,0.681879805009644
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,39591,0.00319607518019595,0.00780780797789243,-0.0121072284564732,0.0184993788168651,0.682295598166005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,39575,0.00352321958623432,0.00863658031867855,-0.0134044778383756,0.0204509170108443,0.683324576856326
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,39526,-0.00276279086940962,0.00677694805336252,-0.0160456090540002,0.0105200273151809,0.683520436126011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,42108,0.00149106368355084,0.00368642180209683,-0.00573432304855894,0.00871645041566063,0.68587021619953
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,41771,0.00167065773291927,0.00416408309444415,-0.00649094513219125,0.0098322605980298,0.688274510686884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39526,-0.00230153638204675,0.00574351699097638,-0.0135588296843605,0.00895575692026696,0.688634856244377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39904,-0.00133055368176488,0.00332928592501682,-0.00785595409479785,0.00519484673126809,0.689420865383903
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39526,0.00334273062439556,0.00837487201464926,-0.013072018524317,0.0197574797731081,0.689799240450763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42048,-0.00187367578876045,0.00469638904861672,-0.0110785983240492,0.00733124674652832,0.689928320140741
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39858,0.00259993463826843,0.00652508742171912,-0.010189236708301,0.0153891059848379,0.690304533018718
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,41771,-0.00582455643548274,0.0146564978247377,-0.0345512921719685,0.0229021793010031,0.691075725759778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39526,0.00141805899810001,0.00357213022913264,-0.00558331625099996,0.00841943424719997,0.691391048824411
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39597,0.00121364281193492,0.00306918973156292,-0.00480196906192841,0.00722925468579825,0.692534897666049
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,41828,0.00465733148546452,0.0118037838519052,-0.0184780848642697,0.0277927478351987,0.693172090625832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,41842,0.00220120270612155,0.00560073350562713,-0.00877623496490763,0.0131786403771507,0.694310716755704
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39696,-0.00282075150351839,0.0071896466188877,-0.0169124588765383,0.0112709558695015,0.694818087910833
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,41828,0.0060231789333174,0.015375835053374,-0.0241134577712957,0.0361598156379305,0.6952638840445
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41771,-0.00336613287722794,0.00860689815093592,-0.0202356532530624,0.0135033874986065,0.69573179283882
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,39512,0.00183266352117077,0.00472116986959916,-0.00742082942324359,0.0110861564655851,0.697890436344395
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39500,0.00187235932120655,0.00484164494597312,-0.00761726477290077,0.0113619834153139,0.698971303846156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42236,-0.000967769445841632,0.00250683522427278,-0.00588116648541628,0.00394562759373302,0.699463975709068
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39575,-0.00199128192894789,0.00520572032127368,-0.0121944937586443,0.00821192990074852,0.702084558413159
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,42072,-0.00107964460445947,0.00283811914796041,-0.00664235813446187,0.00448306892554292,0.703648214773394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,39512,-0.00199106375288312,0.00523628434559079,-0.0122541810702411,0.00827205356447483,0.703771978015475
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,39696,-0.00148246792909767,0.00391107473976123,-0.00914817441902969,0.00618323856083434,0.704662724767279
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39696,0.00304327926024575,0.00806689588026317,-0.0127678366650701,0.0188543951855616,0.705991099197721
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42111,0.00088719923048728,0.00236946952099267,-0.00375696103065836,0.00553135949163291,0.708090692915522
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41766,-0.00207004241532731,0.00560519483681279,-0.0130562242954804,0.00891613946482575,0.711904219281311
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,39904,-0.00175591990583143,0.0047762867969112,-0.0111174420277774,0.00760560221611453,0.713153903037717
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,39590,0.00192840895686705,0.00529145895727569,-0.0084428505993933,0.0122996685131274,0.715537941852258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39500,-0.00124828267864421,0.0034336735861377,-0.00797828290747411,0.00548171755018569,0.71620750461739
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,41842,-0.00204443644810214,0.00562524654542892,-0.0130699196771428,0.00898104678093854,0.716282446643952
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39858,-0.00192905340796756,0.0053290929744425,-0.0123740756378749,0.00851596882193974,0.717369797055811
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39872,0.00295626316494295,0.00819349140537162,-0.0131029799895854,0.0190155063194713,0.718251028116865
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,39661,-0.00132049470270655,0.00366269054920161,-0.00849936817914169,0.0058583787737286,0.718460797198696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39590,0.00164464563243336,0.00458645332302061,-0.00734480288068704,0.0106340941455538,0.71991045640262
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39675,0.00145020238478936,0.00404432458573304,-0.0064766738032474,0.00937707857282611,0.71991827774185
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39872,-0.00273597053035155,0.00771935183181952,-0.0178659001207178,0.0123939590600147,0.723023221071965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,39590,0.00228552254156356,0.00649456878719039,-0.0104438322813296,0.0150148773644567,0.724910331078617
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,41828,0.00266381038814668,0.00771687004735736,-0.0124612549046737,0.0177888756809671,0.729954685137205
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,41828,-0.00229593390394411,0.00667026874255884,-0.0153696606393594,0.0107777928314712,0.73069826435836
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39590,0.00136674360959594,0.00399242744326531,-0.00645841417920407,0.00919190139839595,0.732106106558651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,39500,0.0023872813303439,0.0071859846105611,-0.0116972485063559,0.0164718111670437,0.739734414237693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39526,-0.00428310660826881,0.0129446477164232,-0.0296546161324583,0.0210884029159207,0.740742549875069
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39858,-0.00171665246396874,0.00519099563112459,-0.0118910039009729,0.00845769897303546,0.740878681373241
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39512,0.00182287870233445,0.005552218928064,-0.009059470396671,0.0127052278013399,0.742679538599712
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39491,-0.00297973993990221,0.00907920465048774,-0.0207749810548582,0.0148155011750538,0.742771339247048
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,41842,0.00121741055289787,0.00373840742858218,-0.00610986800712321,0.00854468911291895,0.744694692934765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,39696,0.000821794750960993,0.00254885557249507,-0.00417396217112934,0.00581755167305132,0.747142767487399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39500,0.00208349792830576,0.00646590786422683,-0.0105896814855788,0.0147566773421903,0.747285993177228
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,41747,-0.00124940575196566,0.00387767935937267,-0.0088496572963361,0.00635084579240478,0.747302896231711
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,41828,0.000964276611303269,0.00299512809570042,-0.00490617445626955,0.00683472767887609,0.747496895019143
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39512,-0.00115478850808315,0.00359645449792786,-0.00820383932402174,0.00589426230785545,0.748147719474747
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,39500,0.00175954556923196,0.00550504470905674,-0.00903034206051925,0.0125494331989832,0.749259344614076
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39597,0.00186960955868665,0.00595431694234289,-0.0098008516483054,0.0135400707656787,0.753532857256577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,42222,-0.00137950563391769,0.00439577209116235,-0.00999521893259589,0.00723620766476052,0.753658336471035
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39500,0.00291372672441724,0.00938668648999783,-0.0154841787959785,0.021311632244813,0.756254690381201
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,39597,-0.0018395004471087,0.00594889676351696,-0.0134993381036019,0.00982033720938455,0.757162265351132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39696,-0.0014271274446169,0.00464876970529899,-0.0105387160670029,0.00768446117776913,0.758856477251629
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39927,0.000884062386225749,0.00290532418519611,-0.00481037301675862,0.00657849778921012,0.760912214652532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39526,-0.00179160941560127,0.00593805669678565,-0.0134302005413011,0.00984698171009861,0.762873965586052
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,39479,0.00118957351210307,0.00396637162960798,-0.00658451488192858,0.00896366190613472,0.764247883036894
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,42187,-0.000971348345947186,0.00324602272542658,-0.00733355288778328,0.0053908561958889,0.764759508928041
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,39500,-0.00239513961172249,0.00804070156201572,-0.0181549146732733,0.0133646354498283,0.765802762593071
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39512,-0.00151806188388702,0.00510538727787043,-0.0115246209485131,0.00848849718073902,0.766208714087221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39597,-0.00110048203662792,0.00372716573019258,-0.00840572686780537,0.00620476279454953,0.767801032447943
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39500,-0.00155274480641232,0.00530669537817065,-0.0119538677476268,0.00884837813480216,0.769832656485259
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42048,-0.00179873182529576,0.00619009467925223,-0.0139313173966301,0.0103338537460386,0.771375294878758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39590,0.000975038671448775,0.00345255660624644,-0.00579197227679425,0.0077420496196918,0.777633986536189
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39512,0.00151130899015752,0.00537184138141019,-0.00901750011740645,0.0120401180977215,0.778455662128553
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41919,-0.00102583845986428,0.00369682085445095,-0.00827160733458814,0.00621993041485957,0.781406603198297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,39597,-0.00223903802820322,0.00814969860020582,-0.0182124472846066,0.0137343712282002,0.783522117021247
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41842,-0.000924779832594237,0.0033915533561979,-0.00757222441074212,0.00572266474555365,0.785110020766923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39597,-0.00213714768285859,0.00787133271065229,-0.0175649597957371,0.0132906644300199,0.786003697118992
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42053,-0.000658852219895381,0.0024389249554474,-0.00543914513257229,0.00412144069278153,0.787056368154092
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39512,0.00119639613865294,0.0044415688037743,-0.00750907871674468,0.00990187099405056,0.78765513001995
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39597,0.00133562696893436,0.00496771393665457,-0.00840109234690859,0.0110723462847773,0.788041316559289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41995,0.00164834433392257,0.00621032361659911,-0.0105238899546117,0.0138205786224568,0.790689985478639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,41842,-0.000927433088821822,0.00350618442697606,-0.0077995545656949,0.00594468838805126,0.791388385967306
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,39858,-0.00113524239360041,0.00429938537176593,-0.00956203772226163,0.00729155293506082,0.79174807265127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,39512,-0.00115379664479347,0.00438805616693684,-0.00975438673198969,0.00744679344240274,0.792601586276971
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42236,0.000980503744479915,0.0038133324148267,-0.00649362778858042,0.00845463527754025,0.797086027481701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41766,-0.00156391805049418,0.00611763020963323,-0.0135544732613753,0.0104266371603869,0.798231930723232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,41771,0.0015236975817104,0.00597381748310365,-0.0101849846851727,0.0132323798485935,0.798678711278213
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41766,0.0016833490124579,0.0066500119219052,-0.0113506743544763,0.0147173723793921,0.800168049445794
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41828,0.00209850915355672,0.00833176155988684,-0.0142317435038215,0.0184287618109349,0.801146540559367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39512,-0.00161769961331823,0.00648316991315933,-0.0143247126431105,0.0110893134164741,0.802960995570928
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39597,-0.00154717143044727,0.00628284430995115,-0.0138615462779515,0.010767203417057,0.805490718959393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,42060,0.00516921603034434,0.0210861341245803,-0.0361596068538331,0.0464980389145218,0.80634585347765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42063,0.000839740867348905,0.00351948589683687,-0.00605845149045137,0.00773793322514918,0.811421262391605
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41828,-0.00157334363736622,0.00660572816390764,-0.0145205708386252,0.0113738835638928,0.811746198743767
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39512,0.00178017718337469,0.0075213051302586,-0.0129615808719322,0.0165219352386815,0.812905916689818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39590,-0.00123665996064882,0.00523578491301803,-0.0114987983901642,0.00902547846886652,0.813286688030976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39512,0.00123198867510074,0.00522232520108232,-0.00900376871902061,0.0114677460692221,0.813508431048229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39512,-0.00101851949490727,0.0043387223343786,-0.00952241527028933,0.00748537628047479,0.814406390152796
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41766,-0.00115324415125394,0.00492830015030551,-0.0108127124458527,0.00850622414334486,0.814985164690083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39512,0.00177006381484502,0.00764829582451104,-0.0132205960011966,0.0167607236308867,0.816983199891709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39500,-0.00136229173094775,0.00592502564138371,-0.0129753419880598,0.0102507585261643,0.818156959339865
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,39696,0.00130177372868762,0.00569546829369195,-0.00986134412694861,0.0124648915843238,0.819212741180166
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,41973,-0.00145039616295185,0.00637736096295951,-0.0139500236503525,0.0110492313244488,0.820093729855333
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41990,-0.000738357241060192,0.00325589036149195,-0.00711990234958441,0.00564318786746403,0.820601520310182
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39597,0.00146128245799904,0.00647487217899793,-0.0112294670128369,0.014152031928835,0.821450507542415
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41675,-0.000962441843265797,0.00429726531804971,-0.00938508186664323,0.00746019818011164,0.822787164591659
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,42063,0.000809096441028895,0.00374206996672473,-0.00652536069375158,0.00814355357580937,0.82882244123259
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39869,0.00395074674243427,0.0182847395092685,-0.031887342695732,0.0397888361806006,0.828938668665024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39869,0.00127285745788334,0.00598428774232655,-0.0104563465170767,0.0130020614328434,0.831564885034005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,39590,-0.00091659032181116,0.00446107390913846,-0.00966029518372255,0.00782711454010023,0.837213386673414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,39500,-0.000903196660163905,0.00440755502940789,-0.00954200451780336,0.00773561119747555,0.837638369637178
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,39597,0.000822525465645999,0.00404160734679842,-0.00709902493407891,0.0087440758653709,0.838736724008496
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41900,-0.000541784288391157,0.00270310568999486,-0.00583987144078108,0.00475630286399877,0.841147127679372
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41842,0.00117569113530809,0.00591144634697616,-0.0104107437047652,0.0127621259753814,0.842356666051227
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42063,-0.00254249927638962,0.0130164431450077,-0.0280547278406048,0.0229697292878255,0.845137714590984
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39901,0.000539882291427144,0.0028129301435168,-0.00497346078986578,0.00605322537272007,0.847801430321896
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,39500,-0.00109121542701271,0.00573161789272537,-0.0123251864967544,0.010142755642729,0.849010811274492
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,39526,0.00156948554933078,0.0082537327864599,-0.0146078307121306,0.0177468018107922,0.849191490710953
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39512,-0.000987042652551122,0.00533248059694819,-0.0114387046225696,0.00946461931746732,0.853153969013095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41842,0.000700145684751334,0.00380260181989535,-0.00675295388224356,0.00815324525174622,0.853919941758671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,39339,-0.00140231558084057,0.00774215903577658,-0.0165769472909627,0.0137723161292815,0.856271154054968
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,42125,-0.00074291464746445,0.00411996385689613,-0.00881804380698087,0.00733221451205198,0.856903530079938
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39904,-0.000521954315501316,0.00296878947392573,-0.00634078168439576,0.00529687305339312,0.860443335451592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,39597,-0.000817827541116392,0.00469249998529753,-0.0100151275122996,0.00837947243006677,0.861645502286285
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39526,0.000766725075460545,0.00444111345187938,-0.00793785729022304,0.00947130744114413,0.862935615134368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,39858,-0.00050083071494785,0.00291724355397495,-0.00621862808073875,0.00521696665084305,0.863692642635533
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39512,-0.000928107191511177,0.00549026382832324,-0.0116890242950247,0.00983280991200237,0.865763585087807
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39526,0.00103021659193172,0.00616332122221412,-0.011049893003608,0.0131103261874714,0.867252890758041
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39526,0.000997591609323291,0.0060723426589537,-0.010904200002226,0.0128993832208725,0.869510243821215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,39590,0.00104479730532183,0.00637821436728387,-0.0114565028545546,0.0135460974651982,0.869885951854714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39696,-0.000548494114738293,0.00335278191613325,-0.00711994667035946,0.00602295844088288,0.870053956806905
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,39868,-0.000480326565796653,0.00294492628146569,-0.0062523820774694,0.0052917289458761,0.870440194660629
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,39500,0.00163253792670644,0.0101647720412915,-0.018290415274225,0.0215554911276379,0.87240557787943
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,39500,0.000742606197825862,0.0047201045462751,-0.00850879871287333,0.00999401110852505,0.874989002866867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,41828,-0.000558610304661382,0.00356591231478535,-0.00754779844164067,0.0064305778323179,0.875520844019586
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39895,0.000834957610807296,0.00534497664109268,-0.00964119660573435,0.0113111118273489,0.875867512594408
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39858,-0.00091666573062118,0.00587866115265252,-0.0124388415898201,0.0106055101285778,0.876090176183054
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39689,-0.00170459588555602,0.0110624414698846,-0.0233869811665298,0.0199777893954178,0.877542697494497
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39500,-0.000445055326294567,0.0029320390896507,-0.00619185194200995,0.00530174128942081,0.879355079408641
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,42142,-0.000494086368939747,0.00325621934798984,-0.00687627629099982,0.00588810355312033,0.879397260051818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,41771,0.00129781523416235,0.00861603669601477,-0.0155896166900266,0.0181852471583513,0.880271583720608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39526,0.00113215516828831,0.007815786620659,-0.0141867866082033,0.0164510969447799,0.884828089111816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39858,-0.000560585300992411,0.00391836356108319,-0.00824057788071547,0.00711940727873065,0.886240476088783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41766,0.000557602444214562,0.00426401431348768,-0.00779986561022129,0.00891507049865041,0.895959755941547
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,41842,0.000449760603806787,0.00346410759328954,-0.00633989027904071,0.00723941148665428,0.896699355685727
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,39664,0.000297740428059729,0.00230937968197674,-0.00422864374861468,0.00482412460473414,0.897418086557303
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39526,-0.00130388655164993,0.010128440094932,-0.0211556291377167,0.0185478560344169,0.897569567424258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,39597,0.00055004867671142,0.00429575108857115,-0.00786962345688803,0.00896972081031087,0.898115844727247
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,41842,0.00128559239274869,0.0103247036928383,-0.0189508268452143,0.0215220116307117,0.900908501051442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,39696,0.000367316884706393,0.00303588279681186,-0.00558301339704485,0.00631764716645763,0.903699731201111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39512,0.000514775683081751,0.00431747190236031,-0.00794746924554446,0.00897702061170796,0.905094690715475
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39696,-0.000883442656818443,0.00760431872177584,-0.0157879073514991,0.0140210220378622,0.907514813049356
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,42187,0.00056261334479317,0.00505870777889905,-0.00935245390184898,0.0104776805914353,0.911446064188098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41766,0.000390264757118144,0.00358407811890846,-0.00663452835594243,0.00741505787017872,0.913292616928838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,41842,-0.00047054769715111,0.00432899633933229,-0.00895538052224241,0.00801428512794018,0.913444691496769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,42126,-0.000473414641757118,0.00439003570224773,-0.00907788461816268,0.00813105533464844,0.914125442192823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41766,-0.000778876100667338,0.00724001970629902,-0.0149693147250134,0.0134115625236787,0.91433107367817
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,39597,0.000391917385431526,0.00365109668086086,-0.00676423210905577,0.00754806687991882,0.914519327277016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,39526,-0.0010765125393322,0.0100525084005944,-0.0207794290044972,0.0186264039258328,0.914720381924316
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,39597,-0.000670364402406174,0.00628983651933218,-0.0129984439802972,0.0116577151754849,0.915124933909569
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,39526,-0.000862259562364001,0.00813587868825606,-0.0168085817913459,0.0150840626666179,0.915598299675861
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,39597,-0.000546099777104579,0.00519458715915299,-0.0107274906090444,0.00963529105483528,0.916275667347015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41766,-0.000566671548137228,0.0053919282470065,-0.01113485091227,0.0100015078159955,0.916301019800272
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41771,-0.000528554572911034,0.00529664602274256,-0.0109099807774864,0.00985287163166438,0.920512226318732
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39590,-0.000836008891295965,0.00850125429986314,-0.0174984673190277,0.0158264495364358,0.921664526372972
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,39597,0.000272704008867002,0.00288326771468325,-0.00537850071191216,0.00592390872964617,0.924648906425404
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42050,0.000405270626039974,0.00436748264913279,-0.0081549953662603,0.00896553661834025,0.926069610973278
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42088,-0.00063683345050323,0.00721698213554087,-0.0147821184361633,0.0135084515351569,0.929686470868274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,39872,-0.00149278884170091,0.017199820129329,-0.0352044362951858,0.032218858611784,0.930839217719127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,42108,0.000359964139151848,0.00422276997780679,-0.00791666501734945,0.00863659329565315,0.932068987664579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42048,-0.00056371392657708,0.00672599989411821,-0.0137466737190488,0.0126192458658946,0.933207813664003
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39590,-0.000301712584256838,0.0037462572700754,-0.00764437683360461,0.00704095166509094,0.935811580792757
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,39798,-0.000253012251730464,0.0033671435521433,-0.00685261361393134,0.00634658911047041,0.940103463011113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42063,-0.000286185129667534,0.00391925209740642,-0.00796791924058411,0.00739554898124904,0.941791014665807
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39904,0.000194229724402156,0.0028653904036452,-0.00542193546674244,0.00581039491554675,0.945958195703453
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41629,0.000619819534945634,0.00925958234518628,-0.0175289618616195,0.0187686009315107,0.946631949739712
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39500,0.000242497566261699,0.00367602381785703,-0.00696250911673809,0.00744750424926149,0.947405025986529
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39590,-0.000401785724724709,0.00619543599162847,-0.0125448402683165,0.0117412688188671,0.948293106775519
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,41842,0.000334941446872205,0.00520307325178583,-0.00986308212662801,0.0105329650203724,0.948673585964821
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41771,-0.000402106788817737,0.00625731615437787,-0.0126664464513984,0.0118622328737629,0.948762695391062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39696,0.000552286952073055,0.00880683827028299,-0.0167091160576816,0.0178136899618277,0.949997648338428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41828,0.000216324070861536,0.00345703782781057,-0.00655947007164718,0.00699211821337025,0.950105899337133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39696,0.000305818719231388,0.0048962946924713,-0.00929091887801236,0.00990255631647513,0.950198265796444
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,41771,-0.000610933286704478,0.00978201824059916,-0.0197836890382788,0.0185618224648699,0.950201661177349
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39675,0.00034756065831658,0.00576800156030523,-0.0109577223998817,0.0116528437165148,0.951952286098795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,41809,-0.000349894276242334,0.0062341426199413,-0.0125688138113273,0.0118690252588426,0.955242690960442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,39526,-0.000327389468528789,0.00644264104284092,-0.012954965912497,0.0123001869754394,0.959473042732555
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39526,-0.00028378961885273,0.0059181453017388,-0.0118833544102608,0.0113157751725553,0.961755007796464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,39868,-0.000490241441041325,0.0104332120661251,-0.0209393370906465,0.0199588542085638,0.962523190971167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41771,-0.000603073812490659,0.0135979238228049,-0.0272550045051882,0.0260488568802069,0.964625743624143
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39872,0.000161767761322232,0.00374510605994236,-0.00717864011616479,0.00750217563880926,0.965547301776312
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,39597,-0.000129492065976524,0.00312330469173935,-0.00625116926178566,0.00599218512983261,0.966929970863122
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,42236,7.8156526009959e-05,0.00189477100939523,-0.00363559465240469,0.0037919077044246,0.967098366103382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39597,0.000176630705462088,0.00469604990209243,-0.00902762710263908,0.00938088851356325,0.969997234399051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39575,0.000329729332920257,0.00967535625954425,-0.0186339689357865,0.019293427601627,0.972814537786522
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39526,-0.000127404855070146,0.0038094255291664,-0.0075938788922363,0.007339069182096,0.973320625071662
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39500,-0.00014025188038357,0.00439632943334467,-0.00875705756973912,0.00847655380897198,0.974550755350555
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,39500,0.000109279910593307,0.0040241965159566,-0.00777814526068163,0.00799670508186824,0.978336038685543
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41766,-0.000121872351579579,0.00458413290577716,-0.00910677284690282,0.00886302814374366,0.978790587227051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42047,-0.000150871201822853,0.00646345833804934,-0.0128192495443996,0.0125175071407539,0.981377673196865
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39597,0.000154597641793974,0.00726945470850781,-0.0140935335868813,0.0144027288704693,0.983033257072183
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39868,7.71695289103478e-05,0.00415576974936443,-0.00806813917984394,0.00822247823766464,0.985185062038
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39576,-7.54936782676547e-05,0.00429670955167379,-0.00849704439954828,0.00834605704301297,0.985982117622276
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,39597,8.45221741128363e-05,0.00499101053435006,-0.00969785847321327,0.00986690282143895,0.986488872213413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41771,6.26005721107511e-05,0.00569602115067374,-0.0111016008832098,0.0112268020274313,0.991231409598271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39575,8.56269514621656e-05,0.00785523423635443,-0.0153106321517925,0.0154818860547168,0.991302931119915
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42222,-4.77650597988223e-05,0.006529646804767,-0.0128458727971421,0.0127503426775445,0.99416354887804
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,39526,3.53536756825799e-05,0.00527417181503934,-0.0103020230817945,0.0103727304331597,0.994651805762482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39500,1.96741766301917e-05,0.00603839597266691,-0.0118155819297969,0.0118549302830573,0.997400413281977
